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This thesis is concerned with new applications of tandem oxidation processes 
(TOP) involving manganese dioxide. 
Chapter I reviews the background to the in situ manganese dioxide-oxidation 
and TOP, and outlines the objectives of this research. Chapter 2 describes the 
application of TOP methodology to a formal synthesis of a bioactive natural product, 




In Chapter 3, novel TOP methodologies for synthesising heterocycles are 
discussed. 2-Substituted benzoimidazoles and related compounds were synthesised 
directly from alcohols (Eq.l) using an in situ alcohol oxidation-imine formation-
aromatisation sequence PI Quinolines and their reduced derivatives were prepared by 
in situ alcohol oxidation-imine formation intramo]ccularly (Eq. 2). 6-Membered 
rings with two heteroatoms, i.e. quinoxalines and dihydropyrazines were prepared by 
in situ oxidation-imine formation of u-hydroxyketones with I ,2-diamines (Eq. 3). 
This methodology was further elaborated with oxidation and reduction sequences to 
give pyrazines and piperazines, respectivcly[2l.ll I Chapter 4 extended the TOP 
methodology by using ammonia as the nuclcophile for the in situ oxidation-trapping 
giving a direct route from alcohols to nitriles (Eq. 4)[41 
~OH---
~"u NH 2 
R' 
I R-<:o 
00 ..., N 
RYNX) ~ I h-
N 
R-C-N 
R =Aryl, heteroaryl, alkenyl, alkynyl 
R' =Me, Ph 
[1] Wilfred, CD.; Taylor, R. J. K. Syniett2004, 1628. 
[2] Raw, S. A.; Wilfred, C. D.; Taylor, R. J. K. Chem. Commun. 2003, 2286. 
[3] Raw, S. A.; Wilfred, C. D.; Taylor, R. J. K. 01g. Biomol. Chem. 2004,2, 788. 
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Chapter I: Introduction 
Chapter 1: Introduction 
1.1 Manganese Dioxide 
Manganese dioxide has proved to be an efficient oxidant. It has been 
extensively used in the oxidation of cx,~-unsaturated alcohols, phenols, poly hydroxy 
compounds, amines, hydrazines, hydrocarbons and heterocyclic compounds. 1 It was 
used for the first time in the oxidation of vitamin A 1 (I) to give retinal (2) (Scheme 
I. I). 2 
OH- "o 
2 
Scheme 1.1 Reagents and conditions: Mn02, PE, 25 oc, 6 d, 80 %. 
The oxidation of orgamc compounds requires an activated form of 
manganese dioxide. The structure, composition and reactivity of active manganese 
dioxide varies according to its method of preparation. The preparation of active 
manganese dioxide generally involves precipitation of the reagent by mixing warm 
aqueous solutions of magnesium sulfate with potassium permanganate under either 
acid, neutral, or basic conditions3.4 Pyrolysis of manganese salts such as the 
carbonate or oxalate 220 to 280 °C or nitrate at 400 °C is another means of preparing 
active manganese dioxide 4 The precipitated manganese dioxide can be washed with 
dilute aqueous nitric acid to increase its activity 4 ' Activated manganese dioxide is 
now commercially available. 
Manganese dioxide prepared by precipitation methods are mostly either 
amorphous or of low to moderate crystallinity as shown from X-ray diffraction 
studies. 1" The existence of bonded and non-bonded water molecules in the active 
manganese dioxide had been demonstrated by thermogravimetric analysis 
experiments. 1" Fatiadi proposed a locked water-associated structure for the 
amorphous manganese dioxide based on ESR analysis and other experiments 5 This 
structure offers important active sites of low electron density on the surface of the 
solid and potentially labile hydroxyl molecules (Figure 1.1 ). 1" 
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0- -H-0 0-H- -0 1' ' / "Mn Mn~ ,Mn, // 
0- -H-0 0-H- -0 
Figure 1.1 
The oxidising power and the selectivity of active manganese dioxide are 
strongly influenced by the amount of water present. An excess of water decreases the 
oxidising power, since it prevents the adsorption of the substrate to the oxidatively 
active polar site on the surface of the manganese dioxide6 However, the presence of 
a hydrated manganese dioxide species is essential to obtain an active reagent4 ' 
Therefore, the drying conditions must be carefully controlled. 
Solvent choice is an important factor to consider when performing oxidations 
with manganese dioxide. Primary and secondary alcohols are unsuitable solvents as 
they have been shown to compete directly with the substrate for adsorption on the 
oxide surface. 1" The time required for manganese dioxide oxidation varies from few 
minutes to several days depending on the activity of the manganese dioxide and the 
type of substrate used. Higher temperature can accelerate reaction times, however 
this often reduces selectivity5 Since reaction involving manganese dioxide takes 
place on the surface of the dioxide, the oxidant is nom1ally used in excess, in ratio of 
5: I to 50: I by weight. 1" 
The exact mechanism for manganese dioxide oxidation is still unclear. There 
has been evidence involving radical, ionic or complex pathways. Goldman and 
Henbest proposed a radical intermediate as illustrated below and this has been 
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Hall and Story proposed an ionic mechanism for the oxidation, which 
involved formation of a manganate ester (Scheme 1.3 )-' 







However, a concerted mechanism that involves a manganate complex seems 
more sensible for manganese dioxide oxidation (Scheme 1.4 ). 
~OH 
Mn02 
~0 + Mn(OH)2 
Scheme 1.4 
1.2 Sequential Reactions 
The development of sequential reactions arose in an attempt to overcome the 
problem of having to isolate reactive intermediates. Addition of the next reagent 
without isolation of the intermediate makes the sequence more efficient and can 
improve yields and ease work up procedures. In particular, this applies to aldehydes, 
which are generally easily hydrated, polymerised, readily decompose and can be 
volatile or toxic, making their isolation occasionally problematic 9 The first 
sequential method was developed by Ireland and Norbeck who reported that the 
direct addition of nucleophilic reagents to a crude Swern oxidation mixture could 
avoid side reactions of the aldehyde 9 Methyl 2-(triphenylphosphoranylidene )acetate 
was added to the crude Swern oxidation mixture 4 in a one-pot manner to give the 
unsaturated ester 5 in 98 % yield (Scheme 1.5). The intermediate aldehyde 4 could 
not be isolated in good yield as it was prone to hydration and decomposition. 
3 
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3 4 5 
Scheme 1.5 Reagents and conditions: (a) (i) (COCI)2, DMSO, DCM, -60 °C, 15 min; 
(ii) EtJN, -60 to 0 oc; (b) Ph3PCHC02Me, 0 to 20 °C, 10 min, 98 ";(, 
(E:Z =19:1). 
This one-pot methodology was exploited by Rizzacasa l!t a/. in the synthesis 
of (-)-reveromycin B (8), an epidermal growth factor inhibitor. 10 Oxidation of the 
spiroketal alcohol 6 to the corresponding aldehyde followed by Wittig homologation 
with 2-(triphenylphosphoranylidene)propanal gave the corresponding dienal (7) in 66 




Ho,c 'T - ;---..0./ 






Scheme 1.6 Reagents and conditions: (a) Dess-Martin reagent, DCM, 2 h, rt; 
(b) Ph3PC(Me)CHO, C6H5Cl, 100 oc, 72 h, 66%. 
co,H 
Barrett eta/. used the sequential oxidation followed by Wittig reaction in the 
synthesis ofU-106305 9 (Figure 1.2), which is noted for its anti-fungal property and 
inhibition of the cholcsteryl transfer protein. 11 This compound has five contiguous 
cyclopropane units. The key step is the synthesis of the pcntacyclopropane unit 13. In 
their synthesis, Charette cyclopropanation of the available 2(£)-butene-1 ,4-diol (10) 
gave 11 in excellent yield. Dess-Martin oxidation of the diol proceeded smoothly and 
4 
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the volatile dialdehyde was directly converted without isolation into the diester 12 
(E,E:E,Z = 28: I) by olefination with ethyl 2-(triphenylphosphoranylidene )acetate 




~OH __ a ___ 
HO 
~OH 
H 0 """' · 
10 11 
b Eto,c~ 





Scheme 1.7 Reagents and conditions (a) chiral dioxaborolane, 4 A molecular 
sieves, Zn(CH2!)2.DME, CH2Ch, -40 to 25 "C, 83-91 %; (b) Dess-
Martin periodinane, pyridine, DCM or DMSO, 25 "C, PPh1, ca. I 0 "C; 
Ph3PCHC02Et, 75-81 %. 
1.3 In Situ Oxidation Reactions 
Huang developed the sequential procedure further in the first true in situ 
oxidation reaction by having the Wittig reagent present in the oxidation mixture at 
the start of the reaction. 12 This methodology was used for the synthesis of 1-(4-
methoxybenzoyl)-5-oxo-2-pyrrolidinepropanoic acid ( 16), radio-labelled with 
carbon-14, as a new cognition activating agent required for metabolic and 
pharrnokinetic studies. The original conversion of 14 into 15 required eight steps 
with numerous protection and deprotection steps in an overall yield of 20 %. The 
oxidation of 5-(hydroxymethyl)-2-pyrrolidinone (14) was attempted using a variety 
of conditions, including PDC, PCC, Swem and Dess-Martin periodinane, but the 
desired aldehyde was not produced. However, in the in situ oxidation reaction, 
benzyl 2-(triphenylphosphoranylidene)acetate was mixed with 14 followed by 
addition of Dess-Martin periodinane to give ester 15 (Scheme 1.8). The alcohol was 
5 
Chapter 1: Introduction 
oxidized in situ to the aldehyde, which immediately underwent a Wittig reaction with 




14 o~co,H do 
MeO ~ 16 
15 
Scheme 1.8 Reagent and conditions: (a) Ph3PCH*C02Bn, Dess-Martin periodinane, 
DCM, 0 oc to rt, o/n, 78 %. 
Barrett's group also utilised the in situ oxidation-Wittig reaction in the 
synthesis of diethyl octa-2(£),6(£)-dien-4-yne-1 ,8-dioate (18). Addition of Dess-
Martin period inane to a mixture of 2-butyne-1 ,4-diol (17), ethyl 2-
(triphenylphosphoranylidene)acetate, and benzoic acid, an additive to accelerate the 
reaction and to enhance the E, Z selectivity of the Wittig reaction, efficiently 
provided the adduct 18 as a mixture of E, E and Z, Z- isomers (Scheme 1.9). 13 It was 
clear that the in situ oxidation and Wittig homologation of 17 was very convenient 





Scheme 1.9 Reagents and conditions: Ph3PCHC02Et, PhC02H, Dess- Martin 
periodinane, DMSO, CH,Ch, 89 %. 
Matsuda eta/. described the use of barium permanganate as an in situ oxidant 
with a stabilized phosphorus ylide to convert a,~-unsaturated alcohols 19 into the 
corresponding carbon-elongated diene product 20 in 85 % yield (Scheme 1.1 0). 14 
Compound 20 is a carbocyclic nucleoside, which showed significant anti-viral 
activities. 
6 
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19 20 
Scheme 1.10 Reagents and conditions: BaMn04, Ph3PCHC02Et, DCM, rt, 24 h, 
85 °/>. 
o-Iodoxybenzoic acid (IBX) has also been used as an in situ oxidant for the 
5'-0H in deoxynucleosides 15 This method successfully produced the desired 









Scheme 1.11 IBX, Ph3PCHCOPh, DMSO, 21 h, rt, 63 %. 
0 
Chang et a/. found that [ l{p-cymene )RuChh with Cs2C03 as an additive 
could perform an in situ oxidation-Wittig reaction of benzyl alcohol 23 under air to 
produce a,~-unsaturated ester 24 in good yield (Scheme 1.12). "' 
7 
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Scheme 1.12 Reagents and conditions: [r(p-cymene)RuCh]z, air, Ph3PCHCOzEt, 
toluene, 24 h, 55 oc, 72 'Yo (E:Z = 21: I). 
The homologation sequence was applied to several synthetically useful 
compounds (Figure 1.3). 
0 
OEt OEt 





27 (83%) 28 (28%) 
Figure 1.3 
1.4 In Situ Oxidations using Manganese Dioxide 
In 1998, Wei and Taylor designed an in situ transformation based on 
manganese dioxide-mediated oxidation of primary alcohols, where the aldehydes 
formed were trapped in situ with a range of Wittig reagents17 The manganese 
dioxide is compatible with the phosphoranc and is also easy to use and can be 
removed by simple filtration at the end of the reaction. 
This section on in situ oxidations using manganese dioxide is divided into two; 
( 1) in situ oxidation-Wittig reactions using manganese dioxide, which involves 
stabilised and non-stabilised phosporanes, and (2) in situ oxidations using 
manganese dioxide with other trapping agents. 
8 
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1.4.Iln Situ Oxidations-Wittig Reactions using Manganese Dioxide 
For the synthesis of alisamycin, which has antibiotic activity, the precursor 
bromodienamide 29 (Figure 1.4) was required. Wei and Taylor devised the in situ 
oxidation-Wittig methodology to synthesis bromodienoate 31 from 3-bromopropen-
1-ol (30) (Scheme 1.13). 17 The method greatly improved the yield to 81% compared 









Scheme 1.13 Reagents and conditions: Mn02, Ph3PCI1C02Et, DCM, rt, 2 d, 
81 %(£,£:£,Z:Z,£:Z,Z= 18:6:3:1). 
They also illustrated that the in situ oxidation transformation is applicable to 
a wide range of activated alcohols, including vinylic, Z-alkenyl, alkynyl and benzylic 
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Scheme 1.14 Reagents and conditions: (a) Mn02, Ph3PCHC02Me, DCM, 40 °C, 
16 h, 51% (E:Z = 8:1); (b) Mn02, Ph3PCHC02Me, DCM, rt, 2 d, 
81% (E,Z:Z,Z = 9:1); (c) Mn02, Ph1PCHCOzMe, DCM, rt, 2.5 d, 
82% (E:Z = 4:1); (d) Mn02, Ph3PC(CH3)C02Et, DCM, rt, 15 h, 84% 
(> 98% £). 
The in situ methodology was also employed for a natural product synthesis, 
9-(2-thienyl)-nona-4£, 6£-dien-8-yn-3-ol (42) isolated from the roots of Anthemis 
saguramica Sosn. (Scheme 1.15)." The in situ oxidation-Wittig reaction gave ketone 
40, which was then reduced by sodium borohydridc to give bromodienol 41. The 
dienol underwent Sonogashira coupling with 2-ethynylthiophene to give compound 
42. 
10 




b Br~ c 
41 42 OH 
Scheme 1.15 Reagents and conditions: (a) Mn02, Ph3PCHCOEt, DCM, rt, 56% 
(E,E); (b) NaBH4, MeOH, 0 "C, 1 h, 91 %(E. E); (c) (i) 4 % Pd(PPhJ)4, 
pyrrolidine, rt, 45 min; (ii) 16% Cui, 2-ethynylthiophene, 
24 h, rt, 88 % (E,£} 
In addition to the above, Taylor's group also reported that the in situ 
manganese dioxide oxidation-Wittig methodology could be extended to 
semiactivated and unactivated alcohols although higher temperatures were required 
(Scheme l.l6)19 
~OH a ~C02Me 43 44 
CH 20H 
C02Et b / 






Ph~OH d ~co,Et Ph 
49 50 
Scheme 1.16 Reagents and conditions: (a) Mn02, Ph3PCHC02Me, toluene, reflux, 
4 h, 80 % (> 99 % E); (b) Mn02, Ph3PCHC02Et, toluene, reflux, 20 h, 
74 % (E:Z = 3:1); (c) Mn02, Ph3PCHC02Me, toluene, reflux, 24 h, 
80% (> 98% E); (d) Mn02, Ph3PCHC02Et, toluene, reflux, 6 h, 98% 
(E). 
11 
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When using 1-decanol ( 47) and 1-phenylpropan-3-ol ( 49), the desired enoates 
48 and 50 gave surprisingly high yields when compared to the yields for the 
oxidation step alone. It was thought that the presence of the phosphorane could be 
pushing the equilibrium forward by trapping the aldehyde intermediate. 
Runcie and Taylor further elaborated the scope of the in situ oxidation-
Wittig reaction by treating a-hydroxyketones with manganese dioxide. The 
intermediate a-ketoaldehydes were trapped with phosphoranes giving unsaturated 
ketoesters20 Among the a-hydroxyketones tried, a-hydroxyacetophenone (51), 1-
hydroxy-2-heptanone (53) and 1-(2-furyl)-2-hydroxy-1-ethanone (55) gave good 
yields (Scheme 1.17). 

















Scheme 1.17 Reagents and conditions: (a) Mn02, Ph3PC(Me)C02Me, DCM, reflux, 
I h, 78% (£-only); (b) Mn02, Ph3PCHC02'Bu, DCM, rt, 15 h, 71% 
(£-only); (c) Mn02, Ph3PCHC02Me, DCM, reflux, I h, 67% 
(E:Z = 94:6). 
N-Methoxy-N-methyl-2-(triphenylphosphoranylidine)acetamide was used as 
the trapping agent in the in situ oxidation-Wittig reaction to generate the unsaturated 
Weinreb amide (58). Elaboration of the resulting amide was used as a new route to 
analogue of 5-oxo-eicosatetraenoic acid 59, which is an important mediator of 
inflammatory and allergic reactions (Scheme I 18)21 
12 








Scheme 1.18 Reagents and conditions: (a) Mn02, Ph3PCHCON(OMe)Me, DCM, 
rt, 72 h, 69% (E,Z,Z,Z:Z,Z,Z,Z = 6.4:1 ); (b) "BuLi, THF, -78 oc, 64%. 
Non-activated phosphonium salts, e.g. dibromomethylphosphonium bromide 
was employed efficiently in the in situ oxidation-Wittig reaction for the conversion 
of 4-nitrobenzyl alcohol (60) into the 1,1-dibromoalkene (61) 22 The isolated 1,1-
dibromoalkene was employed further to produce bromoalkyne 62 in the presence of 
1-methyl-1 ,5, 7-triazabicyclo[ 4.4.0]dec-5-ene (MTBD). A direct conversion to 4,5-
dihydro-JH-imidazole (63) was also developed by reacting the dibromoalkene with 







__:___ ~Br 62 H 
~ Br '----- ~N 
o,N 61 c----...._ ~ iL) 
o,N 
63 
Scheme 1.19 Reagents and conditions: (a) Mn02, Ph1P"'CHBr2Br6 , 4 A molecular 
sieves, MTBD, THF, reflux, 17 h, 86 %; (b) MTBD, DCM, rt, 10 min, 
85 %; (c) ethylene diamine, 81 %. 
The in situ oxidation-Wittig reaction, followed by subsequent hydrolysis, had 
also been applied successfully for the conversion of a range of alcohols 64 into a,~­
unsaturatcd aldehydes 66 (Scheme 1.20).23 
13 
a 
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R~) b 
65 
R =Aryl, heteroaryl, alkenyl (including Ph3Sn~OH ), 
alkynyl 
Scheme 1.20 Reagents and conditions: (a) Mn02, dioxolanylethylidenephosphonium 
bromide, MTBD, 4 A molecular sieves, rt; (b) aq. HCl, 33-85 %. 
The in situ manganese dioxide methodology has been employed by other 
groups as well. McKervey et a/. successfully converted N-protected-y-amino 
alcohols 67 into amino-a,~-unsaturated esters 68 with retention of stereochemistry 





: . II 
R~R' 
68 
R =Ph, CH 3 , R' = CH3 , OCH3 
Z = benzyloxycarbonyl 
Scheme 1.21 Reagents and conditions: Mn02, Ph3PCHC02R', CH3CN, reflux, 
16 h, 63 - 89 %. 
Nicolaou et a/. have applied this methodology to the synthesis of ester 70, an 
intermediate in the synthesis of apoptolidin precursor 71 (used for cell death 
mechanistic studies) (Scheme 1.22)25 
Me 





69 70 71 
Scheme 1.22 Reagents and conditions: (a) Mn02, Ph1PC(CHJ)C02Et, DCM, 
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Tavlinova et al. prepared chloro-analogues of polyenes 75 involving a two-
step sequence based on the repetition of the in situ oxidation-Wittig reaction 










73a : R' = H, R = Me 
73b: R' = Me, R = Et 
R' R" 
_c----;~ CI~COOR 
75a : R' = R" = H, R = Me 
75b: R' =Me R" = H, R =Me 
Scheme 1.23 Reagents and conditions: (a) Mn02, Ph3PC(R')C02R, DCM, 20 °C, 
73a = 63 %, 73b = 81 %; (b) DJBAL-11, EbO, -70 °C, 30 min; 
(c) Mn02, Ph3PC(R")C02R, DCM, 20 °C, 75a = 65 %, 75b =59%. 
1.4.2 In Situ Oxidations using Manganese Dioxide with Other Trapping 
Ageuts 
Besides utilising the in situ manganese dioxide oxidation-Wittig reactions to 
produce unsaturated esters from alcohols, other trapping reagents were also explored 
by the Taylor group to generate important functional groups from alcohols. In an in 
situ fashion, alcohols were oxidised with manganese dioxide and the resulting 
aldehydes converted into imines. Benzyl alcohol, substituted benzyl alcohols, allylic 
and propargylic alcohols successfully underwent in situ oxidation-imine formation 



























Scheme 1.24 Reagents and conditions: (a) Mn02, PhCH2NH2, DCM, reflux, 95 %; 
(b) Mn02, 'BuNH2, DCM, reflux, 91 %; (c) Mn02, 'BuNH2, DCM, 
24 h, reflux,> 95 %; (d) Mn02, 'BuNH2, DCM, 24 h, reflux, 88% 
(E:Z = 7:2); (e) Mn02, 'BuNH2, DCM, 24 h, reflux,> 95 %. 
The in situ oxidation-imine formation could be further extended with a 
tandem reduction process to give amines. This tandem process uses a combination of 
manganese dioxide and polymer-supported cyanoborohydride (PSCBH) with acetic 
acid27 or sodium borohydride with methano12g to convert alcohols directly into 
amincs. Some examples are shown below (Scheme 1.25). 
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Scheme 1.25 Reagents and conditions: (a) (i) Mn02, 'BuNH2, PSCBH, DCM, 
reflux, (ii) AcOH, reflux, 74 %; (b) (i) Mn02, ('Bu)2NH, PSCBH, 
DCM, reflux, (ii) AcOH, reflux, 80 %:(c) (i) Mn02, 'PrNH2, 
NaBH4, DCM, reflux, (ii) MeOH, 0 "C tort, 93 %; (d) (i) Mn02, 
'PrNHz, NaBH4 , DCM, reflux, (ii) MeOH, 0 "C tort, 93 %. 
Tandem oxidation processes using sodium cyanide in THF -methanol or 
methanol alone in the presence of activated alcohol 90 and manganese dioxide were 
used to directly produce esters 91. Similarly, use of sodium cyanide in THF 
containing isobutylamine were used to convert alcohols into the corresponding 
ami des 92 (Scheme 1.23 )29 
b 
90 
R =Aryl, heteroaryl, alkenyl, alkynyl 
Scheme 1.26 Reagents and conditions: (a) Mn02, NaCN, THF-MeOH; 41 - 70 %; 
(b) MnO,, NaCN, 'BuNH2, THF, rt, 45 81 %. 
Kanno and Taylor reported that hydroxylamine and 0-alkylamines can also 
be employed as trapping agents in the in situ oxidation-Wittig reaction. They 
synthesised citaldoxime (94) and its analogue, 0-methylcitaldoxime (95), which are 
17 
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anti-fungal natural products, usmg this methodology by mounting the respective 




Scheme 1.27 Reagents and conditions: (a) Mn02, Amberlyst" 15-NH20H, Et20, rt, 
® 26 h, 43 %; (b) Mn02, Amberlyst 15-NH20Me, THF, reflux, 24 h, 49 
% (E:Z = 11: I). 
1.5 Research Aims 
The in situ oxidation-manganese dioxide methodology has been shown to be 
a versatile synthetic tool. The simplicity of the procedure has the advantage of 
avoiding toxic barium permanganate, hazardous preparation of the Dess-Martin 
oxidant and expensive ruthenium catalysts. The initial aim of the research was to 
apply the in situ oxidation-Wittig reaction methodology to natural product synthesis. 
The target molecule was podoscyphic acid (96) (Figure 1.5), which has an unusual 





The second aim was to investigate the use of the in situ oxidation-
transformation reactions for the synthesis of heterocycles (Chapter 3). The first group 
of heterocycles that we considered were 2-substitutcd benzoirnidazoles and related 
heterocycles, from oxidation of alcohols and in situ transformation with substituted 
diamines and related nucleophiles. Next, quinolines and related heterocycles were 
studied. The scope of the in situ oxidation was extended to a-hydroxyketones, which 
18 
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gave highly reactive a,~-dicarbonyls which could be trapped in situ with I ,2-
diamines to give quinoxalines, pyrazines and related heterocycles. 
Finally, ammonia was also investigated as the trapping agent in the in situ 
oxidation reactions of alcohols to give a direct route to nitriles (Chapter 4). 
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Chapter 2: Formal Synthesis of Podoscvphic Acid 
2.1 The Wittig Reaction 
The Wittig reaction is one of the most powerful methods for the 
regiocontrolled and stereocontrolled formation of double bonds. The Wittig reaction 
involves the reaction of a phosphonium ylide with an aldehyde or a ketone to 
constmct the double bond (Scheme 2.1 )3 1 The phosphonium ylide (phosphorane) 
may be commercially available, or can be prepared by treatment of a phosphonium 






R' X >=< + (R")3P=O 
R y 
Scheme 2.1 General Wittig reaction. 
High selectivity for Z- or E-alkenes is possible, depending on the reaction 
conditions, in particular on the type of ylide and carbonyl compound used. E-
Alkcnes usually predominate with stabilised ylides, i.e. those with strongly 
conjugating substituents such as carboxylic esters or nitriles. Z-Alkenes are generally 
the major product when non-stabilised ylides, e.g. with alkyl substituents, are used. 32 
The Wittig reaction rs widely used in organic synthesis because of its 
versatility. Crimmins and co-workers used ethyl 2-
(triphenylphosphoranylidene)propanoate to construct a,~-unsaturated ester 98 from 
the corresponding aldehyde 97 with high E- stereocontrol (Scheme 2.2).JJ 






Scheme 2.2 Reagents and conditions: Ph3PC(Me)C02Et, DCM, reflux, 5 h, 91 % 
(£-isomer). 
Wittig homologation of ketone 99 with triphenyl(propylidene)phosphorane 
proceeded to give alkene 100 in 87 %yield with 60 % conversion into the Z-isomer 
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for elaboration into erythronolide A, which is known for its anti-bacterial properties 
(Scheme 2.3)34 
9SiMe21Bu i?SiMe,'Bu 




Mp: CH 20Bz 
Me 
I 0 C02Me 
Et 100 99 
Scheme 2.3 Reagents and conditions: Ph3PCHCH2CH3, THF, -78 to 25 "C, 87% 
(60% Z-isomer). 
Two Wittig reactions were employed in the synthesis of the spirotetronic acid 
portion of kijanolide, known for its antibiotic properties35 Enoate 102 was obtained 
in an E,Z ratio of ca. 3:7 !rom olefination of dioxolane 101 with ethyl 2-
(triphenylphosphoranylidene)propanoate. The second Wittig reaction furnished the 





I 6 b 
102 X 
t~ 
I yH 20CH20Me 




Scheme 2.4 Reagents and conditions (a) Ph3PC(Me)C02Et, benzene, rt, 96 %, 
(E,Z, ca. 3:7); (b) Ph3PCHMe, THF, -70 to 0 "C, 70% (Z- isomer). 
The Wittig reaction has also been used in industrial synthesis. The reaction 
between phosphonium ylide lOS and enal 106 proceeded smoothly to fonn the 
acetate of Vitamin A 107 (Scheme 2.5)36 
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"\>Phl ~Ac-"" + "" """' "" Ac 0 
105 106 107 
Scheme 2.5 Reagents and conditions: NaOMe, DMF, 40 %. 
Wittig reagents can also be used in the sequential and in situ oxidation-
reactions for the elaboration of alcohols using various oxidants as discussed in 
Chapter One. 
2.2 In Situ Oxidation-Wittig Reaction towards Synthesis of Podoscyphic Acid 
(96) 
The in situ oxidation transformation of alcohols developed by Taylor et a/. 
based on manganese dioxide oxidation, followed by in situ trapping of the resulting 
aldehydes with Wittig reagents, has found many applications in natural product 
synthesis. This methodology is applicable for activated (benzylic, vinylic, alkenyl, 
alkynyl), semi-activated, unactivated alcohols and a-hydroxyketones 
(Scheme 2.6).17, 18, 19,20 
RCH 20H = Activated, semi-activated and unactivated 
alcohols and a-hydroxyketones 
Scheme 2.6 In situ oxidation using Mn02 and Ph3PCHC02R'. 
With the success of the in situ oxidation-Wittig reaction methodology, we 
were keen to apply it to synthesis of podoscyphic acid (96), which was found to be 
an effective and selective inhibitor of reverse trancription with an IC50 value of 15 
!lglm! for avian myeloblastosis virus reverse transcriptase 37 This makes podoscyphic 
acid (96) a potential anti-viral chemotherapeutic ' 8 Podoscyphic acid (96) was 
originally isolated from the mycelium of the basidiomycete Podoscypha petalodes39 
Podoscypha petalodes, or to give it its common name 'wine glass', forms thin paper-
like funnels on short stalks, with ruffled edges (Figure 2.1) 40 
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Figure 2.1 
Podoscyphic acid (96) was found to contain a highly unusual y,8-
dioxoacrylate moiety (Figure 2.2),39 which dictates the path for its synthetic route. 
Figure 2.2 
Sterner et a/. reported the only total synthesis of podoscyphic acid to date 
(Scheme 2.7).41 
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0 0 A _a_.. 














d ~ co,H 
96 0 
Scheme 2.7 Reagents and conditions: (a) LDA, THF, (Et0)2P(O)CH2CH=CHC02Et, 
-78 to 20 "C, 72% (E:Z = 9:1); (b) Os04, K1Fe(CN)6, K2C01, 
quinuclidine, 'BuOH/fhO, 4 d, 51%; (c) TEMPO, DCM, 0 "C, 
100 %; (d) Novozyme 435, isopropyl ether, 2 h, 70 %. 
This route starts from the commercially available dodecanal. The coupling of 
dodecanal with triethyl 4-phosphonocrotonate using the Wadworth-Emmons 
conditions proceeded smoothly to give ethyl (2£,4£)-2,4-hexadecadienoate (108) in 
72 % yield (as a 9: I mixture of the E- and Z- isomers). The diene was thereafter 
subjected to catalytic dihydroxylation with osmium tetroxide (Os04) for four days 
and the racemic 4,5-dihydroxylated compound 109 was obtained in 51 % yield. The 
I ,2-diketone functionality was then introduced by oxidation of 109 with (2,2,6,6)-
tetramethyl-1-piperdinyloxy (TEMPO), giving the ethyl ester of podoscyphic acid 
llO in quantitative yield. The final step, the hydrolysis of the ester, was carried out 
with lipase to give 96. This route took four steps with an overall yield of 25 %. 
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2.3 Attempted Synthesis of Podoscyphic Acid {96) via In Situ Oxidation-Wittig 
Reaction of 1-Hydroxy-2,3-tetradecanedione (111) 
Enzymatic hydrolysis of the ethyl ester of podoscyphic acid 110 would 
provide podoscyphic acid (96). We envisaged synthesising the y,8-dioxoacrylate 
ester 110 from the in situ oxidation-Wittig reaction of 1-hydroxy-2,3-
tetradecanedione (111) with a suitable phosphorane. a-Hydroxylation of 2,3-
tetradecanedione (112) would provide a-hydroxy-l ,2-diketone 111 required for the 















Scheme 2.8 Proposed retrosynthetic analysis to podoscyphic acid (96). 
2.3.1 Synthesis of 2,3-Tetradecanedione (112) 
In order to carry out the retrosynthetic analysis outlined in Scheme 2.8, 2,3-
tetradecanedione (112) had to be prepared. 
2.3.1.1 Unsuccessful Route to 2,3-Tetradecanedione via Organometallic 
Chemistry 
We attempted two different organometallic routes to synthesise the title 
compound as shown in the reaction sequence below (Scheme 2. 9). In the first 
attempt, 2-oxopropanoyl chloride (113), prepared earlier by reacting oxalyl chloride 
with pyruvic acid, was subjected to nucleophilic substitution with a Grignard reagent 
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in the presence ofCuBr/LiBr. Decyl magnesium bromide (C 1oH21MgBr) was initially 
used since it was commercially available. The reaction failed to give the desired 
compound 114. Next, we took Weinreb amide liS, prepared from reaction of N,N'-
dimethoxy-N,N'-dimethyl-oxalamide with methyl magnesium bromide, and 
subjected it to the similar reaction with C 10H21 MgBr. This reaction was also 




Scheme 2.9 Reagents and conditions: (a) CtoH2 tMgBr, CuBr, LiBr, THF, 0 'C; 
(b) Ct 0Hz 1MgBr, THF, 0 'C. 
2.3. 1.2 Synthesis of 2,3-Tetradecanedione (121) via Diol Oxidation 
With failures in the organometallic route, we sought another approach for the 
synthesis of 2,3-tetradecanedione (112). The reaction scheme is shown below 




(b) CH 3 
117 OH 
(c) CH 3 
112 0 
Scheme 2.10 Reagents and conditions: (a) Ph3PCHzCH3Br, MTBD, reflux, THF, 
24 h, 66% (E:Z = I :2.5); (b) Os04, NMO, rt, THF/H20 (1: 1 ), 18 h, 
57%; (c) TFAA, DMSO, Et3N, DCM, -60- 5 'C, 1.5 h, 40%. 
CH 3 
Dodecanal was reacted in a Wittig reaction with ethyl triphenylphosphonium 
bromide and MTBD42 to furnish 2-tetradecene (116) in 66 % yield (as a 1:2.5 
mixture of the£- and Z- isomers). The alkene was initially treated with KMn04 in 
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ethanol to obtain the diol 117, · but this was produced in a poor yield of 10 %. We 
turned to a dihydroxylation protocol, which is known to give cis-dihydroxylation of 
alkenes. With a catalytic amount of Os04 and NMO as co-oxidant,44 we successfully 
synthesised diol 117 in a mixture of diastereomers in 57 % yield. The diol 117 was 
then subjected to various oxidants for transformation into I ,2-diketone 112 (Table 
2.1). 
Table 2.1 Oxidation conditions for transformation of diol 117 into I ,2-diketone 112. 
Entry Reagents and Conditions Yield of 112 
I TEMPO, DCM, 0 "C, 15 min 0 
II Dess-Martin periodinane, DCM, -I 0 "C, I h 0 
Ill TPAP with NMO 0 
IV (i) TFAA, DMSO, DCM, -60 "C for 1.5 h, (ii) E(JN, 
-60 to 5 "C. 40 
The oxidation of diol 117 was initially attempted with TEMPO (entry i), 
which had successfully been used to transform diol 109 to its corresponding I ,2-
diketone 110 in the !iterature 41 This reaction, however, failed to produce the desired 
compound, and instead the starting material was recovered in 53 % yield. Oxidation 
was attempted with Dess-Martin periodinane, a mild oxidising reagent (entry ii) 45 
This reaction also failed to give I ,2-diketone (112). Oxidation carried out with tetra-
N-propylammonium perruthenate (TPAP) and NMO failed as well (entry iii)46 We 
then turned to the Swem oxidation protocol developed by Banwell et a!., which was 
effective for the conversion of vicinal diols into I ,2-dicarbonyls47 This oxidation 
method was reported to be independent to the geometry of the hydroxyl groups of 
dials. The oxidation was carried out treating diol 117 with trifluoroacetic anhydride 
(TFAA) in the presence of dimethyl sulfoxide at -60 "C and subsequently with 
triethylamine. To our delight, the reaction successfully gave 2,3-tetradecanedione 
( 112) in 40 % yield. This is the first reported synthesis of this novel compound, 
which was fully characterised. 
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2.3.2 Synthesis of 1-Hydroxy-2,3-tetradecanedione (111) 
With 2,3-tetradecanedione (112) in hand, we next attempted to prepare the 
novel compound, 1-hydroxy-2,3-tetradecanedione (111) as outlined in the 
retrosynthetic analysis. 
2.3.2.1 Unsuccessful Route to 1-Hydroxy-2,3-tetradecanedione (111) via 
a-Hydroxylation of 2,3-Tetradecanedione {112) 
There is no known literature precedent for the a-hydroxylation of a I ,2-
diketone, and therefore we had to rely on known a-hydroxylation methods of methyl 
ketones. We envisaged preparing 1-hydroxy-2,3-tetradecanedione (111) by 
epoxidation of silyl enol ether (118) with m-CPBA (Scheme 2.11) 4 s The silyl enol 
ether (118) would be prepared by reacting 2,3-tetradecanedione (112) with 











Scheme 2.11 Proposed route for a-hydroxylation: (a) Et1N, TMSCI (b) m-CPBA. 
However, efforts to make the TMS-enol ether 118 failed. We suspect that in 
the initial deprotonation step by Et1N, the availability of ~-hydrogens on either side 
of the 2,3-tetradecanedione (112) could complicate the reaction. We substituted the 
base with lithium diisopropyl amide (LDA) hoping for better selectivity, but the 
desired product was not obtained. Trimcthylsilyl enol ethers are known to be 
unstable, and so we changed the silylating reagent to a bulkier group, tert-
butyldimethysilyl chloride (TBMSCI), hoping to get a more stable silyl enol ether. 
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This also failed to gtve the desired product. After numerous attempts the a-
hydroxylation step via silyl enol ether 118 was abandoned. 
We also attempted the a-hydroxylation of l ,2-diketone 112 using hypervalent 
iodine chemistry, which has been known to successfully a-hydroxylate methyl 
ketones. Employing vanous hypervalent iodine reagents, i.e. 
[bis(trifluoroacetoxy)]iodobenzene (Phi(OCOCF3) 2) in the presence oftrifluoroacetic 
acid (TFA),49 o-iodosylbenzoic acid [C6H5(IO)C02H] in KOH/MeOH50 and 
hydroxy(tosyloxy) iodobenzene (HTIB) in DMSO-water51 in separate reactions, 
however, gave decomposition products and no sign of" Ill. 
Failures to a-hydroxylate 1 ,2-diketones via silyl enol ethers, and with various 
hypervalent iodine reagents under different conditions led us to suspect the 1,2-
dikctone moiety, or the product, was unstable to these a-hydroxylating procedures. 
2.3.2.2 An Indirect Route to 1-Hydroxy-2,3-tetradecanedione (Ill) 
The a-hydroxylation was unsuccessful in introducing the terminal hydroxyl 
group in the presence of 1 ,2-diketone moiety. We decided to introduce the hydroxyl 
group masked with a protecting group before constructing the 1 ,2-diketone moiety. 
The sequence followed is shown in Scheme 2.12. The homologation of dodecanal 
would provide a,~-unsaturated ester 119, which upon reduction would give allylic 
alcohol 120. Protection of the alcohol would be carried out with a silyl chloride to 
provide 121. The alkene moiety on silyl ether 121 would then be subjected to 
oxidation to give 1 ,2-diketone 122. Finally, deprotection of silyl ether would be 
carried out to provide 1-hydroxy-2,3-tetradecanedione (Ill), which would be taken 
through to an in situ oxidation-Wittig reaction. 
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This reaction improved the yield to 60 %. The ee was not investigated as the diol 
was to be oxidised. The transformation to I ,2-diketone 122 was then carried out 
using the oxidation protocol developed by Banwell et a/47 This time this procedure 
failed to provide 1,2-diketone 122, and instead diol123 was recovered in 40% yield. 
Other oxidising reagents such as TEMP0,41 Dess-Martin periodinane, 45 TPAP in 
NM046 were also used in separate reactions to transform diol123 to compound 122. 
All of these reactions failed to provide 1 ,2-diketone 122. The oxidation procedure 










Scheme 2.13 Reagent and conditions: (a) AD-mix ~. CH3S02NH2, 'BuOH/ 
H20 (1:1), rt, 20 h, 60% (ee not determined); (b) TFAA, DMSO, 
Et3N, DCM, -60 to 5 °C. 
There is literature precedent for the preparation of I ,2-diketoncs via the 
oxidation of a-hydroxyketones 54 We therefore tried this out on a model system 
(Scheme 2.14 ). Compound 124 was prepared by treatment of (£)-2-tridecen-1-o1, 
which is available commercially with TBDMSCI. The alkene 124 was transformed 
into a-hydroxyketone 125 with aqueous KMn04.55 The a-hydroxyketone 125 was 
subjected to Dess-Martin periodinane to form 1,2-diketone 126. The reaction 
proceeded smoothly to give compound 126 in 72 % yield. With I ,2-diketone 126 in 
hand, deprotection was attempted to provide the a-hydroxyl-! ,2-diketone 127. 
Various deprotecting reagents for silyl ether 126 were tried, including TBAF and 
TBAF in acid, 56 HCI57 and HF-pyridine58 In all these conditions, we observed silyl 
ether 126 (or the product 127) undergoing decomposition. 
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Scheme 2.14 Reagent and conditions: (a) KMn04, acetone, acetic acid, 65 %; 
(b) Dess-Martin periodinane, -10 oc, DCM, I h, 72 %; (c) deprotection. 
We were unsuccessful in forming the required a-hydroxy-l ,2-diketone via a-
hydroxylation of a 1,2-diketone or via desilylation of a protected hydroxyl group 
adjacent to a I ,2-diketone. We therefore had to abandon this route to podoscyphic 
acid synthesis. 
2.4 Formal Synthesis of Podoscyphic Acid (96) via In Situ Oxidation-Wittig 
Reaction of a Semi-Activated Alcohol 
We decided next to synthesise podoscyphic acid via an in situ oxidation of a 
semi-activated alcohol followed by a Wittig reaction. Taylor eta/. have shown that in 
situ oxidation-Wittig reaction of semi-activated alcohols with manganese dioxide 
using ethyl 2-(triphenylphosphoranylidene)acetate in retluxing toluene are useful 
and, for example, could convert alcohol 45 into the a,~-unsaturated ester 46 
(Scheme 2.15). 19 
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Scheme 2.15 Reagents and conditions: 10 equiv. Mn02, 1.2 equiv. Ph1PCHC02Et, 
toluene, reflux, 20 h, 74 % (E:Z = 3:1). 
The reaction sequence followed for the planned route is shown in Scheme 
2.16. Diol123, prepared using the earlier route, would be protected to give acetonide 
128. Desilylation of compound 128 would then provide alcohol 129 required for the 
in situ oxidation-Wittig reaction for transformation into u,~-unsaturated ester 130. 
The diol functionality would then be returned by deprotection of the acetonide to 
give 109, which would be oxidised to give y,8-dioxoacrylate 110. This is the known 
ethyl ester of podoscyphic acid. 
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130 0 0 OH 
(d)~ 0~ 
109 OH 0 
(e) 0 
0~ 
110 0 0 
Scheme 2.16 Reagents and conditions: (a) 2,2-dimethoxypropane, CSA, acetone, 
rt, 18 h, 83 %; (b) TBAF, THF, rt, 18 h, 97 %; (c) 15 equiv. Mn02, 
1.2 equiv. Ph3PCHC02Et, DCM, reflux, 18 h, 87% (E:Z = 3:1); 
(d) p-TsOH, MeOH, rt, 18 h, 50% (E- only); (e) TEMPO, 0 "C, 
10 min, 62%. 
The protection of diol 123 was carried out smoothly with dimethoxypropane 
and a catalytic amount of 10-camphorsulfonic acid (CSA)50 to give acetonide 128 in 
83 % yield. The deprotection of the silyl ether was initially attempted using TBAF at 
-78 "C. The reaction gave only starting material. Carrying out desilylation at warmer 
temperature (0 "C) gave compound 129 in 45% yield. We decided to run the reaction 
at room temperature, and to our delight desilylation proceeded smoothly under these 
conditions, forming alcohol 129 in 97 % yield. The ease of desilylation with 
compound 128 contrasts to the desilylation of compound 126, which has a silyl ether 
adjacent to a I ,2-diketone. Desilylation of a silyl ether adjacent to semi-activated 
group apparently produced a more stable compound, which lacked the hyper-
reactivity of I ,2-diketone group. 
34 
Chapter 2. Formal Synthesis ofPodoscyphic Acid 
We attempted an in situ oxidation-Wittig reaction on semi-activated alcohol 
129 with ethyl 2-(triphenylphosphoranylidene)acetate under various conditions as 
shown in Table 2.2. 
Table 2-2 In situ oxidaton-Wittig reaction of compound 129.' 
Entry Conditions Yield of 130 
(%) 
I DCM, reflux, 18 h 87 
(£:Z=3:1) 
II CHC1 3, reflux, 18 h 80 
(£:Z=3.3:1) 
Ill Toluene, reflux, 8 h 72 
(E:Z= 3.5:1) 
'ReactiOn earned out wtth 15 equtv. of Mn02 added m three equal 
portions, 1.2 equtv. of Ph1PCHC02Et and 4A molecular stcves. 
Alcohol 129 was treated with 15 equivalents of manganese dioxide (added 
m three equal portions), 1.2 equivalents of ethyl 2-
(triphenylphosphoranylidene)acctate and 4A molecular sieves in DCM under reflux 
condition for 18 hours (entry i). We were delighted to find that the reaction 
proceeded smoothly to give a.,p-unsaturated ester 130 in 87% yield with an E,Z ratio 
of 3:1. The 111 NMR spectrum showed the Z- and E- coupled protons having a 
coupling constant of 11.6 Hz and 15.6 Hz, respectively. When the reaction was 
performed under reflux in CHCh, the yield reduced slightly to 80% with an E,Z ratio 
of 3.3:1 (entry ii). The in situ reaction was also attempted with toluene at reflux 
(entry iii). We observed the yield of 130 reduced fUI1her to 65 % but the E,Z ratio 
improved to 3.8: 1. The reduced yield could be due to a lower degree of stability of 
either ester 130 or the intermediate aldehyde in toluene under reflux conditions. 
Separation of the isomeric mixture at this stage was not possible as the two products 
co-ran by TLC. No attempts were taken to convert the Z-isomer into the £-isomer. 
!laving built the acrylate moiety, we took the reaction further to construct the 1,2-
diketone unit. 
We first carried out the deprotection of the acetonide 130 under vanous 
conditions to provide diol I 09 as shown in Table 2.3. 
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Table 2.3 Deprotection of compound 130. 
Entry Reagents and Conditions Yield of 109 
(%) 
I Amberlyst"l5, MeOH, rt, 18 h 0 
II TFA/CH3CN/H20 (2:2: I), 0 "C tort, I h 0 
Ill 0.2 equiv. p-TsOH, MeOH, rt, 18 h 25 %(£-only) 
IV 0.7 equiv.p-TsOH, MeOH, rt, 18 h 50%(£- only) 
The hydrolysis conditions for the deprotection of acetonide 130 needed to be 
selective to avoid cleavage of the acrylate moiety. At first, we attempted the 
hydrolysis with Amberlyst®15 in the presence of McOH at room temperature (entry 
i). The reaction gave decomposition products only. TFA in aqueous CH3CN had 
been reported to efficiently cleave acetonides 60 When we subjected compound 130 
to the above conditions, decomposition was again observed (entry ii). Compound 130 
was next subjected to a catalytic amount of p-tolucnesulfonic acid (p-TsOH) (0.2 
equivalents) in methanol (entry iii) 61 This gave diol 109 in 25% yield with 45% of 
recovered starting material. To our delight, using 0. 7 equivalents of p-TsOH gave 
diol I 09 in 50 % yield with isomerisation of the alkene to the all £-product. The 
crude product was separated by column chromatography eluting with DCM:MeOH 
(6:0.5). The 1H NMR spectrum showed the £-coupled protons having a coupling 
constant of 15.9 Hz at o 6.94 and 6.13 ppm. 
Diol 109 was oxidised to ethyl (E)-4,5-dioxo-2-hexadecenoate (liO) 
following the literature precedent with TEMPO at 0 "C in 62 % yield 41 The proton 
belonging to the carbon adjacent to y ,o-dioxoacrylate showed a triplet with coupling 
constant of 7.3 Hz at o 2.81 ppm. The olefinic protons at o 7. 70 and 6.94 ppm had 
coupling constants of 15.9 Hz. The 13C NMR spectrum showed three carbonyl peaks 
at 8 200.0, 187.5 and 165.4 and two olefinic peaks at o 135.6 and 132.9 ppm. The 
spectral data for compound II 0 matched the data obtained by Sterner as shown in 
Table 2.4 41 
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Table 2.4 Comparison of literature and experimental values for ethyl (E)-4,5-dioxo-
2-hexadecenoate ethyl (110)' 
p n h 
0 
b a r 
~ 0---../ e 
0 m k g d c q 0 0 
Spectrum Data 
Literature HNMR 7.78 (IH, d, J 16.4 Hz, CH'), 6.92 (IH, d, J 
values (110) 41 I 6.4 Hz, C:Hb), 4.28 (2H, q, J 7.0 Hz, 
r C:H24), 2.81 (2H, t, J 7.5 Hz, C:H2 ), 1.63 
(2H, rn, C:H,'), 1.29 (3H, t, J 7. I Hz, CH3'), 
1.15-1.42 (16H, m, CH/.0 ), 0.87 (3H, t, J 
7.5 Hz, CHl) 
uC NMR I 99.9 (C), I 87.4 (C), 165.3 (C), 135.6 
(CH), 132.9 (C), 62.0 (CH2), 36.4 (CH2), 
31.9 (CH2), 29.7 (CH2), 29.6 (CH2), 29.5 
(CH,), 29.4 (CH2), 29.3 (CH2), 29.1 (CH2), 
22.9 (CH2). 22.7(CH,), 14.3 (CH3), 14.1 
(C:HJ) 
Experimental 'HNMR 770 (IH, d, J 15.9 Hz, CH'), 6.94 (IH, d, J 
Values (11 0) 15.9 Hz, CHb), 4.29 (2H, q, J 7.0 Hz, 
4 r CH, ), 2.81 (2H, t, J 7.3 Hz, C:H2 ), 1.60-
1.62 (2H, rn, CH2'), 1.33 (3H, t, J 7.0 Hz, 
CH3'), 1.25-1.29 (16H, rn, CH,h-o), 0.86 
(3H, t, J 7.0 I lz, CHl) 
"CNMR 200.0 (C), I 87.5 (C), 165.4 (C), 135.6 
(CH), 132.9 (C), 62.1 (CHz), 37.0 (CH2), 
32.4 (C:H,), 30.0 (CHz), 29.9 (CH2), 29.8 
(CH2), 29.8 (CH2), 29.7 (C:Hz), 29.5 (CH2), 
23. I (C:H,), 23.l(C:H,), 14.6 (C:H3), 14.5 
(C:HJ) 
" NMR spectra m CDCI1. 
Finally, following the literature precedent, we attempted hydrolysis of the 
ethyl ester of podoscyphic acid 110 using a lipase enzyme, Novozyrne 435 41 After 
several attempts with this enzyme, the reaction did not produce podoscyphic acid 
(96). At this point we had used all our material and therefore stopped at a formal 
synthesis of the natural product. 
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2.5 Conclusions and Future Work 
The in situ oxidation-Wittig reaction using a semi-activated alcohol as 
precursor had been successfully used to synthesise a highly functionalised y,8-
dioxoacrylate, which was elaborated to give a formal synthesis of podoscyphic acid 
(96). The route could be elaborated, substituting the undecyl group with an alkyl 
chain or carbon chains with a range of functionality. This makes the methodology 
viable for synthesis for a range of podoscyphic acid analogues. 
The in situ oxidation-Wittig experimental procedure could be simplified by 
using polymer-supported phosphoranes. We have successfully synthesised in our lab 
polymer-supported 1-methoxycarbonyltriphenylphosphonium bromide from reaction 
of triphenylphosphorane poylstyrene with methylbromoaceate62 Deprotonation of 
the phosphonium with a strong base63 provided polymer-supported Wittig reagent 
131. Preliminary work has shown that activated benzylic alcohol 87 could be 
transformed into a,~-unsaturated ester 132 in the presence of polymer-supported 
Wittig reagent 131 and manganese dioxide (Scheme 2.17). We hope to expand this 
procedure to semi-activated alcohol 129, where simple filtration could afford 





R = p-methoxybenzyl 
PS = Polymer support 
Scheme 2.17 Reagents and conditions: 15 equiv. Mn02, 5.5 equiv. 131, DCM, rt, 
3 d, 65 %(£-only) 
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Chapter 3: Tandem Oxidation Processes-Heterocycle Formation 
3.0 Heterocycles 
Heterocycles are cyclic structures with one or more atoms other than carbon 
in the ring. They are widely found in nature and have importance in many aspects of 
chemistry, for example, in the pharmaceutical, pesticide, dyestuff and polymer 
industries, as well as intermediates in organic synthesis64 Until now, the success of 
the in situ oxidation manganese dioxide transformations has involved formation of 
aliphatic functional groups. We were interested to extend its application to the 
synthesis of heterocycles. The heterocycles involved in our research are grouped into 
(a) 5-membered rings with two heteroatoms, (b) 6-membered rings with one 
hetcroatom and (c) 6-membered rings with two heteroatoms. 
3.1 5-Membered Rings with Two Heteroatoms 
The heterocycles in this group, that we were interested to synthesise were ( i) 
benzimidazoles and related heterocycles, (ii) 2-substituted-benzoxazoles and 
benzothiazoles, and (iii) 2-substituted-imidazolidines, imidazolines and imidazoles. 
3.1.1 Synthesis of 2-Substituted Benzimidazoles and Related Heterocycles 
Benzimidazoles are aromatic molecules with pyrrole and pyridine-type 
annular nitrogens. 65 Hence, their properties are predicted to mimic pyrrole and 
pyridine. There are many methods available for the synthesis of benzimidazoles. 
Reaction of I ,2-phenylenediamines with carbonyl reagents is the major route for 
preparing 2-substituted benzimidazoles. Early work by Harwood et a!. used glacial 
acetic acid with 1,2-phenylenediamine (133) under reflux, which gave 2-
methylbenzimidazole (134) (Scheme 3. I )66 




Scheme 3.1 Reagents and conditions: Reflux, 30 min. 
~X) H,C~ I 
N h 
134 
Condensation between carboxylic acids 135 and I ,2-phenylenediamines 136 
in the presence of a catalytic amount of polyphosphoric acid (PPA) at I 70-180 °C 
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has also successfully been used to form a range of 2-arylbenzimidazoles 137 
(Scheme 3.2). 67 However, both these reactions required extremely harsh conditions. 





G- NYYR N o--\~~ 
137 
R = CH3, H 
Q = CH 2, (E)-CH=CH2-
R 
Scheme 3.2 Reagents and conditions: (a)(i) PPA, 170- 180 oc; (ii) NH40H to pH 8; 
75-91%. 
An alternative approach to the synthesis of 2-substituted benzimidazoles is to 
use aldehydes, or their derivatives as the condensation partner with I ,2-
phenylenediamine. Kus et a/. reacted the sodium metabisulfite adduct of p-
fluorobenzaldehyde 138 with I ,2-phenylenediamine derivative 139 to provide 2-( 4-













Pibenzimol analogues (143), found to have activity against L 1210 murine 
leukaemia, have two benzimidazole groups linked in a head-to-tail manner. These 
compounds were synthesised by reaction of benzaldehyes 141 and 3,3',4,4'-
tetraaminobiphenyl (142) by refluxing the reactants in nitrobenzene at !50 °C for 8-
12 hours (Scheme 3.4)69 
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P x ~ ~ N 
lH, 




Scheme 3.4 Reagents and conditions: C6H5N02, 150 "C, 8- 12 h, 23-35 %. 
More recently, Chen et al. used an acyl fluoride mounted on polyethylene 
glycol methyl ether (PEG) 144 to react with 1 ,2-phenylenediamine (133) to form 
amide 145. Compound 145 was then refluxed in 1 ,4-dioxane with acetic acid to 
produce the solid- supported benzimidazole 146. The PEG adduct was cleaved with 











PS = Polymer support 
Scheme 3.5 Reagents and conditions: (a) Et3N, DCM, rt; (b) 1,4-dioxane, 50 oc; 
(c) NaOMe, MeOH, 44%. 
Watanabe et a/. reported a direct preparation of 2-substituted benzimidazoles 
149 from alcohols 148 by ruthenium-catalysed reaction of 1,2-phenylenediamine 
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(133) (Scheme 3.6). 71 The ruthenium complex operates as a dual catalyst for both the 





R = Aryl, alkyl and alkenyl 
Scheme 3.6 Reagents and conditions: RuCh(PPh3) 3, toluene, 200 "C, 51 - 80 %. 
3.1.1.1 Importance of2-Substituted Benzimidazoles and Related Heterocycles 
2-Substituted benzimidazoles and their derivatives have been shown to 
exhibit fungicide, anti-tumuor, immuno-suppressant and anti-convulsant properties. 65 
For example, compound 150 has been found to selectively inhibit HIV-1 
replication72 and (E)-1-methyl-2-styrylbenzimidazole analogues (151) have been 
reported to show significant inhibiting activity towards monoamine oxidase B 
(MAO-B), which could enhance anti-Parkinsonian activity. 73 More recently, 2-
substituted benzimidazoles 152 have been employed as ligands in asymmetric 










/, ~ -N  
Cl N ~ /; 
151 
R = CH3 
X= H, Cl, F 
R = Bn, Pr, 'Bu 
Figure 3.1 
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3.1.2 Preparation of2-Snbstituted Benzimidazoles and Related Heterocycles 
via Tandem Oxidation Processes (TOP) 
The in situ manganese dioxide-mediated tandem oxidation processes (TOP) 
developed by the Taylor group have successfully converted primary alcohols into 
. ~ . I . A d 17 18 19 . 27 28 d 1mportant tunctwna groups, z. e. a,f'-unsaturate esters, ' ' ammes ' an 
amides 29 We envisage the preparation of 2-substituted benzimidazoles using TOP. 
Alcohols of the form IS3 would be converted into aldehydes IS4 and trapped by N-
substituted-phenylenediamines to give dihydrobenzimidazoles ISS. In the same pot, 
manganese dioxide could oxidise the dihydrobenzimidazoles 1SS into 
benzimidazoles IS6 (Scheme 3. 7). This transformation would involve an oxidation-










Scheme 3. 7 TOP for benzimidazole formation using Mn02 and N-substituted 
phenylenediamine. 
To determine the optimum conditions for the transformation of alcohols IS3 
to 2-substituted benzimidazoles 1S6, we treated benzyl alcohol (23) as the model 
alcohol with N-methyl-phenylenediamine (IS7) in the presence of manganese 
dioxide under various conditions to give 1-methyl-2-phenyl-benzimidazole (ISS). 
The results of the study are shown in Table 3 .I. 
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Table 3.1 TOP conditions for 1-methyl-2-phenyl-benzimidazole (158) formation.' 
Me 
Me I 
Me tf::O H)O I + I ~ VOH+ o:NH 
-
N o:N;N NH ~ 2 NH 
I 
Me 
23 157 158 159 
Entry N-Methyl-1,2- Conditions Yield of 158 
Phenylenediamine (%) 
(157) 
I I equiv. DCM, reflux, 18 h 10 
11 2 equiv. DCM, reflux, 18 h 35 
lll 2 equiv. Benzene, reflux, 18 h 54 
IV 2 equiv. Toluene, reflux, 18 h 78 
v 2 equiv. Toluene, reflux, 
18 h, KOH (MeO!l) 76 
VI 2 equiv. Toluene, reflux, 
18h,DDQ 72 
Vll 2 equiv. Toluene, reflux, 
18 h, 5 mol% HCl 75 
Vlll 2 equiv. Toluene, reflux, 
18 h, 10 mol% HCl 76 
IX 2 equiv. Toluene, reflux, 
18 h, 15 mol% HCl 80 
X 2.5 equiv. Toluene, reflux, 
18 h, 15 mol% HCl 90 
a 15 equtv. of manganese dwxtde, and 4 A molecular Steves were used. 
Initial studies were attempted by using 1 equivalent of N-methyl-1 ,2-
phenylenediamine (157) with 15 equivalents of manganese dioxide in DCM at reflux 
for 18 hours (entry i). Numerous products were seen on the TLC. The crude products 
were isolated by column chromatography on silica, which produced 1-methyl-2-
phenyl-benzimidazole (158) and N-methyl-2- {2-[2-
(methylamino)phenyl]diazenyl}aniline (159) in 10 °;(, and 52% yields, respectively. 
The latter was formed from oxidation of N-methyl- I ,2-phenylenediamine (157). A 
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similar occurrence was also reported by Bhatnagar eta!. when I ,2-phenylenediamine 
(133) was subjected to manganese dioxide oxidation. 75 
We decided to increase the amount of N-methyl-1 ,2-phenylenediamine (157) 
two fold to provide sufficient nucleophile for trapping of the aldehyde (entry ii). This 
gave benzimidazole 158 in 35 %yield. High temperature normally increases the rate 
of aromatisation, and so we carried out the reaction in benzene at reflux (entry iii). 
This improved the yield to 54 % and a further increase was seen when we carried out 
the reaction in refluxing toluene (78 % yield) (entry iv). Reagents that assist 
dehydrogenation were added to further optimise the yield. Methanolic KOH was 
added to the reaction mixture (entry v) and this gave 76 %yield of benzimidazole 
158. Addition of 2,3-dichloro-5,6-dicyano-1 ,4-benzoquinone (DDQ) did not have 
huge impact on the yield of compound 158 either (72 %) (entry vi). Optimisation 
studies were also carried out to accelerate condensation step. This was done by 
adding various amounts of HCl (2 Min ether). Neither 5 nor 10 mol % of HCl had 
any significant effect on benzimidazole 158 fonnation (75 and 76 % yields, 
respectively) (entries vii and viii). We found the yield of the benzimidazole 158 
increased to 80% when 15 mol% of 2M HCl was used (entry ix). To our delight, 
TOP with 15 mol %of 2M HCl and 2.5 equivalents of diamine 157 in the presence 
of 15 equivalents of manganese dioxide and 4 A molecular sieves in toluene at reflux 
for 18 hours, gave benzimidazole 158 and compound 159 in 90 % and 5 % yields, 
respectively (entry x). 
Having completed this optimisation study, we proceeded to investigate the 
TOP sequence on a range of alcohols using N-methyl-1 ,2-phenylenediamine (157). 
The results of TOP for various benzimidazole formations are shown in Table 3.2. 
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ReactiOns earned out wlth 15 eqmv. of Mn02, 2.5 eqmv. of N-methyl-1 ,2-
phenylenediamine (157), 15 mol% HCI, 4 A molecular sieves, toluene, reflux, 18 h. 
No product was obtained after refluxing for 18 h under the above conditions. 
** N-methyl-1 ,2-phenylenediamine (157) was replaced by N-phenyl-1 ,2-
phenylenediamine and 1 ,2-phenylenediamine (133), (entries x and xi, respectively). 
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The reaction gave decent yields of the 2-substituted benzimidazoles (160 and 
161) with both electron-rich and electron-deficient benzyl alcohols (entry ii and iii, 
65 and 56%, respectively). The presence of a bromide (entry iv) on the ring does not 
significantly affect the yield of the 2-substituted benzimidazole 163. Naphthalene-1-
methanol (164) also underwent the TOP sequence smoothly to give 1-methyl-2-
naphthalen-2-yl-benzimidazole (165) in 71 % yield (entry v). Next, allylic and 
propargylic alcohols (79 and 83) were examined (entries vi and vii). Both of these 
worked, g1vmg 1-methyl-2-styryl-benzimidazole (I 66) and 1-methyl-2-
phenylethynyl-benzimidazole (167), respectively, in fair yields. Compound 166 has 
been reported to show significant inhibiting activity towards MAO-B.73 Products 166 
and 167 were obtained in lower yield, possibly due to the formation of Michael-
adducts. A heterocycle example was studied next: 3-pyridine-methanol (168) 
successfully underwent the TOP to give 1-methyl-2-pyridin-3-yl-benzimidazole 
(169) in 55% yield (entry viii). 
We also tested the TOP on 3-phenyl-propan-1-ol 49 (entry ix), but the 
conversion into the anticipated heterocycle 170 was not observed in the usual time 
period. Instead, we recovered starting material (62 % yield). The recovery of the 
starting material indicated that alcohol 49 was not oxidised under these conditions. 
The scope of the TOP was next explored with respect to the diamine. When we 
substituted N-methyl-1 ,2-phenylenediamine (157) with N-phenyl-1 ,2-
phenylenediamine to react with benzyl alcohol (23) (entry x), I ,2-diphenyl-
benzimidazole (171) was formed in 76 %yield (entry x). An attempt to use 1,2-
phenylenediamine (133) to react with benzyl alcohol (23) in TOP was unsuccessful 
(entry xi), although we observed benzaldehyde and diazenyl-aniline formations. 
3.1.3 Preparation of 2-Phenyl-Benzoxazole and Benzothiazole via TOP 
Benzoxazole and benzothiazole are important heterocycles and have been 
extensively employed in areas of pharmaceuticals. 83 For example, they are known to 
have the potential to induce cytochrome P450 !AI mRNA enzymes in cancer cell 
lines, which is useful for predicting drug interactions and drug side effects84 These 
compounds are normally synthesised by condensation of 2-aminophenol or 2-
aminothiophenol with acids, acid chlorides, amides or esters. 2-Pyridin-4-yl-
benzoxazole (175), for example, has been prepared by condensation of aldehyde 173 
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with 2-aminophenol (174) in EtOH in the presence of iodobenzene diacetate 
(Scheme 3.8)85 




173 174 175 
Scheme 3.8 Reagents and conditions: lodobenzene diacetate, EtOH, rt, 2h, 32 %. 
2-Substituted benzothiazole 178 on the other hand, has been prepared by 
reacting 4-bromobenzaldehyde (176) with 2-aminothiophenol (177) in DMSO at 150 




176 177 178 
Scheme 3.9 Reagents and conditions: DMSO, 150 "C, 55%. 
More recently, polymer-bound ester 179 has been reacted with 2-
aminothiophenol (177) in the presence of a Lewis acid, e.g. AIMe3 in refluxing 






179 177 180 
PS = Polymer support 
Scheme 3.10 Reagents and conditions: AIMe3, toluene, reflux, 24 h, 50%. 
We anticipated that the synthesis of 2-phenyl-benzoxazole (181) and 2-
phenyl-benzothiazole (180) could be achieved using TOP. The optimum conditions 
used for the benzimidazole synthesis was employed. N-Substituted I ,2-
phenylenediamine was replaced by 2-aminophenol (174) or 2-aminothiophenol (177) 
and reacted with benzyl alcohol (23) in a TOP manner (Scheme 3.11 ). 
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(a) (b) sl) Ph~ I 
N h 
23 180 
Scheme 3.11 Reagents and conditions: (a) 15 equiv. Mn02, 2.5 equiv. 
2-aminophenol, 15 mol % HCl, 4 A molecular sieves, toluene, 
reflux, 18 h, 73 %; (b) 15 equiv. Mn02, 2.5 equiv. 2-aminothiophenol, 
15 mol % HCl, 4 A molecular sieves, toluene, reflux, 18 h, 
66%. 
Using 15 equivalents of manganese dioxide, 15 mol % HC1 (2M in ether) and 4 
A molecular sieves with 2.5 equivalents of the 2-aminophenol (174) in refluxing 
toluene, we obtained 2-phenyl-benzoxazole (181) in 73 % yield. 2-Phenyl-
benzothiazole (180) was also produced in 66 % yield using similar conditions with 
2.5 equivalents of 2-aminothiophenol (177). The success of TOP with both of these 
nucleophiles indicates that the method could be used to prepare a range of these 
types of heterocycles. 
3.1.4 Preparation of 2-Substituted lmidazolidines, Imidazolines and Imidazoles 
via TOP 
Imidazole and its analogues have been known to exhibit cytotoxicities to a 
range of human tumour cell lines.'8 Reactions of carboxylic acids (182) with 
ethylenediamine (183) at high temperature in the presence of a dehydrogenating 
agent produced 2-substituted imidazoles 184 (Scheme 3 .12)89 In the absence of the 









Scheme 3.12 Reagents and conditions: Pt/Al, 370-400 "C, 72-95 %. 
We envisaged the synthesis of 2-substituted irnidazolidines 186 from 
condensation of a N-substituted aliphatic diamine, N-rnethyl-ethylenediamine (185) 
with aldehyde 154. The optimum conditions used for benzimidazole synthesis was 
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employed in these reactions. In principle, the imidazolidines 186 could be further 
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Scheme 3.13 Reagents and conditions: (a) 15 equiv. Mn02, 2.5 equiv. 
N-methylethylenediamine, 15 mol% HCI, 4 A molecular 
sieves, toluene, reflux. 
188 
Benzyl alcohol (23) was treated with N-methyl-ethylenediamine (185) in the 
presence of 15 equivalents of manganese dioxide, 15 mol % HCI (2M in ether) and 4 
A molecular sieves in refluxing toluene. This produced a mixture of 1-methyl-
imidazolidine (189a) and the ring-opened imine 189b in tautomeric equilibrium, in 
an overall yield of70% with a 6:1 ratio of the isomers (Scheme 3.14). The 1H NMR 
spectrum showed two singlet peaks at ii 3.80 and 8.26 ppm belonging to protons 
between the two nitrogen atoms in imidazolidinc 189a (R'N-CH-NH) and ring-
opened imine isomer 189b, respectively. We attempted aromatisation by adding 
methanolic KOH and DDQ in separate reactions, but with no success. When N-
methylethylenediamine (185) was replaced by N-phenyl-ethylenediamine (190) in 
the TOP, the crude product showed presence of 2-phenyl-imidazolidine (191a) and 
ring-opened imine 191b isomers in a ratio of 0.6: 1. The difference in the ratio of 
imidazolidine-ring opened imine tautomers is due to the steric effect of the a-carbon 
of the N-substituent, which plays a crucial role in the addition to the C~N bond90 
Further aromatisation studies were attempted as before, but failed. 4-Nitrobenzyl 
alcohol (60) was subjected to a TOP with N-phenyl-ethylenediamine (190) in a 
similar manner. The formation of imidazolidine 192a and ring-opened-imine 192b in 
tautomeric forms were again observed in the crude products, in ratio of 2: I. The 
findings in these reactions showed TOP between N-substituted ethylenediamine and 
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alcohol gave imidazolidines and ring-opened imines. However, further 
transformations to imidazolines and imidazoles could not take place, and so this 
approach was not persued. 
R' =Me, 185, R' =Ph, 190 
~OH 
R~ 
23, R = H 





189a, b = R =H. R' = CH3 (70 %, a:b = 6:1) 
191a, b = R = H, R' =Ph (crude products, a:b = 0.6:1) 
192a, b = R = N02, R' =Ph (crude products, a:b = 2:1) 
Scheme 3.14 Reagents and conditions: 15 equiv. Mn02, 2.5 equiv. 
N-methyl-ethylenediamine 15 mol % I ICl, 4 A molecular 
sieves, toluene, refux. 
3.2. 6-Membered Rings with One Heteroatom 
Next, we explored the use of TOP methodology to prepare the following 6-
membered heterocycles: (i) quinolines, (ii) tctrahydroquinolines and (iii) 
dihydroquinolines. 
3.2.1 Synthesis of Quinolines and Related Heterocycles 
Quinolines are b-fused pyridines. There are numerous routes for quinoline 
synthesis. The classical methods for quinoline synthesis are (a) condensation of an 
aniline with a reactant that provides a three carbon unit, traditionally represented by 
Skraup, Combes and Doebner-Miller syntheses; and (b) condensation of artho-
carbon-substituted anilines with a reactant that provides a two-carbon unit to 
complete the quinoline ring, typically represented by Friedlander, Pfitzinger and 
N. k' h '' Iementows 1 synt eses. 
A transition metal-catalysed route has also been developed as an alternative 
method for quinoline synthesis. Palladium-catalysed coupling of 2-iodoaniline (193) 
and allylic alcohols 194 provided quinolines 195 (Scheme 3.15)92 
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R = CH3, C6H5 
Scheme 3.15 Reagents and conditions: PdCh, PPh3, NaHC03, HMPA, 
140 "C, 24 h, 50- 62 %. 
Free radical cyclisation has also been used in the synthesis of quinolines, for 
example, in Fukuyama's synthesis, isonitrile 196 was treated with an excess amount 
of tributyltin hydride, resulting in quinoline 197 and indole 198 in 53 %and 10% 
yields, respectively (Scheme 3.16).93 
(J()c,H, + 
N 
196 197 198 
Scheme 3.16 Reagents and conditions: Bu3SnH, AIBN, benzene, 197 =53%, 
198= 10%. 
More recently, Banik eta/. prepared quinoline (200) by an indium-mediated 





00 .--;; N 
200 
Scheme 3.17 Reagents and conditions: Indium powder, H20, NH4Cl, EtOH, 
reflux, 90 %. 
3.2.1.1 Importance ofQuinolines and Related Heterocycles 
The most important application of quinolines are their anti-malarial 
properties. Quinine (201), chloroquinine (202), amodiaquinine (203) and 
mefloquinine (204) have been used for malaria chemotheraphy for much of the past 
40 years (Figure 3.2)95 
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Besides anti-malarial activity, quinolines 205 and 206 have been shown to be 
potent inhibitors of platelet-derived growth factor receptor (PDGR) tyrosine kinase, 
which is vital for embryogenisis regulation (Figure 3.3)96 
r- CN 
I CH30 :::::,__ r- '-'::: CN 
:::::,__ 
I 
-"' CH30 N Cl 
205 206 
Figure 3.3 
3.2.2 Preparation of Quinoline and Related Heterocycles via TOP 
The Taylor group have successfully developed TOP methodology for the 
elaboration of alcohols into imines. 27 Benzyl alcohol, substituted benzyl alcohols, 
allylic and propargylic alcohols successfully underwent in situ oxidation-imine 
formation with a range of amines. 
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We envisaged the synthesis of quinolines by employing TOP, where the 
resulting aldehyde is trapped by amine present in the molecule with instantaneous 
cyclisation. A dual functionality consisting of a Z-allylic alcohol and amine on the 
starting material is warranted for TOP. By subjecting Z-3-(2-amino-phenyl)-prop-2-
en-1-ol (207Z) to in situ oxidation, the resulting aldehyde 208 would be trapped by 
the amine intramolecularly to form the quinoline ring (200) (Scheme 3 .18). 
~OH 
~.,u --NH2 [ro] NH2 0 co /-N 
207Z 208 200 
Z = Z-isomer 
Scheme 3.18 TOP for quinoline formation using Mn02. 
3.2.3 Synthesis of Z-3-(2-Amino-phenyl)-prop-2-en-1-ol (207Z) 
In order to carry out the synthetic route outlined in Scheme 3.18, Z-(amino-
phenyl)-prop-2-en-1-ol (207) had to be prepared. 
3.2.3.1 Synthesis of Z-3-(2-Amino-phenyl)-prop-2-en-1-ol (207Z) via (2-Nitro-
phenyl)-propynoate 210 
We envisaged the synthesis of Z-3-(2-amino-phenyl)-prop-2-en-l-ol (207Z) 
via an alkynyl intermediate following the reaction sequence below (Scheme 3 .19). 
The Z-allylic alcohol would be constructed by reduction of the a,p-unsaturated ester 
209Z. Compound 209Z could be prepared by hydrogenation of a (2-nitro-phenyl)-
propynoate 210, which selectively reduces the alkynyl to the Z-alkenyl and the nitro 
group to an amine. Cross-coupling of 2-iodonitrobenzene (211) with propiolate 212 
would furnish compound 210. 
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Z = Z-isomer 
Scheme 3.19 Retrosynthetic analysis to Z-3-(2-amino-phenyl)-prop-2-en- I -ol 
via propynoate 210. 
3.2.3.1.1 Attempted Synthesis of Ethyl (2-nitro-phenyll-propynoate (210) 
The synthesis of ethyl (2-nitro-phenyl)-propynoate (210) was attempted by 
Sonogashira coupling under various conditions as shown in Table 3.3. 
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Entry Reagents and Conditions 
I Hunig's base/THF, 50 oc, 24 h 
ii* Hunig's base/THF, 50 "C, 24 h 
Ill Et2NH/THF, 50 oc, 24 h 
IV K2C03/THF, 65 oc, 24 h 
v K2COJiDMF, 100 oc, 24 h 
VI Ag2C03/THF, 65 °C, 24 h 
VII K3POJTHF, 65 °C, 24 h 
viii** ZnBr2. ElJN, Pd(PPh3), rt, 24 h 















ReactiOns earned out m the presence PdC!,(PPh3), and Cui. 
* 2-Iodonitrobenzene (211) was replaced by 2-iodoamline (193) as the 
coupling partner. 
** Reaction carried out with Negishi cross-coupling protocol. 
Employing a Sonogashira cross-coupling alkynylation protocol, 2-
iodonitrobenzene (211) was treated with ethyl propiolate (212) in the presence of a 
catalytic amount of PdC!z(PPh3)2 and Cui in a mixture of HOnig's base and THF (I: 1 
v/v) at 50 oc for 24 hours (entry i) 97 The reaction yielded by-products, which were 
identified as Michael adducts (28 %yield) and alkyne homocoupling compounds (32 
%yield), with no desired cross-coupling product. We tried to reduce the formation of 
homocoupling product by degassing the solvent and by slow addition of the 
propiolate 212, but with no improvement. 2-lodoaniline (193) was also subjected to 
the above cross-coupling alkynylation reaction conditions, but without success (entry 
ii). We believe the presence of free amine group complicated the reaction. The cross-
coupling was attempted on 2-iodonitrobenzene (211) with diethylamine as base 
under the same reaction conditions (entry iii), but once again, only by-products were 
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obtained. We assumed the Michael adducts resulted from the organic base attacking 
the propiolate and we therefore decided to substitute the organic base with inorganic 
bases. We adapted the procedure of Ipaktschi et a/. using K2C01 as the base in 
Sonogashira cross-coupling alkynylation98 2-Iodonitrobenzene (211) was treated 
with ethyl propiolate (212) in the presence of with 2 equivalents of K2C03 and a 
catalytic amount of PdCh(PPh,)2 and Cui in THF at 65 "C for 24 hours (entry iv). 
This gave a low yield of cross-coupling compound 210 (22 %). Attempts were taken 
to optimise the yield, by running the reaction at higher temperatures with DMF as the 
solvent at I 00 "C (entry v). These changes however, reduced the yield to 5 %. Other 
inorganic base such as AgC03 and K3P04 were tried in the reaction, resulting in 
reduction of yields (entries vi and vii). 
Palladium-catalysed alkynylation reactions with an alkynylmetal such as Mg 
or Zn have been reported to generate a more nucleophilic alkynyl99 Using the 
method developed by Negishi eta/., we treated 2-iodonitrobenzene (211) and ethyl 
propiolate (212) with premixed zinc bromide and triethylamine in THF in the 
presence of Pd(PPh3) 4 at room temperature for 24 hours (entry viii). 100 There was no 
cross-coupling product formed, instead we observed the starting material and 
homocoupling products. Employing the alternative method developed by Negishi, we 
substituted triethylamine with LOA and added zinc bromide at -78 "C (entry ix). 100 
This still gave no cross-coupling product. 
Our efforts to synthesise ethyl (2-nitro-phenyl)-propynoate (210) gave 22 % 
as the best yield. We decided to approach another route to synthesise Z-3-(2-amino-
phenyl)-prop-2-en-1-ol (207Z). 
3.2.3.2 Synthesis of Z-3-(2-Amino-phenyl)-prop-2-en-1-ol (207Z) via (Zl-3-[2-
(Acetylamino)phenyl]-2-propenoate 214Z 
We sought to synthesise Z-3-(2-amino-phenyl)-prop-2-en-1-ol (207Z) via the 
alkenyl intermediate following the retrosynthetic analysis below (Scheme 3 .20). 
Deprotection of amide 213Z would provide Z-3-(2-amino-phenyl)-prop-2-en-1-ol 
(207). Compound 213Z could be constructed from reduction of (Z)-3-[2-
(acetylamino )phenyl]-2-propenoate 214Z. Synthesis of propenoate 214Z is envisaged 
from the cross-coupling of the protected 2-iodobenzene 215 with Z-vinyl stannane 
216Z. 2-Jodoaniline (193) would be subjected to N-acetylation to provide the 
required cross-coupling partner, 215. 
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OH ~OH ccrOR 
=>I =>I 0 NH2 ....:;; NHPG ....:;; NHPG 
207Z 213Z 




CCI ~0'-./ + "Bu3Sn 11 NHPG O 
215 216Z 
PG = Protecting group 
Z = Z-isomer 
Scheme 3.20 Retrosynthetic analysis to Z-3-(2-amino-phenyl)-prop-2-en-1-ol via 
Propenoate 214Z. 
Addition of acetyl chloride and triethylamine to 2-iodoaniline (193) at 0 oc 
gave N-(2-iodo-phenyl)-acetamide (215) in 87 % yield (Scheme 3.21 ). 101 
(YI 
~' NH 2 
193 
0 CC I N)lCH 
H ' 
215 
Scheme 3.21 Reagent and conditions: AcCl, Et3N, 0 octo rt, 18 h, 87 %. 
We subjected compound 215 to various cross-coupling reactions to synthesise 
ethyl (Z)-3-[2-(acetylamino)phenyl]-2-propenoate (214Z). The conditions and results 
of these various cross-coupling reactions are shown in Table 3 .4. 
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Table 3.4. Cross-coupling of N-(2-iodo-phenyl)-acetamide 215 with 




Entry Reagents and Conditions 
I Pd(PPh3)4, toluene, 
reflux, 18 h 
II PdCh(PPhJ)2. toluene, 
reflux, 18 h 
Ill PdBnCI(PPh3) 2, toluene, 
reflux, 18 h 
IV Pd(PPh3)4, toluene, 
rt, 24 h 
v PdC12(PPh3)2, toluene, 
rt, 24 h 
VI PdBnCI(PPh3)2. toluene, 
rt, 24 h 
vii* Pd(PPh3) 4, toluene, 
reflux, rt, 24 h 
viii** Pd(OAc )2, Cu(OAc )2, DMF, 
100 °C, 24 h 
~OR 
~"UAo Q NHAc 
214 
(Z = Z-isomer, E = E-isomer) 
Yield of cross-coupling 
product 214 (%) 
20 % of £-isomer 
35 % of £-isomer 
18 % of £-isomer 
83 % of in a ratio of I: I 
15% of in a ratio of I :I 
23 % of in a ratio of I: I 
50% of Z:E isomer in a 
ratio of I :3.5 
32 % of £-isomer 
* Reactwn was earned out With 2-wdomtrobenzene (211) and Z-vmyl stannane 
2162 in a Stille cross-coupling reaction to give ethyl 3-[2-nitro- phenyl]-
2-propenoate (217). 
** Reaction was carried out with nitroboronic acid and ethyl acrylate (212) in a 
Mizoroki-Heck reaction to give ethyl 3-[2-nitro-phenyl]-2-propenoate (217). 
We employed Stille's palladium-catalysed cross-coupling methodology with 
the Z-vinyl stannane 216Z in an effort to synthesise compound 214Z. 102 Organotin 
compounds are known to tolerate a wide range of functional groups in either one or 
both of the coupling partners. Ethyl (Z)-3-(tributylstannyl)-2-propenoate (216Z) as 
the organotin nucleophile partner was prepared by radical addition of tributyltin 
hyride to propiolate ester. 103 This gave the stannane 216 in 68% yield as a separable 
mixture of Z- and£- isomers (216Z and 216£, respectively) with a ratio of I: 1.6. We 
carried out the cross-coupling of Z-vinyl stannane 216Z with iodobenzene 215 in the 
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presence of a catalytic amount of Pd(PPh3)2 in toluene at reflux, which gave ethyl 
(E)~3~[2~(acetylamino)phenyl]~2~propenoate (214£) in 20% yield (entry i). We also 
screened two different palladium catalyst, PdCh(PPh3)2 and PdBnCl(PPh3)2 which 
are commonly used in Stille reaction (entries ii and iii). These reactions gave the E~ 
isomers of the cross~coupling compounds 214£ in 35 and 18% yields, respectively. 
Stille coupling reactions are known to be regio~selective and stereo~selective, 
preserving the configuration of the coupling partners used to the cross~coupling 
product. 104 We suspect that the reaction would have produced the Z~isomers 214Z as 
predicted, but that the high temperature may have isomerised the product to E~ 
isomer. Hence, we decided to repeat the cross~coupling reactions with each of the 
catalysts at room temperature. To our delight, stirring the reaction in the presence of 
Pd(PPh3)4 in toluene at room temperature for 24 hours, gave compound 214 in 83 % 
yield with a Z,E ratio of 1:1 (entry iv). The 1H NMR spectrum showed the Z~isomer 
peaks at i5 7.80 and 6.71 ppm with J values of 9.5 Hz, while the £~isomer peaks were 
at 8 8.00 and 6.40 ppm with J values of 16.0 Hz. This is the first reported synthesis 
of two novel compounds, which were fully characterised. Reactions with 
PdCh(PPh3) 2 and PdBnCI(PPh3)2 gave compound 214 in 15 and 23 % yields, 
respectively, with Z,E ratio of I :I (entries v and vi). The isomers were separated by 
column chromatography in which Z~isomer 214Z eluted first. The cross~coupling 
reaction was also attempted with 2~iodonitrobenzene (211) as the cross~coupling 
partner (entry vii). We managed to obtain 50%, yield of ethyl 3~[2~nitro~phenyl]~2~ 
propenoate (217) with a Z,E ratio of I :3.5. 
A Mizoroki~Heck reaction was also tried following a literature procedure, by 
coupling 2~nitroboronic acid with ethyl acrylate (212) in the presence of a catalytic 
amount of Pd(OAc )2 and Cu(OAc )2 at I 00 "C (entry viii). 105 This gave the cross~ 
coupling product 217 in 32% yield as the£~ isomer. 
The use of organotin compounds in palladium~catalysed cross~coupling 
reactions had successfully yielded ethyl (Z)~3~[2~(acetylamino)phenyl]~2~propenoate 
(214Z) in 42% yield. With this in hand, we were ready for the deprotection step as 
outlined in Scheme 3 20. 
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3.2.3.2.1 Synthesis of Z-N-!2-13-Hydroxy-propenyl)-phenyl!-acetamide (213Z) 
and Z-3-(2-Amino-phenyll-prop-2-en-1-ol 1207 Z) 
We initially carried out the reduction of ethyl (Z)-3-[2-
(acetylamino)phenyl]-2-propenoate (214Z) with 2.2 equivalents of DIBAL-H at 0 
"C. The reaction proceeded to give 1-H-quinolin-2-one (218) in 72% yield (Scheme 
3.22). We suspect that DIBAL-H deprotected the acetate to give an amine, which 
then displaced the ester in a nucleophilic substitution reaction. The Z-propenoate 
214Z was also subjected to lithium aluminium hydride reduction at 0 "C. Again, the 




Scheme 3.22 Reagents and conditions: 2.2 equiv. DIBAL-H, 0 "C, I h, 72% or 
LiAIH4, 0 "C, I h, 78 %. 
We decided to carry out the reduction of ethyl (Z)-3-[2-(acetylamino)phenyl]-
2-propenoate (214Z) with 2.2 equivalents of DIBAL-H at a lower temperature ( -78 
"C) in toluene (Scheme 3.23). This reaction proceeded to give Z-hydroxy-acetamide 
213Z in 42% yield after one hour of reaction time. The 1H NMR spectrum showed 
the Z-isomer peaks at 8 6.80 and 6.52 ppm with J values of 11.4 Hz, confirming that 







Scheme 3.23 Reagents and conditions: 2.2 equiv. DIBAL-H, -78 "C, I h, 
42 % (Z- only). 
With ethyl Z-N-[2-(3-hydroxy-propenyl)-phcnyl]-acetamide (213Z) in hand, 
we were ready to deprotect to give Z-3-(2-amino-phenyl)-prop-2-en-1-ol (207). A 
methanolic solution of K2C03 was added to 213Z at room temperature, but after 2 
days, only starting material was observed. When we heated the mixture to 50 "C for 2 
days, compound 207 was isolated in 20 % yield (with a Z,E ratio of 0.6: I) (Scheme 
3.24). These reaction conditions probably favour £-isomers formation due to the 
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heating. Separation of the isomeric mixture at this stage was not possible as the two 
products co-ran by TLC. We also attempted deprotection of the hydroxy-acetamide 
213Z by adding triethylamine to methanolic solution of K2C03, which gave 
decomposition products. KOH in methanol and HCI (2M in ether) were also tried in 








Scheme 3.24 Reagent and conditions: K2C03 in MeOH, 50 °C, 48 h, 
20% (Z:£ = 0.6: I). 
We attempted a double ester reduction-deprotection by subjecting ethyl (Z)-3-
[2-(acetylamino)phenyl]-2-propenoate (214Z) to 2.2 equivalents of DIBAL-H in 
ether at -78 °C. To our delight, this reaction gave hydroxy-acetamide 2l3Z and 
amino-alcohol 207Z in 20 % and 26 'Yo yields, respectively, with retention of 
configuration (Scheme 3.25). We imagine the DIBAL-H had firstly reduced ethyl 
propenoate 214Z to the hydroxy-acetamide 2l3Z and further deacetylation to amino-
alcohol207Z. The 1H NMR spectrum showed the Z-isomer peaks of compound 207Z 
at 8 6.48 and 6.00 ppm with J values of 11.3 Hz. The a,~-ester reduction with 
concomitant deacetylation was also reported by Ralph et a!. for the synthesis of 
coniferaldehyde. 106 Even though we obtained a yield of 26 % of compound 207Z 
with the one-pot reduction-deprotection, we had circumvented the deprotection step 











Scheme 3.25 Reagents and conditions: 2.2 equiv. Dll3AL-H, E~IO, -78 oc, 1 h, 
213Z = 20% (Z-only), 207Z = 26% (%-only). 
We also took the £-isomer of ethyl 3-[2-(acctylamino)phenyl]-2-propenoate 
(214£) and treated it in a one-pot reduction-deprotection manner with DIBAL-H in 
62 
Chapter 3: Tandem Oxidation Processes-Heterocycle Formation 
ether at -78 "C. The reaction proceeded to give £-hydroxy acetamide 213£ and£-
amino-alcohol 207 E in 30 and 32 % yields, respectively. 
3.2.4 Preparation of Quinoline via TOP 
With Z-3-(2-amino-phenyl)-prop-2-en-l-ol (207Z) in hand, we attempted the 
synthesis of quinoline (200) by a TOP procedure (Scheme 3.26). We treated Z-3-(2-
amino-phenyl)-prop-2-en-l-ol (207Z) with 15 equivalents of manganese dioxide in 
DCM at room temperature. This successfully formed quinoline (200) in 38 % yield 
after l hour. The quinoline (200) is volatile and the some of the compound was 
probably lost during work up procedures. The 1 H NMR spectrum showed aromatic 
peaks at 6 8.92, 8.21, 8.17, 7.88, 7.75, 7.60 and 7.45 ppm, which, are consistent with 








Scheme 3.26 Reagents and conditions: 15 equiv. Mn02, DCM, rt, I h, 38 %. 
We also subjected the £-isomer (207£) to manganese dioxide oxidation. This 
also gave quinoline (200) in 20 % yield, clearly indicating the preference of the Z-
isomer for cyclisation, but also showing that E to Z-isomerisation occurs during the 
oxidation-cyclisation process. 
3.2.5 Preparation of Tetrahydroguinoline via TOP 
These studies were further extended to investigate TOP approach to 
tetrahydroquinoline. Tetrahydroquinoline analogues (219 and 220) are known for 
their anti-malarial and toxicological properties (Figure 3.4). 10H 
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""" """ 0 OH ~ N 
""" I 0 
OMe Me ~ 
219 220 
Figure 3.4 
Taylor eta!. have showed that TOP could be extended to a tandem-oxidation-
reduction process using Mn02\NaBH4 to give amines. 28 There has also been 
precedent m reducing quinoline derivatives with NaBH4 to give 
tetrahydroquinolines. 109 We envisaged the use of the TOP-reduction methodology for 
the formation of tetrahydroquinolines (Scheme 3 .27). In a one-pot reaction, Z-3 -(2-
amino-phenyl)-prop-2-en-1-ol (207Z) was subjected to 15 equivalents of manganese 
dioxide and 4 equivalents of NaBH4 in DCM at room temperature. Following the 
reaction by TLC, methanol was added after complete consumption of amino-alcohol 
207Z. The reaction was then left stirring at room temperature. After 18 hours, 
tetrahydroquinoline (221) was formed in 30% yield. The tetrahydroquinoline (221) 
is volatile, and some of the compound could have been lost during work up 










Scheme 3.27 Reagent and conditions: (a) (i) 15 equiv. Mn02, 4 equiv. NaBH4, 
DCM, rt, 1 h; (ii) MeOH, rt, 18 h, 30 %. 
3.2.6 Preparation of 1,2-Dihvdroquinoline via TOP 
We were also keen to extend the TOP methodology with a selective reduction 
process to synthesise 1 ,2-dihydroquinoline. 1 ,2-Dihydroquinolines have been used as 
intermediates for the synthesis of compounds that possess anti-bacterial, anti-diabetic 
and anti-inflammatory activities. 111 
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In a model study, we have successfully reduced quinoline (200) to I ,2-
dihydroquinoline (222) in 56% yield using 1.1 equiv of DIBAL-H at 0 oc following 
a literature procedure (Scheme 3.28). 112 
co co N 
200 222 H 
Scheme 3.28 Reagents and conditions: DIBAL-H, THF, 0 "C, 1 h, 56%. 
Armed with the success from the above reaction, we envisaged a TOP 
sequence for 1,2-dihydroquinoline formation (Scheme 3.29). The resulting quinoline 
(200) formed from in situ oxidation should be selectively reduced by DIBAL-H to 
give 1 ,2-dihydroquinoline (222). Z-3-(2-Amino-phcnyl)-prop-2-en-1-ol (207Z) was 
subjected to 15 equivalents of manganese dioxide in DCM at room temperature, 
whereupon after complete consumption of amino-alcohol 207 Z (by TLC 
monitoring), 2 equivalents of DIBAL-H was added cautiously at 0 "C. The reaction 
was then left stirring at room temperature. After 1 hour, we observed only quinoline 
(200) and none of the reduced compound. Prolonging reaction time and adding more 
amount of DIBAL-H (3 equivalents) were also unsuccessful in forming I ,2-
dihydroquinoline (222). We suspect that the combination of manganese dioxide and 
DIBAL-H as the imine-reducing reagent in this one pot reaction was not compatible. 
~OH 
~ .. u (a) 
NH 2 co reo 
H 
207Z 200 222 
Scheme 3.29 Reagents and conditions: (a) (i) 15 equiv. Mn02, DCM, rt, 1 h; 
(ii) 2 equiv. DIBAL-H, 0 °C tort, 1 h. 
Although, these routes to quinoline and its reduced derivatives showed 
promise, the starting amino-alcohols are not readily accessible. We therefore, moved 
on to investigate more useful applications of TOP methodology in heterocycles 
synthesis. 
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3.3 6-Membered Rings with Two Heteroatoms 
The heterocycles that we investigated next were (i) quinoxalines, (ii) 
dihydropyrazines (iii) pyrazines and (iv) pipcrazines. 
3.3.1 Synthesis of Quinoxalines 
Quinoxalines are heterocyles containing two nitrogen atoms. The synthesis of 
quinoxalines is carried out by the condensation of a,p-dicarbonyl compounds with 
I ,2-phenylenediamine, for example, 2-(2,4-dimethyl-phenyl)-quinoxaline (224) was 
formed from reaction of a,p-dicarbonyl 223 with 1,2-phenylenediamine (133) 










Scheme 3.30 Reagents and conditions: CH3COOH, I 00 "C, 30 min, 55%. 
Miyashi eta/. also used this route to prepare 5,8-diiodoquinoxaline (227) by 
treating glyoxal (225) with 3,6-diiodo-1 ,2-phenylenediamine (225) in ethanol 







225 226 227 
Scheme 3.31 Reagents and conditions: EtOH, reflux, 24 h, 57 %. 
3.3.1.1 Application of Quinoxalines 
Quinoxalines exist in nature in relatively small numbers and exhibit a range 
of biological properties, for example, 3-phenyl-6,7-dimethylquinoxaline (228) and 
3,(3',4'-dihydrophenyl)-6, 7-dimethylquinoxaline (229) are platelet-derived growth 
factors (PDGF) (Figure 3.5).96 
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228 229 
Figure 3.5 
3.3.2 Preparation of Quinoxalines via TOP 
The a-ketoaldehydes used in quinoxaline synthesis are highly reactive 
compounds that can easily undergo hydration, aerial oxidation and polymerisation. 9 
Generally, they are prepared by oxidation of a-hydroxyketones with copper(!) 
acetate, although this often leads to carbon-carbon cleavage when other oxidants are 
employed. 115 Vicinal diols have also been oxidised to a-ketoaldehydes using Swem 
oxidation conditions and elaborated into esters using Wittig reagents 9 
We therefore envisaged the preparation of quinoxalines directly from a-
hydroxyketones, thus avoiding the need to use the hyper-reactive a-ketoaldehydes. 
Taylor et a!. have successfully employed a-hydroxyketones in a TOP procedure, in 
which the resulting a-ketoaldehydes were trapped with Wittig reagents to give a,~­
unsaturated esters20 We envisaged synthesis of quinoxalines 232 by 
subjecting a-hydroxy-ketone 230 to TOP, where the resulting dicarbonyl 231 
would be trapped with 1,2-phenylenediamine (133) (Scheme 3.32). 
R~OH RYNX) ~ 10 
N 
230 231 232 
Scheme 3.32 Transformation of a-hydroxyketones to quinoxa1ines using TOP. 
We wanted to find optimum conditions for the transformation of a-
hydroxyketone 230 to quinoxaline 232. Initial studies concentrated on a-
hydroxyacetone (233) as the model compound, reacting with 1 ,2-phenylenediamine 
(133). The results of the studies are shown in Table 3.5. 
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Table 3.5 TOP conditions for quinoxaline 234 formation.' 
H2)) 
JCoH H2Nl) I~ H3C'(N)) cxN=N + 7 H3C I "' I ~ + HN ~ N NH 2 
233 133 234 
Entry Reagents Conditions 
I 15 equiv. Mn02, 1.1 equiv. 133 DCM, reflux, 20 h 
ll 15 equiv. Mn02, 1.1 equiv. 133, DCM, reflux, 20 h 
1 %AcOH 
Ill 15 equiv. MnOz, 1 .1 equiv. 133, DCM, reflux, 20 h 
1% KzC01 
IV 15 equiv. Mn02, 1.1 equiv. 133 Et20, reflux, 20 h 
v 15 equiv. Mn02, 1.1 equiv. 133 THF, reflux, 20 h 
vi* 15 equiv. Mn02, 1.1 equiv. 133 DCM, reflux, 20 h 
VII 15 equiv. Mn02, 3.0 equiv. 233, DCM, reflux, 20 h 
1 equiv. 133 
Vlll 10 equiv. Mn02, 2.0 equiv. 133, DCM, reflux, 1 h 
4 A molecular sieves 
* I ,2-Phenylenediamme (133) was added m three equal batches. 
** Yield base on I ,2-phenylenediamine (133 ). 
2 
235 










We treated a-hydroxyacetone (233) with 15 equivalents of manganese 
dioxide and 1.1 equivalents of 1 ,2-phenylenediamine (133) in DCM at reflux for 20 
hours (entry i). This gave 2-methylquinoxaline (234) in 43% yield. The reaction also 
yielded 2-[(2-aminophenyl)diazenyl]anilinc 235 as a by-product in 15 % yield and 
polymeric adducts, which were formed by oxidation of 1 ,2-phenylenediamine (133). 
Addition of acid and base (entries ii and iii), or changing the solvents (entries iv and 
v) gave no improvement to the yield of quinoxaline 234. We observed the oxidation 
of 1 ,2-phenylenediamine (133) to compound 235 was much faster than the oxidation 
of a-hydroxyacetone (233). We therefore investigated batchwise addition of the 
reagents (entry vi) and the use of different stoichiometries (entries vii and viii). 
Addition of 1 ,2-phenylenediamine (133) was carried out in three batches (entry vi), 
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hoping that the oxidation of the a-hydroxyacetone (233) would be well advanced. 
Then again, this reaction gave quinoxaline 234 in 39 % yield. The amount of a-
hydroxyacetone (233) was increased three fold, which improved the yield of 
quinoxaline 234 to 51 % (entry vii). To our delight. the use of two fold excess of 
diamine 133 and shorter reaction time (to reduce polymerisation), gave 2-
methylquinoxaline (234) and compound 235 in 79 % and 6 % yields, respectively 
(entry viii). The 1H NMR spectrum of 2-methylquinoxaline (234) showed 8 8.72, 
7.98- 8.03, 7.65-7.75 and 2.78 ppm, which agress with literature values. 116 
We had successfully transformed a-hydroxyacetone (233) into quinoxaline 
234 in 79 % yield using I 0 equivalents of manganese dioxide, 2 equivalents of 
diamine and 4 A molecular sieves in DCM at reflux for I hour. We proceeded to 
investigate this TOP method on a range of a-hydroxyketones with I ,2-
diphenylenediamine (133). The results of these reactions are shown in Table 3.6. 
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Table 3.6 Results of TOP for quinoxaline formation.' 
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Reactwns earned out w1th I 0 eqwv. of Mn02, 2 eqmv. of I ,2-phenylened~amme 
(133), 4 A molecular sieves, DCM, reflux, 15 min- 3 h. 
* I ,2-phenylenediarnine (133) was replaced by 4,5-dimethyl-1 ,2-phenylenediamine. 
The reaction of a-hydroxyacetophenone (51) with 1,2-phenylenediamine 
(133) m DCM at reflux was complete m 30 minutes, indicating that a-
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hydroxyacetophenone (51) was highly reactive towards manganese dioxide 
oxidation. This gave gave 2-phenylquinoxaline (236) in 79 % yield (entry ii). 1-(2-
Furyl)-2-hydroxy-1-ethanone (55) and 1-cyclohexyl-2-hydroxy-1-ethanone (238), 
which were prepared by a-hydroxylation of the corresponding methyl ketones as 
described by Moriaty et a/,49 underwent TOP smoothly to give compounds 237 and 
239 in 89 and 78% yields, respectively (entries iii and iv). 
We next treated benzoin (240), a secondary alcohol to TOP methodology. It 
was readily transformed to 2,3-phenylquinoxaline (241) in 15 minutes in 75% yield. 
The scope of the TOP methodology was also explored with respect to the diamine. 
I ,2-Phenylenediamine (133) was substituted with 4,5-dimethyl-1 ,2-
phenylenediamine and reacted with a-hydroxyacetophenone (51) in the same 
reaction conditions. This gave 2-phenyl-6,7~dimethylquinoxaline (242) in 66% yield 
(entry vi). Reaction of 4,5-dimethyl-1 ,2-phenylenediamine with 1-cyclohexyl-2-
hydroxy-1-ethanone (238) yielded quinoxaline 243 in 89 % yield (entry vii). 1-
Hydroxy-2-heptanone (53), which was prepared a similar a-hydroxylation 
procedure,49 was subjected to TOP with 4,5-dimethyl-1,2-phenylenediamine. This 
reaction gave 2-pentyl-6,7-dimethylquinoxaline (244) in 62 % yield (entry viii). 
Methyl glycolate (245) was also used as the oxidation substrate in the in situ 
oxidation with 1,2-phenylenediamine (133) (entry ix). This reaction proceeded to 
give 2(1H)-quinoxalinone (246) in 44% yield. 
3.3.3 Preparation of Dihydropyrazines via TOP 
Dihydropyrazines arc partially reduced pyrazine compounds, formed from 
condensation of a,p-dicarbonyl compounds with ethylenediamine. 4-Methyl-5-
phenyl-2,3-dihydropyrazine (248) was formed from condensation of I ,2-diketone 
247 with ethylenediamine (183) (Scheme 3.33). 120 
./'... ,NH 






Scheme 3.33 Reagents and conditions: EtOH, reflux, 80 %. 
Dihydropyrazines have been known to exhibit genetoxicity activities, for 
example, 5,6-dimethyl-2,3-dihydropyrazines 249 and 250 have shown DNA strand-
breakage activities (Figure 3.6). 121 
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H3CXN*CH3 
H3C N CH3 
249 
H3C"f''Nl 
HC~ CH 3 3 
250 
Figure. 3.6 
With the success of quinoxaline synthesis, we were interested in adapting this 
methodology to the preparation of dihydropyrazines. The resulting a-ketoaldehydes 
231 from TOP will be trapped with ethylenediamine (183) to form dihydropyrazines 








Scheme 3.34 Transformation of a-hydroxyketones to dihydropyrazines using TOP. 
Initial studies concentrated on the preparation of 5-furan-2-yl-2,3-
dihydropyrazine (252), using 1-(2-furyl)-2-hydroxy-1-ethanone (55) as the model a-
hydroxyketone with ethylenediamine (183) (Scheme 3.35). The optimum conditions 
used for quinoxaline synthesis were applied for dihydropyrazine formation. After 2 
hours, the reaction was complete by TLC monitoring. Dihydropyrazine 252 was 
isolated m 27 % yield along with the by-product, N-[2-
(formylamino)ethyl]benzamide (253) in 38 °/t, yield. The bis-amide 253 was believed 
to have been formed from oxidative cleavage of the bis-hemi-aminal intermediate 
facilitated by manganese dioxide. 122 Bis-amide 253 could be minimised by addition 
of HCl and it was found that 2 equivalents of HCl (2M in ether) gave the best result. 
Under these conditions, dihydropyrazine 252 and bis-amide 253 were obtained in 38 
% and 18 % yields, respectively. 
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~0 
OH 
Or:: N + 
55 252 
Scheme 3.35 Reagents and conditions: I 0 equiv. Mn02, 2 equiv. ethylenediamine, 
4 A molecular sieves, 2 equiv. ofHCI, DCM, reflux, 2 h, 252 ~ 38 %, 
253 ~ 18 %. 
We went on to determine the scope of the TOP with a range of a-
hydroxyketones. The results are summarised in Table 3.7. 
Table 3.7 Results of TOP for dihydropyrazine formation." 












































' ReactiOns earned out wtth 10 equtv. of Mn02, 2 eqmv. of ethylenedtamme (183), 
4 A molecular sieves, 2 equiv. ofHCl, DCM, reflux, 1 ~ 2.5 h. 
Dihydropyrazines are known to be prone to dimersation, particularly when 
left standing in crude form. 121 Therefore, isolation was carried out immediately using 
deactivated neutral alumina. TOP with 1-cyclohcxyl-2-hydroxy-1-ethanone (238) 
proceeded to give 5-cyclohexyl-2,3-dihydropyrazine (254) in 31 % yield (entry ii). 
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The moderate yield could be explained by the volatility of dihydropyrazine 254. 
With 4-bromophenyl-2-hydroxyethanone (255), the transformation to 
dihydropyrazine 256 was achieved in 39 % (entry iii). A co-worker attempted the 
TOP of a-hydroxyacetophenone (51) with ethylenediamine (183) and obtained 5-
phenyl-2,3-dihydropyrazine (257) in 53 % yield (entry iv). 122 The presence of 
aromatic substituents in the above reactions seems to facilitate dihydropyrazine 
formation. We also attempted in situ oxidation on benzoin (240), which gave 
dihydropyrazine 258 in 42% yield (entry v). 
3.3.4 Preparation of Pyrazines via TOP 
Pyrazines are generally formed by a two-step reaction sequence: firstly, the 
formation of dihydropyrazine, followed by oxidation using KOH (this transformation 
presumably involves oxygen). 2-Phenylpyrazine (260) was synthesised from 
condensation of a-ketoaldehyde 259 with ethylenediamine (183), which gave 2,3-
dihydropyrazine 257, that was subsequently treated with KOH (Scheme 3.36). 124 
PhtN (b) ~) ~ "'I 
N 
259 257 260 
Scheme 3.36 Reagents and conditions: (a) ethylenediamine, EtOH, 10 min; 
(b) KOH, reflux, 5 h, 34 %. 
Pyrazines exhibit important biological properties, for example, pyrazines 261 
and 262 have been known to bind to the estrogen receptor, that controls the female 
reproductive system (Figure 3.7). 125 
HO 
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We envisaged the synthesis ofpyrazine 263 from elaboration of the TOP with 
an a-hydroxyketone 230. This was carried out by subjecting the resulting 










Scheme 3.37 TOP transformation of a-hydroxyketones to dihydropyrazines, 
followed by elaboration to pyrazines. 
Initial studies concentrated on synthesis of 2-furan-2-yl-pyrazine (264) by 
treating 1-(2-furyl)-2-hydroxy-1-ethanone (55) with ethylenediamine (183) (Scheme 
338). The optimum conditions used for dihydropyrazine synthesis were employed 
for pyrazine formation. 1-(2-Furyl)-2-hydroxy-1-ethanone (55) underwent the TOP 
sequence to give dihydropyrazine 252. The dihydropyrazine 252 formed after 2 
hours was subjected to extended heating in the presence of excess manganese 
dioxide, with the hope that would further oxidise dihydropyrazine 252 to pyrazine 
264. After 18 hour of heating, only dihydropyrazine 252 was observed. The reaction 
was also repeated at higher temperature using toluene at reflux. This also failed to 
form pyrazine 264. Addition of DDQ and CAN in separate reactions, resulted in 
decomposition of the dihydropyrazine 252. We decided to add 0.4 M methanolic 
KOH in the same pot to further elaborate dihydropyrazine 252. To our delight, the 
reaction yielded 60 % of pyrazine 264. The higher yield obtained for pyrazine 264 
compared to its corresponding dihydropyrazine 252, demonstrated that aromaticity 




N Or:'J N 
55 252 264 
Scheme 3.38 Reagents and conditions: (a)(i) I 0 equiv. Mn02, 2 equiv. 
ethylenediamine, 4A molecular sieves, 2 equiv. HCI, DCM, 
reflux, 2 h; (ii) 0.4 M KOH in MeOH, reflux, 18 h, 60 %. 
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We proceeded to investigate TOP methodology on a range of a-
hydroxyketones. The results are shown in Table 3.8. 
Table 3.8 Results of TOP-aromatisation for pyrazine formation. a 
Entry I a-Hydroxyketone I 
Product I Isolated yield I m.p./lit. m.p. 
(%) ("C) 
~0 ~) 60 oil 
OH N 
55 264 
II ~0 C\NJ 33 oil 
OH N 
238 265 




IV ~0 ~N 57 74/72-73 114 ~J OH N 
51 260 




vi* ~0 ~ 52 152-154/154-155 117 OH N I "' 51 
"' 
268 
'ReactiOns earned out with I 0 eqUJv. of Mn02 , 2 eqUJv. of ethylened1amme (183), 
4 A molecular sieves, 2 equiv. ofHCl, DCM, reflux, 1-2.5 h, after which 0.4 M 
KOH in MeOH was added and returned to reflux for 18 h. 
* Ethylenediamine (183) was replaced by I ,2-diphenylethane-1 ,2-diamine. 
With 1-cyclohexyl-2-hydroxy-1-ethanone (238) subjected to TOP-
arornatisation, we obtained the corresponding pyrazine 265 in 33 % yield (entry ii). 
This low yield could be explained by the lack of an aromatic substituent that could 
assist aromatisation. When we subjected 4-bromophenyl-2-hydroxyethanone (255) 
and a-hydroxyacetophenone (51) (entries iii and iv) to TOP-aromatisation, the 
transformations to pyrazines 266 and 260 were achieved in 57 % yields, separately, 
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proving that the presence of aromatic substituents facilitate pyrazine formation. We 
also attempted TOP-aromatisation on benzoin (240) and isolated 2,3-diphenyl-
pyrazine (267) in 52 % yield (entry v). The scope of TOP-aromatisation was 
extended to the substituted diamine, I ,2-diphenylethane-1 ,2-diamine. Reaction 
between a-hydroxyacetophenone (51) and I ,2-diphenylethane-1 ,2-diamine under 
TOP-aromatisation gave 2,3,5-triphenyl-pyrazine (268) in 52% yield (entry vi). 
3.3.5 Preparation of Piperazines via TOP 
Piperazines are normally prepared in two steps; firstly, the formation of 2,3-
dihydropyrazines followed by reduction to pipcrazines. Reaction of of I ,2-
diphenylethane-1 ,2-diamine (270) with diketone 269 gave dihydropyrazine 271, 
which consequently underwent reduction with sodium cyanoborohyride to produce 
piperazine 272 (Scheme 3.39). m 
269 270 271 
H 
_:,cXNXPh 






H,C N "Ph 
H 
272b 
Scheme 3.39 Reaction and condition: (a) (i) benzene, reflux, 12 h; (ii) NaBH3CN, 
PPTS, MeOH, -30 to -20 oc, 85 %(ratio 272a:272b = 15: I). 
Piperazine analogues are important pharmaceutical compounds, for example, 
compound 273 is a selective inhibitor of dopamine reuptake and is used in the 
treatment of cocaine abuse, 129 and compound 274 has shown anti-carcinogenic, anti-
fungal and anti-viral activities (Figure 3.8). 130 
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TOP followed by a tandem reduction process with methanolic NaBH4 has 
successfully transformed alcohols into amines 28 This methodology also worked for 
formation of tetrahydroquinoline (221) from Z-3-(2-amino-phenyl)-prop-2-en-1-ol 
(207Z). We envisaged formation of piperazine 275 trom a-hydroxyketone 230 using 
a similar approach. The optimum conditions for the synthesis of dihydropyrazines 
were applied to piperazine synthesis, with the addition of four equivalents of NaBH4. 
After complete consumption of the a-hydroxyketonc 230, methanol was added and 
the mixture stirred at room temperature (Scheme 3.40). 
230 251 275 
Scheme 3.40 Reaction and condition: (a)(i) 10 equiv. Mn02, 2 equiv. 
ethylenediamine, 4 A molecular sieves, 2 equiv. HCl, 4 equiv. 
NaBH4, DCM, reflux; (ii) MeOH, rt. 
The results of TOP-reduction are shown in Table 3.9. 
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Table 3.9 Results of the TOP-reduction for piperazine formation.' 



























































" ReactiOns earned out wrth I 0 eqmv.of Mn02, 2 eqmv. of ethylenedrarmne (183), 
4 A molecular sieves, 2 equiv. ofHCI, 4 equiv. ofNaBH4 , DCM, reflux, after which 
MeOH was added and stirred at rt. 
* These dihydropyrazines underwent decomposition under this reaction conditions. 
** Ethylenediamine (183) was replaced by trans-! ,2-dtaminocyclohexane and no HCI 
was used. 
In an attempt to synthesise 2-furanpiperazine (276) from 1-(2-furyl)-2-
hydroxy-1-ethanone (55) by TOP-reduction, we observed the formation of 2,3-
dihydropyrazine 252 as the intermediate, but this underwent decomposition when 
subjected to methanolic NaBH4 (entry i). A similar occurrence happened with 4-
bromophenyl-2-hydroxyethanone (255) (entry ii). When 1-cyclohexyl-2-hydroxy-1-
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ethanone (238) was subjected to TOP-reduction sequence, the conversion gave a fair 
yield of piperazine 278 (34 %) after acid-base work-up (entry iii). Piperazines are 
known to be hygroscopic, making their isolation problematic. Coupled with high 
volatility, this could explain the low yield obtained with 1-cyclohexyl-2-hydroxy-1-
ethanone (238). Nevertheless, this is the first time this compound has been 
synthesised. A co-worker attempted TOP-reduction of a-hydroxyacetophenone (51) 
with ethylenediamine (183), in which the conversion into piperazine 279 went 
smoothly in 52% yield (entry iv). The scope of TOP was also extended in respect to 
the diamine. A co-worker replaced ethylenediamine (183) with a more hindered 
diamine, trans-] ,2-diaminocyclohexane. 122 1-(2-Furyl)-2-hydroxy-1-ethanone (55) 
underwent TOP-reduction with trans-! ,2-diaminocyclohexane to form piperazine 
280 as its diacetate derivative in 60 % yield (entry v). 1-Cyclohexyl-2-hydroxy-1-
ethanone (238) and a-hydroxyacetophenone (51) (entries vi and vii) also underwent 
TOP-reduction efficiently with this diamine to give compounds 281 and 282 in 84 
and 75 % yields, repectively. The success obtained in synthesising piperazines with 
these diamines, suggests that a hindered diamine facilitates the reduction step, or that 
the tri-substituted piperazine products are more stable. 
3.4 Conclusions and Future Work 
(a) 5-Membered Rings with One or Two Nitrogen Atoms 
In summary, we have shown that activated alcohols undergo a TOP sequence 
involving oxidation, double condensation and aromatisation to afford 2-substituted 
benzimidazoles in good yield using manganese dioxide as the in situ oxidant131 
Allylic and propargylic alcohols 79 and 83, however produced the corresponding 
benzimidazoles only in fair yields due to a competing Michael addition. We also 
managed to transform a substrate with a pendant alcohol into 2-substituted-
benzimidazoles via TOP. Replacing N-methyl-1 ,2-phenylenediamine (157) with N-
phenyl-1,2-phenylenediamine also gave a good yield of the benzimidazole, hence 
demonstrating the viability of TOP with other substituents on the diamine. 
Employing 1,2-phenylenediamine (133) as the trapping agent did not produce the 
corresponding benzimidazole, indicating that TOP are suitable for synthesising 1-
alkylated-2-substituted benzimidazoles from activated alcohols but not for the parent 
1-H benzimidazole. 
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Our results also show that 2-aminophenol (174) and 2-aminothiophenol (177) 
could be used in TOP to produce important heterocycles, benzoxazoles and 
benzothiazoles. This opens many opportunities for the synthesis of their derivatives, 
which could be of biological importance. On the other hand, TOP with aliphatic N-
substituted-diamines gave imidazolidines and ring-opened imines in tautomeric 
equilibrium. Addition of dehydrogenating agents such as methanolic KOH or DDQ 
failed to transform imidazolidines into imidazolines and imidazoles. Further work is 
required to study the effects of other dehydrogenating reagents such as NBA, NIS 
and chloroanil that have successfully been used in dehydrogenation of 
imidazolidines. 112 
The conditions used in TOP involved toluene at reflux for 18 hours. We 
believe this can be greatly improved by microwave-assisted dielectric heating. There 
is a precedent for synthesis of 2-substituted benzoxazoles 285 using microwave by 
reacting acyl chloride 283 with 2-aminophenol 284 in 1 ,4-dioxane (Scheme 3.41 ). 111 
We anticipate microwave heating could enhance synthesis of 2-substituted 
benzimidazoles and analogues from TOP of alcohols. This, if successful, could be 
further extended to the use of unactivated alcohols, whose conversion to 
benzimidazole failed with TOP. 









MeO I' 1 
0 h CH3 MeO 
285 
Scheme 3.41 Reagents and conditions: 1,4-dioxane, 210 'C (flW), 15 min, 92%. 
(b) 6-Membered Rings with One Nitrogen Atom 
We have successfully synthesised quinoline (200) via TOP methodology. 
Even though the yield is moderate, we believe that attaching substituents onto the 
1 ,4-amino-alcohol starting material will produce bring upon a more stable substituted 
quinoline in a higher yield. TOP-reduction was also applied to the synthesis of 
tetrahydroquinoline (221 ). The TOP-reduction using a combination of manganese 
dioxide and DIBAL-H, however, failed to convert Z-3-(2-amino-phenyl)-prop-2-en-
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1-ol (207Z) into 1,2-dihydroquinoline (222). These reactions yielded the in situ 
oxidation product, quinoline (200). Further study is required to find a compatible 
reducing reagent to produce I ,2-dihydroquinoline (222 ). 
(c) 6-Membered Rings with Two Nitrogen Atoms 
We have shown that reaction between a-hydroxyketones and I ,2-
phenylenediamine with manganese dioxide under TOP went smoothly to give 
quinoxalines, both known and novel compounds. 122 The method worked well with a-
hydroxyketones attached to methyl, pentyl, phenyl, diphenyl, 2-furyl and cyclohexyl 
groups. The method is simple with the oxidant filtered off after completion of the 
reaction. Most importantly, it prevents the need to isolate a-ketoaldehydes, which are 
unstable. 
Reactions of a-hydroxyketones with alphatic diamines under TOP gave 
moderate yields of dihydropyrazines. The presence of aromatic substituents seems to 
assist dihydropyrazine formation. TOP was further elaborated to allow direct 
synthesis of pyrazines from a-hydroxyketones. Methanolic KOH was added in the 
same pot to oxidise the dihydropyrazines into pyrazines. Again, the presence of 
aromatic substituents facilitated pyrazine formation. TOP-reduction with methanolic 
NaBll4 on the other hand, transformed 1-cyc!ohcxyl-2-hydroxy-l-ethanone (238) 
into piperazine 278 in moderate yield. We had more success in this methodology 
when hindered diamines were used since stable piperazines could be formed. 
We also envisaged other TOP that could produce heterocycles of importance. 
We have synthesised 2-phenyl-benzoxazole and benzothiazole by reacting benzyl 
alcohol with 2-aminophenol or 2-aminothiol employing TOP. These reactions could 
be further elaborated by replacing the benzyl alcohol with a a-hydroxyketone 230, 
which would be oxidised into dicarbonyl 231. The dicarbonyl would then be trapped 
by two molecules of nucleophilc to form tetrahydro-[2,2']bibenzoxazolyl 286 or 
bibenzothiazolyl 287 (Scheme 3.42). 
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286, X= 0 
287, X= S 
Scheme 3.42 TOP for formation of tetrahydro-[2,2']bibenzoxazolyl 286 or 
bibenzothiazolyl 287. 
The reaction between benzene-! ,2-dicarbaldehyde (288) with hydrazine 
hydrate 289 has been used to form phthalazine (290), which is used for its medicinal, 
herbicidal and anti-bacterial properties (Scheme 3.43). 134 
CCoo + H2N-NH2.H20 CCN ~ 
288 289 290 
Scheme 3.43 Reagents and conditions: (a) (i) EtOH, 0 °C, I h, (ii) rt, 2 h, 99 %. 
We envisage syntheses of phthlazines with TOP in which 1,4-
benzenedimethanol (291) is transformed into dialdehyde 292 and trapped by 
hydrazine to give phthlazine 293 (Scheme 3.44). 
e{X~: --- [ '-cc~] .............. _ R-cc~ 
291 292 293 
Scheme 3.44 TOP for formation of pthlazines. 
There is also room for improvement for TOP. Attention should focus on the 
use of polymer-supported species. It is anticipated that polymer-supported trapping 
reagents could be used in TOP. New products such as, I ,2-diaminoethane trityl 
polystyrene resin 294 (Aldrich, catalogue number 54300-4) (Figure 3.9) could be 
explored as an alternative for the solution phase diamine. This would simplify the 
work-up process since the by-products could be filtered from the desired products 
and then cleaved. 
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294 PS = Polymer support 
Figure 3.9 
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4.0 Tandem Oxidation Processes-Nitrile Formation 
We have seen that alcohols can undergo in situ oxidation transfonnations to 
fonn a variety of heterocycles. These reactions involve trapping of the aldehyde(s) 
with N-substituted diamincs, amino-alcohols or amino-thiols and diamines. We were 
interested in expanding the scope of TOP by exchanging the trapping agent for 
ammonia, which would hopefully produce nitriles using this methodology. 
4.1 Synthesis of N itriles 
One of the general methods for the synthesis of nitriles IS the direct 
substitution of alkyl halides with inorganic cyanide (Scheme 4.1 ). 135 
NaCN 
RBr 
R ="Bu. "Pr, 'Bu, Pr 
Scheme 4.1 Reagents and conditions: Ethylene glycol, 60- 101 "C, 15 min -I h, 
39-92%. 
a,J3-Unsaturated nitriles 296 were prepared by reacting aldehydes with 
cyanoalkyl phosphonates 295 in a Homer-Wadworth-Emmons reaction (Scheme 
4.2).136 
RCHO + (Et20J2P(O)CH =N 
295 
---l~ RCH=CII N 
296 
R ~Aryl, 2-furyl, "C7H15• alkenyl 
Scheme 4.2 Reagents and conditions: LiOH, 70 "C, 30 min, 70 "C-rt (after addition 
of aldehyde), 70- 78 %; E,Z ranges from 2.2: I to 9: 1. 
Another popular route for nitrile synthesis is by the dehydration of aldoximes. 
Chang et a!. have shown that aldoximes 297 can be transfonned into nitriles by a 
dehydration process using a catalytic amount of [RuCI2(p-cymene)]2 in the presence 
of molecular sieves (Scheme 4.3). 137 However, this method is limited by the 
preparation of aldoximes, which can be problematic because of the reactivity of the 
aldehydes. 
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R =N + H20 
R =Aryl, heteroaryl, alkenyl, alkynyl 
Scheme 4.3 Reagents and conditions: [RuCh(p-cymene)]z, 4 A molecular sieves, 
CH3CN, 80 "C, 10 -60 min, 80-99%. 
Direct conversion of aldehydes into nitriles has received much attention, 
smce it does not involve isolation of any unstable intermediates. Treatment of 
aldehydes with hydroxylamine hydrochloride in 95-98 % formic acid had 
successfully provided nitriles in good to excellent yield (Scheme 4.4). 138 
R = Aryl and alkyl 
Scheme 4.4 Reagents and conditions: NH2-0H.HCI, 95- 98% formic acid, reflux, 
30 min, 77 - 99 %. 
Condensation of aldehydes with ammoma forming the intermediate 
aldimines, is another route for nitrile synthesis. A method developed by 
Parameswaran eta/. involved slow bubbling of ammonia gas into benzene containing 
the aldehydes and simultaneously adding Pb(OAc)4 portion-wise (Scheme 4.5). This 
procedure is tedious, and only small-scale reactions were demonstrated to give 
nitriles. 130 
RCHO + NH, 
Pb(OAc)4 R -N 
R =Aryl, alkenyl and 2-furyl 
Scheme 4.5 Reagents and conditions: Benzene, 37- 59%. 
Williams et al. proposed adding a mixture of H20 2 (50 % solution) and 
aldehydes slowly into ammonia in 2-propanol saturated with CuCJ to produce 
nitriles. 140 However, this method required cautious cooling (Scheme 4.6). 
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RCHO + NH3 
H,O, 
R =Aryl, heteroaryl, cyclohexyl, 
alkenyl, alkyl 
Scheme 4.6 Reagents and conditions: CuCl, 32- 87 %. 
A more recent paper by Fang et al. outlined the treatment of various 
aldehydes with iodine (1.1 equivalents) in aqueous ammonia at room temperature, 
which afforded moderate to high yields of nitriles (Scheme 4.7)141 This method is 
ideal for water-soluble substrates such as carbohydrates. However, it is known that 
iodine reacts with aqueous ammonia to give nitrogen triiodide monoamine 
(NI3.NH3), which can easily explode by mechanical shock. 
RCHO + NH3 
I, 
R =Aryl, heteroaryl, aliphatic, 
saccharides 
Scheme 4.7 Reagents and conditions: NH3, h, THF, 57- 97 %. 
Recently, Lai's group treated aromatic aldehydes with NH3 (2 M in 2-
propanol), magnesium sulfate and manganese dioxide in THF at room temperature 
(Scheme 4.8). 142 The reaction proceeded to give aromatic nitriles in high yields (76-
93 %). 
Mn02 , MgS04 
ArCHO + NH3 
Scheme 4.8 Reagents and conditions: THF, rt, 16- 22 h, 76 - 93 %. 
4.1.1 Importance of Nitriles 
Nitriles are important constituents of numerous natural products. They are 
important synthetic intermediates for pharmaceutical, agricultural chemical, dye and 
material sciences. Gallardo et a!. synthesised 1 ,2,4-oxadiazole derivative 300 from 
nitrile 298 that was later converted in three steps into compound 301, which is a 
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OH 
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Scheme 4.9 Reagents and conditions: (a) NI-120!-I.HCI, NaHC03, EtOH, I-120, reflux, 
3 h, 66 %; (b) 2-carbomethoxybenzoyl chloride, pyridine, 100 oc, 4 h, 
66%. 
Tetrazoles 303, which play important role in medical chemistry, can be 
prepared by addition of azide ion to nitriles 302 (Scheme 4.1 0). 144 
NaN3 
302 303 
R =Aryl, heteroaryl, alkenyl 
Scheme 4.10 Reagents and conditions: NH4C!, DMF. rtW, 10-20 min, 36-98 %. 
4.2 Preparation of Nitriles via TOP 
We decided to adapt Lai's protocol 142 in the preparation ofnitri1es using TOP, 
by replacing the aldehydes with a variety of alcohols. Hence, we envisaged an in situ 
oxidation of alcohols to aldehydes, which would then be trapped by ammonia to give 
imines. In the same pot, imines would be oxidiscd into nitriles by the excess 
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manganese dioxide (Scheme 4.11 ). This procedure would be particularly useful when 
the aldehydes are difficult to isolate due to volatility, toxicity or reactivity. 
Scheme 4.11 Synthesis of alcohols into nitriles using Mn02 and NH3 
4.2.1 Preparation of Aromatic Nitriles via TOP 
Initially, we treated 4-bromobenzyl alcohol ( 162), as the model alcohol, with 
4 equivalents of ammonia (2M in 2-propanol), 15 equivalents of manganese dioxide 
and 15 equivalents of magnesium sulfate in THF at room temperature for 18 hours. 
This reaction proceeded efficiently to give 4-bromonitrobenzene (304) in 81 % yield 
(m.p. 113 'C, lit. 145 m.p. I 14-114.5 "C). The 1H NMR spectrum gave peaks at 7.62-
7.66 ppm and 7.5 l -7.54 ppm, which agrees with literature values. 146 The presence of 
the nitrile was confirmed by 13C NMR spectroscopy with a signal at I l 8.3 ppm and 
by infra-red spectroscopy with a Vma., at 2224 em·'. We extended TOP methodology 
using the conditions decribed above to a range of aromatic alcohols. The results of 
these reactions are shown in Table 4. l. 
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I Isolated yield(%) 1 m.p./lit. m.p. ('C) 
81 113/114-114.5 145 
81 147-148/148 147 
87 94-96/ 97-98 148 
78 224-225/227 149 
82 76-77178 150 
0 
0 
" Reactwns earned out with 15 eqmv. ofMn02, 15 eqmv. ofMgS04, 4 eqmv. of 
NH3 (2M in 2-propano1) in THF at rt for 18 h. 
* 30 equiv. of Mn02 used in this example. 
** No product was obtained after stirring under the above conditions. 
The presence of electron-withdrawing or electron-donating substituents had 
no adverse effect on the TOP for nitrile formations. 4-Nitrobenzyl alcohol (60) and 
2-hydroxybenzyl alcohol (306) (entries ii and iii) gave high yields ofnitriles 305 and 
307 (81 and 87 %, respectively). I ,4-Bcnzenedimethanol (77) with two benzylic 
alcohols was reacted with ammonia in the TOP sequence (entry iv) giving dinitrile 
308 in 78 % yield, very close to the yield obtained when carrying out the reaction 
directly from the dialdehyde (80 %)151 1-Naphthalenemethanol (164) also underwent 
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TOP smoothly to give the corresponding nitrile 309 in high yield (82 %) (entry v). 
TOP on 2,6-dichlorobenzyl alcohol (310) did not produce any nitrile (entry vi). 
Similarly, with 3,5~dichlorobenzyl alcohol (312), only the starting material was 
recovered. We tried to facilitate the oxidation by heating these reactions to reflux in 
THF, but with no success. Changing the solvent to DCM or toluene did not help 
either. We assumed that these alcohols might be too hindered for the manganese 
dioxide adsorption. In addition, the presence of two electron withdrawing groups 
near the alcohol could reduce its nucleophilicity. 
4.2.2 Preparation of Heterocyclic Nitriles via TOP 
We expanded the scope of TOP for nitrile formation to heterocyclic alcohols. 
The heterocyclic group should activate the alcohols to oxidation. The conditions used 
for the aromatic alcohols were applied to heterocyclic alcohols. The results of these 
reactions are shown in Table 4.2. 
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!Isolated yield(%) I m.p./lit. m.p. ('C) 
44 142-144/142 152 
48 166-1671169 153 
80 179-1801179-180 154 
93 177-179/179-180 155 
30 47-48/48-50 156 
60 110-111/107-109157 
65 132-134/131 158 
77 180/180'" 
44 76-77/78.5-81.5 160 
"Reactwns earned out w1th 15 eqmv. ofMn02, 15 equ1v. ofMgS04, 4 eqmv. of 
NH3 (2M in 2-propanol) in THF at rt for 18 h. 
Almost all of the heterocyclic alcohols (with the exception of 2-pyridine-
methanol (322) and 3-indole-methanol (326)) underwent TOP to give amides. 
Furfuryl alcohol (314) underwent TOP to produce 2-furancarboxamide (315) in 44% 
92 
Chapter 4: Tandem Oxidation Processes-Nitrile Formation 
yield (entry i). The 13C NMR spectrum showed the presence of an amide with a C=O 
peak at. 160.3 ppm, which corresponds to the literature value of 160 ppm161 The 
reaction was also carried out in DCM and petroleum ether, which gave amide 315 in 
31 and 19% yields, respectively. We added various amounts of 2M HCl in ether 
(0.1 equivalents - 2 equivalents) in the hope that this would enhance nitrile 
formation. These reactions, however, produced amide 315. We suspect that the nitrile 
was initially formed, but was too reactive in the reaction mixture, and was rapidly 
hydrated to amide 315. Attempts to isolate the nitrile intermediate, by stopping the 
reaction immediately after complete consumption of the alcohol, only yielded amide 
315. 
The same result was observed with 3-furan-methanol (316), which gave 
amide 317 in 48% yield (entry ii). 2-Thiophene- and 3-thiophene-methanol (318 and 
320) underwent TOP to afford amides 319 and 321 (entries iii and iv) in 80 and 93% 
yields, respectively. 2-Thiophenecarboxamide 319 is known for its ability to inhibit 
poly(ADP-ribose)polymerase (PARP), that inhibits repair of damaged DNA. 162 The 
higher yields obtained with 2-thiophene- and 3-thiophene-methanol (318 and 320) 
could be explained by the fact that the aldehydes formed in situ are less volatile than 
furfural. When pyridine-2-methanol (322) was subjected to TOP, we observed 
formation of both nitrile 323 and amide 324 in 30 and 60 % yields, respectively 
(entry v). In a separate flask, we treated the 2-pyridine-nitrile 323 with manganese 
dioxide and MgS04. This reaction yielded amide 324 in 60 % yield (Scheme 4.12) 





Scheme 4.12 Reagents and conditions: 15 equiv. Mn02, 15 equiv. MgS04, 
THF, rt, 6 h, 60 %. 
3-Pyridine-methanol (168) underwent TOP to give amide 325 as the sole 
product (entry vi). On the other hand, TOP with indole-3-methanol 326 produced 
nitrile 327 in good yield (77 %) (entry vii). Finally, we attempted the conversion of 
!e!rahydrofuranmethanol (328) into nitrile under TOP methodology (entry viii). 
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Although this is an unactivated alcohol, the heteroatom coordination may assist 
manganese dioxide oxidation. The reaction gave amide 329 in 44 % yield. In all 
cases mentioned above, the observed spectroscopic data were consistent with 
published values. 
Liu et al. reported that nitriles 330 could easily be converted into amides 331 







R =Benzyl, 3-pyridyl, cinnamyl, alkyl 
Scheme 4.13 Reagents and conditions: 1.5 equiv. Mn02, hexane, 35-100%. 
With heterocyclic systems, the presence of nearby proximal heteroatom 
seems to play a role in increasing the reactivity of the nitrile and inducing its 
hydration to form the amide. We attempted TOP with alcohols attached to a longer 
carbon chain on the heterocyclic system in order to reduce the heteroatom effect. For 
example, we tried TOP on 2-pyridine-ethanol (332). This reaction underwent TOP to 
give amide 324 previously observed tfom oxidation of pyridine-2-methanol (322). 
We assume that oxidative degradation occurred to give 2-pyridinecarbaldehyde 
(333), which reacted with ammonia to form amide 324 via the corresponding nitrile 
(Scheme 4.14). Oxidative degradation by manganese dioxide was also reported by 
Crotti and Macchia where 2-phenylethanol gave benzaldehyde instead of 2-phenyl-
acetaldehyde.115b 
~OH OyNH2 
332 333 324 
Scheme 4.14 Reagents and conditions: 15 equiv. MnOz, 15 equiv. MgS04, 
4 equiv. NH1 (2M in 2-propanol), THF, rt, 30 %. 
0 
The results of TOP with most of the heterocycles gave amides. We were keen 
to expand the scope of amide formations with other nucleophiles. The ammonia used 
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in the TOP was replaced by a primary amine to see if a substituted amide could be 
formed. We treated furfuryl alcohol (314) with aniline (334) under the TOP 
conditions. Not unexpectedly, in view of earlier studies in our group,27 the 





v ~Nl) o I ~ 
335 334 
Scheme 4.15 Reagents and conditions: 15 equiv. Mn02, 15 equiv. MgS04, 
THF, rt, 40 %. 
4.2.3 Preparation of Aliphatic Nitriles via TOP 
We further expanded the scope of this TOP sequence by investigating 
aliphatic alcohols, some containing activating alkenyl and alkynyl groups. The 
conditions used for the aromatic alcohols were applied to these aliphatic alcohols. 
The results of these reactions are shown in Table 4.3. 
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Table 4.3 Results of TOP for nitrile formation with aliphatic alcohols.' 



























































I 04-1 06!1 07-108 165 
Reactwns earned out wrth 15 egUJv. ofMnO,, 15 eqUJv. ofMgSO,, 4 egurv. of 
NH3 (2M in 2-propanol) in THF at rt for 18 h. 
* Reactions carried out under the above conditions for 24 h. 
" No product was obtained under the above conditrons. 
"*Reaction carried out under the above conditrons for 2 h. 
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TOP with (E)-2-nonen-1-ol (336) using 15 equivalents of Mn02, 
15 equivalents of MgS04 and 4 equivalents of NH3 (2 Min 2-propanol) in THF at 
room temperature for 24 hours gave (E)-2-nonenenitrile (337) in 82 % yield (entry i). 
The 1H NMR spectrum showed alkenic peaks at 6.50 and 5.26 ppm with J values 
of 16.1 Hz. (Z)-2-nonen-1-ol (338) underwent TOP giving nitrile 339 as a mixture of 
Z- and £-isomers in a ratio of 5:1 (entry ii). The Z-nitrile is presumed to partially 
isomerise to the £-nitrile under these reaction conditions. The 1 H NMR spectrum of 
the Z-isomer showed alkenic peaks at 6. 72 and 5.23 ppm with J values of 10.9 Hz. 
In all cases mentioned above, the observed spectroscopic data were consistent with 
published values. Smaller carbon chains attached to allylic alcohol, e.g. E- and Z- 2-
hexen-1-ol (340 and 34, respectively) (entries iii and iv) were subjected to TOP, but 
these reactions did not produce any nitriles. We suspect that these alcohols produced 
aldehydes that were too volatile or underwent polymerisation due to their high 
reactivity. TOP was also attempted on trans-2,3-dibromo-2-butene (343), but this 
reaction gave only starting material. 
The propargylic alcohol, 2-nonyn-1-ol (345) underwent TOP to produce 
nitrile 346 in good yield (87 %) (entry vi). 3-Phenyl-2-propyn-1-ol (83) underwent 
the in situ oxidation to give nitrile (347) in 82% yield after 2 hours (entry vii). The 
13C NMR spectrum showed a signal at 116.9 ppm, which agrees with the literature 
value. 166 When we subjected alcohol 83 to TOP for 18 hours, the reaction gave a 
mixture of nitrile 347 and amide 348 in 30 % and 60% yields, respectively (entry 
viii). The 13 C NMR spectrum of amide 348 had a peak at 156.1 ppm for the given 
C=O (literature value is 156.0), 167 whilst infra-red spectroscopy showed vm, at 3376 
and 1635 cm·1 for NH2 and C=O absorptions, respectively It is proposed that in this 
reaction the nitrile 347 was initially formed, but underwent manganese dioxide-
assisted hydration to form amide 348 as observed before (Scheme 4.16). 163 
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Ph---,::::=--CON H 2 
83 347 348 
Scheme 4.16 Reagents and conditions: 15 equiv. Mn02, 15 equiv. MgS04, 4 equiv. 
NH3 (2M in 2-propanol), THF, rt, 18 h, 347 = 30 %, 348 = 60 %. 
TOP was also applied to decanol ( 47) (entry ix), but only starting material 
was recovered from the reaction. We suspect the manganese dioxide could not 
oxidise the unactivated alcohol under these reaction conditions. 
4.3 Conclusions and Future Work 
TOP has been successfully applied to a range of aromatic alcohols to produce 
nitriles, with the exception of 2,6-dichoro- and 3,5-dichloro-benzyl alcohol (310 and 
312). 168 The methodology could prove useful as alternative route for synthesising 
aromatic nitriles, for example, in making compound 350, which has the potential to 
be used as an IMPDH (inosine 5'-monophosphate dehydrogenase) inhibitor for 
treatment of the Hepatitis C virus, 169 5-nitro-2-(4-trifluoromethyl-phenoxy)-
benzonitrile (351) and 5-nitro-2-(2-bromo-phenoxy)-benzonitrile (352), which 
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TOP with heterocyclic alcohols, i.e. 2-pyridinemethanol (322) and indole-3-
methanol (326) provided nitriles, although 2-pyridine-2-methanol (322) also gave 2-
pyridinecarboxamide (324). Likewise, the rest of the heterocyclic alcohols in our 
study gave amides under the in situ oxidation conditions. The results of our studies 
also showed that allylic alcohols, i.e. (£)-2-nonen-1-ol (336) and (Z)-2-nonen-1-ol 
(338) underwent TOP smoothly to give high yields of nitriles, even though a small 
amount of isomersation of the Z- to the £-isomer was observed. 2-N onyn-1-ol (345) 
and 3-phenyl-2-propyn-1-ol (83) also underwent TOP efficiently to afford nitriles 
346 and 347, respectively. 
More studies are required to optimise the reaction of heterocyclic alcohols to 
form nitriles. On the other hand, the formation of the amides could be useful for the 
direct conversion of alcohols into amides. Amides attached to heterocycles have 
important medicinal values, for example, 2-pyridinecarboxamide (324) is known for 
its anti-arthritic property, 171 while 4-pyridinecarboxamide is used for treatment of 
tuberculosis. 172 
Khadlkar et al. reported synthesis of amides 354 from the microwave-
promoted hydration ofnitriles 353 using manganese dioxide and silica under solvent-
free conditions (Scheme 4.17). 1 JJ 
354 
R = Aryl, pyrazines and piperazines 
Scheme 4.17 Reagents and conditions: Mn02/Si02, ~tW, 2- 14 min, 41-99%. 
The reaction could be explored further by using alcohols as the starting 
material. Hence, we envisage synthesis of amides 357 from TOP of alcohols 355 
(Scheme 4.18). This alternative route offers a practical approach to amide formation, 
since the alcohols are available commercially. 
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Route B (a) (i) 





Route A Aryl and aliphatic 
Route B: Heterocyclic 
Scheme 4.18 Reagents and conditions: (a) (i) 15 equiv. Mn02, 15 equiv. MgS04, 
4 equiv. NH3 (2M in 2-propano1), THF, rt, 18 h; (ii) Si02, )lW. 
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5.1 General 
Chapter 5: Experimental 
All reagents were purchased from commercial sources and were used 
without further purification unless stated in the text. Activated manganese dioxide 
was purchased from Aldrich, catalogue number 21,764-6. Anhydrous reactions were 
performed in flame-dried glassware under a nitrogen atmosphere. THF and EhO 
were distilled from sodium benzophenone kctyl and DCM was distilled from calcium 
hydride prior to use. The inorganic solutions used were either saturated; brine 
(NaCl), NH4Cl, NaHC01, Na2C03 or of the approximate concentration indicated in 
the text. TLC analysis was performed using Merck silica gel 60 F254 aluminium-
backed plates. Compounds were visualized using UV (254 nm) light, a basic aqueous 
solution of permanganate, an ethanolic solution of vanillin or an ethanolic solution of 
2,4-dinitrophenylhydrazine. Column chromatography was performed using silica gel 
35-70rt which was purchased from Fluka. Silica filtrations were carried out using 
Celite 521 purchased from Aldrich. 
5.2 Spectroscopic and Analytical Techniques 
Low and high field resolution electron impact (EJ) and chemical ionisation 
(CJ) mass spectrometry experiments were performed by Dr. T. A. Dransfield and Mr. 
B. R. Glennie using a Fisons Analytical (VG) Autospec instrument. Infra-red 
spectroscopy was carried out using an ATI Mattson Genesis FT -IR or ThermoNicolet 
IR 100 spectrometer. The samples were either recorded between NaCl plates as neat 
films or in solution. 1H and 13C NMR spectra were recorded on a JEOL EX-270 
instrument operating at proton and carbon frequencies of 270.01 and 67.9 MHz, 
respectively, AMX 300 at 300.13 and 75.0 MHz, respectively, JEOL ECX-400 
instrument at 400.00 MHz and 100.0 MHz, respectively. Chemical shifts are quoted 
in parts per million (ppm) using tetramethylsilane as the internal standard. Coupling 
constants are given in Hz and the 'Jc: spectra were verified using DEPT experiments. 
Melting points were recorded on a GallcnKamp melting point apparatus and are 
uncorrected. 
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5.3 Assignment of Data 
The hydrogen and carbon atoms in the compounds illustrated in this 
Chapter have been assigned letters. These letters are used as reference points in the 
text to clarify assignment of the data described, and have been used in preference to a 
numbering system to avoid confusion with numbers in the IUPAC nomenclature. 




g e c a 
:::-._ CH3 
d b 
Dodecanal (1.1 0 ml, 5.00 mmol), MTBD (1.6 ml, 11.0 mmol) and ethyl 
triphenylphosphonium bromide (2.04 g, 5.50 mmol) were added to THF (30 ml). 
The mixture was heated at reflux under N2 for 24 h. It was concentrated in vacuo and 
the residue was purified by column chromatography (PE:EtOAc, 18:1) to give the 
title compound 116 (with £:2 ratio of I :2.5) (0.647 g, 66 %) as a colourless oil, Rr 
0.40 (PE:EtOAc, 15:1); vm., (neat)/cm' 1 1593 (C=C), 700 (H-C=C); 8H (300.13 
MHz, CDC]]) 5.36-5.50 (2.3H, m, CHb,c E and Z), 198-2.04 (2.3H, m, CH2d E and 
Z), 1.62-164 (IH, m, CH/ E), 159-161 (2.5H, m, CH34 Z), 107-1.24 (21H, m, 
Cth'·m E and Z), 0.89 (3.5H, t, J 7.0 Hz, CH3' E and Z); mlz (EI) 196 (M+). CDW 
5/1 0/2a. The spectroscopic data were consistent with those reported in the 
literature. 174 
2,3-Tetradecanediol (117) 
m k g 
OH a e 
b CH 3 
n h f d c 
OH 
(a) To 2-tetradecene (116) (0.223 g, 1.14 mmol) dissolved in EtOH (100 ml) and 
stirred at -20 "C, was added a solution of KMnOa (0.122 g, 0.76 mmol) and MgS04 
(0.091 g, 0.76 mmol) in HzO (30 ml) over a period of 20 min. The mixture was 
filtered through Celite® and the cake washed with MeOH (30 ml) and Et20 (30 ml). 
The filtrate was concentrated, diluted with brine (20 ml), and extracted with Et20 (2 
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x 10 ml). The organic extracts were combined and dried with MgS04, filtered and 
concentrated in vacuo. The residue was purified by column chromatography 
(PE:EtOAc, 3:2) to give the title compound 117 (0.0262 g, 10 %) as a colourless oil, 
Rr 0.65 (PE:EtOAc, 1:2); vm, (neat)/ cm·1 3305 (OH); 8H (300.13 MHz, CDCh) 
3.80-3.81 (2H, m, CHb·'), 3.62-3.64 (2H, m, CHct), 1.18-1.25 (18H, m, CH/-m), 1.14 
(3H, d, J 6.3 Hz, CH3'), 0.87 (3H, t, J 6.7 Hz, CH3"); c (75.0 MHz, CDCb) 75.5 
(CH), 71.0 (CH), 34.2 (CH,), 32.5 (CH,), 32.5 (CH,), 31.5 (CH,), 31.1 (CH, X 2), 
30.2 (CH,), 30.0 (CH2), 26.6 (CH,), 23.3 (CH,), 17.2 (CH3), 14.7 (CH3); m!z (CI) 
248 (MNH/ 100%) [HRMS (CI) calcd. for C 14H34N02 (MNH/), 248.2590, found: 
248.2586 (1.6 ppm error)]. CDW 5/10/2-1 b. 
(b) A solution ofOs04 (0.9 ml, 0.1 mmol) was added to a solution of2-tetradecene 
(116) (0.872 g, 4.45 mmol) and NMO (0.574 g, 4.90 mmol) in 1:1 THF/H20 (30 ml). 
The reaction was stirred at rt for 18 h before being quenched with sodium 
metabisulfite, NaS20 5 (6.0 g). It was left to stir for 1 h. The dark mixture was then 
diluted with EtOAc (15 ml) and the organic layer was washed with H,O ( 10 ml) 
before being dried with MgS04 and filtered. The solvent was removed in vacuo and 
the residue was purified by column chromatography (PE:EtOAc, 3:2) to give the title 
compound 117 (0.583 g, 57%) as a colourless oil, R10.65 (PE:EtOAc, 1:2). Spectral 
data is as provided above. 
2,3-Tetradecanedione (112) 
m k g e a b CH 3 
n h d c 
0 
TFAA (0.32 ml, 2.10 mmol) was added dropwise to a solution ofDMSO (0.2 ml, 2.3 
mmol) in DCM ( 4 ml) under N2 at ca. -60 oc. The solution was stirred for 10 min, 
after which time 2,3-tetradecanediol (117) (0.167 g, 0. 73 mmol) dissolved in 
minimum volume of DCM (2 ml), was added dropwise. The mixture was stirred at -
60 "C for 1.5 hand EtJN (0.50 ml) was added dropwise. It was left to warm to ca. 5 
"C, poured into aqueous 2 M HCl (3 ml) and extracted with Et,O (1 0 ml). The 
organic layer was dried with MgS04, filtered and concentrated in vacuo. The residue 
was purified by column chromatography (PE:DCM, 3:1) to give the title compound 
112 (0.066 g, 40 %) as a colourless oil, Rr 0.40 (PE:DCM, 3:2); vm, (neat)/cm·1 
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1708 (C=O), oH (300.13 MHz, CDCb) 2.74 (2H, t, J 7.4 Hz, CH}), 2.31 (3H, s, 
CH1'), 1.24-1.25 (18H, m, CH{m), 0.87 (3H, t, J 6.7 Hz, CH1"); . .: (75.0 MHz, 
CDCb) 211.3 (C), 200.2 (C), 40.5 (CH2), 36.4 (CH2), 32.5 (CHz), 30.2 (CH2), 30.0 
(CH2), 29.9 (CH2), 29.7 (CH2), 24.4 (CH2), 23.7 (CH2), 23.3 (CH2), 16.8 (CH3), 14.7 
(CH3); m/z (CI) 244 (MNH/ 100%) [HRMS (CI) calcd. for C,4H1oN02 (MNH/), 
244.2276, found: 244.2273 (1.5 ppm error)]. COW 5/12/2a. 
Methyl (E)-2-tetradecenoate (119) 
m k g e c a n o ~ 0 -cH 
3 
h f d b 
0 
Methyl 2-(triphenylphosphoranylidene)acetate (9.80 g, 29.30 mmol) was added to 
dodecanal (4.50 g, 24.41 mmol) in DCM (60 ml). The mixture was stirred at rt under 
N2 for 24 h. It was concentrated in vacuo and the residue was purified by column 
chromatography (PE:EtOAc, 24:1) to give the title compound 119 (4.94 g, 88 %) as a 
colourless oil, Rr 0.45 (PE:EtOAc, 19:1); Vm., (neat)/cm·' 1729 (C=O), 1658 (C=C); 
b OH (400.00 MHz, CDCb) 6.99 (IH, dt, J 15.6, 17.1 Hz, CH ), 5.82 (IH, d, J 15.6 
Hz, CH'), 3. 70 (3H, s, CH3 '), 2.14-2.19 (21-1, m, CI-1/), 1.28-1.41 (18H, m, CH/1), 
0.86 (31-1, t, J 6.8 Hz, CH3m); mlz (Cl) 248 (MNH/ 100%). COW 7/44/la. The 
spectroscopic data were consistent with those reported in the literature. 175 
(E)-2-Tetradecen-1-ol (120) 
n h f d b 
~ OH 
m k g e c a 
DIBAL-H in hexane ca. 1 M (43.0 ml, 41.90 mmol) was added dropwise to a 
solution of methyl (E)-2-tetradecenoate (119) (4.83 g, 21.00 mmol) in DCM (100 
ml) at 0 °C under N2. The mixture was stirred for 45 min and quenched with 20 % 
w/v KNaC4H406.4H20, Rochelle's salt, (100 ml) until clear separation of the two 
phases. It was extracted with EhO ( 100 ml). The organic layer was washed with H20 
( 100 ml), dried with MgSO• and filtered. The solvent was removed in vacuo and the 
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residue was purified by column chromatography (PE:EtOAc, 4:1) to give the title 
compound 120 (3.46 g, 78 %) as a colourless oil, Rr 0.25 (PE:EtOAc, 3:1); Vm., 
(neat)/cm-1 3332 (OH), 1670 (C=C); 8H (400.00 MHz, CDCh) 5.60-5.70 (2H, m, 
CHb·'), 4.07 (2H, dd, J 5.1, 1.0 Hz, CH2'), 2.00-2.04 (2H, m, CHzct), 1.25-1.32 (ISH, 
m, CH2'-m), 0.88 (3H, t, J 6.8 Hz, CH 3"); m/z (Cl) 230 (MNH/ 85%). CDW 
7/45/1a. The spectroscopic data were consistent with those reported in the 
literature. 176 
tert-Butyl( dimethyl)[ (E)-2-tetradeceuyloxy] silane (121) 
n h 






DMAP (0.92 g, 4.77 mmol) and TBDMSCl (2.50 g, 10.50 mmol) were added to a 
solution containing (E)-2-tetradecen-1-ol (120) (2.02 g, 9.54 mmol) and Et3N (2.1 0 
ml) in DCM (100 ml) under N2. The mixture was stirred at rt 18 h. The mixture was 
extracted with EtzO (100 ml) and washed with H20. The aqueous layer was extracted 
with DCM (20 ml), then the combined organics dried with MgS04 and filtered. The 
solvent was removed in vacuo and the residue was purified by column 
chromatography (PE:EtOAc, 30:1) to give the title compound 121 (2.80 g, 90 %) as a 
colourless oil, Rr 0.80 (PE:EtOAc, 20:1); vm., (neat)/cm-1 968 (H-C=C); 8H (400.00 
MHz, CDC]]) 5.59-5.63 (IH, m, CH'), 5.52-5.56 (1H, m, CHb), 4.12 (2H, dd, J 5.2, 
1.2 Hz, CHz"), 2.04-2.06 (2H, m, CHzct), 1.43-1.48 (ISH, m, CHz'-m), 0.91 (9H, s, 
CHl), 0.88 (3H, t, J 6.8 Hz, CH3"), 0.06 (6H, s, CH3°); c (100.0 MHz, CDC]]) 
132.1 (CH), 129.5 (CH), 64.6 (CH2), 32.7 (CH2), 32.4 (CH2), 30.1 (CH2), 30.1 
(CHz), 29.9 (CHz), 29.8 (CHz), 29.7 (CHz), 26.5 (CIIz), 26.5 (CH2), 26.5 (CH3 x 3), 
23.2 (C), 19.0 (CHz), 14.6 (CH3), -4.6 (CH1 x 2); mlz (CI) 311 (M+- 15 100 %). 
[HRMS (Cl) calcd. for C 19H390Si ((M+- 15), 311.2772, found: 311.2770 (0.5 ppm 
error)). CDW 7/46/1a. 
105 
Chapter 5: Experimental 
1-{ [tert-butyl( dimethyl)silyl] oxy}-2,3-tetradecauediol (123) 
0 
n h d OH 
CH3 I~ c 0-yi 
b 
m k 9 e a CH3 OH 
To a solution of AD-mix ~ (9.00 g) in 1 1 tert-butylalcohoi/HzO (64 ml) was added 
CH1SOzNHz (0.61 g, 6.42 mmol) and the resulting mixture was stirred for 15 min. It 
was cooled to 0 oc and /er/-butyl(dimethyl)[(E)-2-tetradecenyloxy]silane (121)(2.09 
g, 6.41 mmol) was added to the mixture. It was stirred at rt for 20 h. Na2S20 5 (9.0 g) 
was added and it was left to stir for I h, followed by extraction with EtOAc (50 ml). 
The aqueous layer was further extracted with EtOAc (2 x 50 ml) and the combined 
organic layer was washed with 2 M KOH (20 ml) then dried with MgS04 and 
filtered. The solvent was removed in vacuo and the residue was purified by column 
chromatography (PE:EtOAc, 6:1) to give the title compound 123 (1.38 g, 60 %) as a 
colourless oil, Rr 0.22 (PE:EtOAc, 6:1); Vma' (neat)/cm·' 3401 (OH); 81! (270.01 
MHz, CDCI3) 3.76 (I H, dd, J 10.1, 3.7 Hz, CH'), 3. 70 (IH, dd, J I 0.3, 5.1 Hz, CH'), 
3.59-3.65 (IH, m, CHb), 3.45-3.49 (IH, m, CH'), 2.75 (IH, s, br, OH), 2.65 (IH, s, 
br, OH), 1.50-1.52 (2H, m, CH2"), 1.35-1.38 (ISH, m, CH2'-m), 0.91 (9H, s, CH/), 
0.88 (3H, t, J 6.8 Hz, CH1"), 0.07 (6H, s, CH3°); c (67.9 MHz, CDCIJ) 73.4 (CH), 
72.8 (CH), 66.4 (CHz), 34.1 (CHz), 32.4 (CHz), 30.1 (CH2 x 2), 30.1 (CH2), 30.1 
(CHz), 30.1 (CHz), 29.8 (CHz), 26.3 (CH1 x 3), 26.1 (C), 23.1 (CH2), 18.6 (CH2), 
14.5 (CH3), -5.5 (CH3), -5.6 (CH3); mlz (Cl) 361 (MH+ 100%) [HRMS (CI) calcd. 
for CzuH450 3Si (MH\ 361.3134, found: 361.3127 (3.0 ppm error)]. CDW 7/47/1a. 
1-{ [ tert-Butyl( dimethyl)silyl] oxy }-2-hydroxy-3-tridecanone (125) 
0 
m k 9 e b a 
h f d c 
OH 
To /ert-butyl(dimethyi)[(E)-2-tridecenyloxy]silane (124) (1.24 g, 3.60 mmol), was 
added acetone (23 ml), HzO (5 ml) and acetic acid (0.5 ml) in a H20 bath. A solution 
of KMn04 (0.79 g, 5.00 mmol) in H20 (3 ml) and acetone (14 ml) were quickly 
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added to the mixture. It was stirred for 15 min and the manganese dioxide formed 
was dissolved using minimum amount ofNaN02 (0.4 g) and dilute H2S04 (0. I M, 5 
ml). The mixture was washed with brine (I 0 ml) extracted with Et20 (3 x I 0 ml). 
The organic layer was concentrated and washed with 5% NaOH (2 x 10 ml). It was 
then washed with brine (I 0 ml), dried with MgS04 and filtered. The solvent was 
removed in vacuo and the residue was purified by column chromatography 
(PE:EtOAc, 4:1) to give the title compound 125 (0.804 g, 65 %) as a colourless oil, 
Rr0.60 (PE:EtOAc, 3:1); vm., (neat)/cm-1 3476 (OH), 1717 (C=O); 8H (270.01 MHz, 
CDC13) 4.08-4.13 (IH, m, CHb), 3.95 (lH, dd, J 10.7, 3.4 Hz, CH'), 3.75 (IH, dd, J 
10.6, 4.0 Hz, CH'), 3.62 (lH, s, br, OH), 2.40-2.60 (2H, m, CH2ct), 1.20-1.21 (16H, 
m, CH,'\ 0.86 (3H, t, J 7.0 Hz, CH1m), 0.83 (9H, s, CH1"), 0.00 (6H, s, CH3°); c 
(67.9 MHz, CDC13) 211.0 (C), 77.0 (CH), 64.3 (CH,), 38.2 (CH,), 31.4 (CH,), 29.2 
(CH,), 29.1 (CH,), 29.0 (CH,), 28.9 (CH,), 28.8 (CH,), 25.3 (CHJ X 3), 22.9 (CH,), 
22.3 (CH,), 19.0 (C), 13.7 (CH3), -5.1 (CHJ), -5.3 (CH1); m/z (CI) 345 (MH+ 100 %) 
[HRMS (CI) calcd. for C 19H41 0 3Si (MH+), 345.2825, found: 345.2830 (1.3 ppm 
error)]. CDW 6/34/2a. 
1-{ [ tert-Butyl( dimethyl)silyl [ oxy }-2,3-tridecanedio ne ( 126) 
n 
m k g e 
h d c 
0 
To a stirred solution of 1- {[tert-butyl( dimethyl)silyl]oxy} -2-hydroxy-3-tridecanone 
(125) (0.478 g, 1.39 mmol) in DCM (8 ml) at -10 oc, was added pyridine (0.18 ml) 
and Dess-Martin periodinane (0.882 g, 2.08 mmol) under N2. The solution was 
stirred at -I 0 oc for I h. It was quenched with sodium thiosulfate (1 0 ml), extracted 
with Et20 (10 ml) and washed with NaHC03 (10 ml). The organic layer was dried 
with MgS04 and filtered. The solvent was removed in vacuo and the residue was 
purified by column chromatography (PE:EtOAc, 3: I) to give the title compound 126 
(0.342 g, 72 %) as a yellow oil, Rr 0.75 (PE:EtOAc, 2:1); vm., (neat)/cm-1 1713 
(C=O), 1650 (C=O); 8H (270.01 MHz, CDC~]) 4.65 (2H, s, CH,'), 2.65 (2H, t, 17.3 
Hz, CH,ct), 1.16-1.18 (16H, m, CH,'\ 0.86 (3H, t, J 7.1 Hz, CH1m), 0.83 (9H, s, 
CH/), 0.00 (6H, s, CH3"); c (67.9 MHz, CDC~]) 196.4 (C), 194.2 (C), 66.0 (CH2), 
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36.6 (CHz), 31.8 (CH2), 29.5 (CH2), 29.4 (CHz), 29.3 (CH2), 29.1 (CHz), 29.1 (CHz), 
29.1 (CH2), 25.7 (CHJ x 3), 22.7 (CH2), 19.0 (C), 14.0 (CH3 ), -5.6 (CH3 x 2); mlz 
(CI) 343 (MH+ 100 %), 360 (MNH/ 35 %) [HRMS (CI) calcd. for C19H4zN03Si 
(MH\ 360.2934, found: 360.2938 (0.9 ppm error)]. CDW 6/39/Ia. 





CH3 o n o-F-* 
m k g a CH3 
0 
To a solution of l-{[tert-butyl(dimethyl)silyl]oxy}-2,3-tetradecanediol (123) (1.19 
g, 3.30 mmol) in anhydrous acetone (18 ml) was added 2,2-dimethoxypropane (3.40 
ml, 26.33 mmol) and CSA (0.08 g, 0.33 mmol). The mixture was stirred at 25 °C for 
18 h and quenched with Et3N (2 ml). The organic solvent was removed in vacuo. 
HzO (I 0 ml) was added to the residue and the organic compound was extracted with 
Et20 (I 0 ml). The organic layer was dried with MgS04 and filtered. The solvent was 
removed in vacuo and the residue was purified by column chromatography 
(PE:EtOAc, 8:1) to give the title compound 128 (1.10 g, 83 %) as a colourless oil, 
Rr 0.58 (PE:EtOAc, 8: I); Vm, (neat)/cm-1 1464, 1368, 1089 (C-O); 811 (400.00 MHz, 
CDCI3) 3.88 (IH, dt, J 10.7, 4.6 Hz, CH\ 3.71-3.79 (2H, m, CH23), 3.59-3.60 (IH, 
m, CH'), 1.58-1.61 (2H, m, CH2ct), 1.40 (3H, s, CH3q), 1.37 (3H, s, CH3q), 1.25-1.28 
(ISH, m, CHze-m), 0.86 (3H, t, 17.0 Hz, CH0 ), 0.83 (9H, s, CH3°), 0.07 (6H, s, CHJP); 
c (100.0 MHz, CDCh) 108.7 (C), 81.6 (CH), 79.2 (CH), 64.2 (CH2), 33.9 (CH2), 
32.4 (CHz), 30.2 (CH2), 30.1 (CH2), 30.1 (CH2), 30.1 (CH2), 30.0 (CH2), 29.9 (CH3), 
27.9 (CH3), 27.4 (CHz), 26.5 (CH2), 26.4 (CH3 x 3), 23.2 (C), 18.8 (CH2), 14.6 
(CH,), -4.9 (CH3), -5.0 (CH3); mlz (CI) 401 (MH+ 15 %) [HRMS (CI) calcd. for 
C23 H.90 3Si (MH+), 401.3451, found: 401.3455. (1.1 ppm error)]. CDW 7/48/lb. 
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(2,2-Dimethyl-5-undecyl-[1,3[-dioxalan-4-yl)methanol (129) 
0 
n h OH 
m k g e a 0 
TBAF in 1.0 M THF (4.0 ml, 4.0 mmol) was added to a solution of tert-butyl[(2,2-
dimethyl-5-undecyl-l ,3-dioxolan-4-yl)methoxy ]dimethylsilane (128) (0. 800 g, 2.00 
mmol) in THF (32 ml) at rt under N2. The mixture was stirred for 18 h. EhO (20 ml) 
was added and the organic layer was washed with H,O (20 ml), dried with MgS04 
and filtered. The solvent was removed in vacuo and the residue was purified by 
column chromatography (PE:EtOAc, 6: I) to give the title compound 129 (0.555 g, 97 
%) as a colourless oil, Rr 0.38 (PE:EtOAc, 3:1); vm" (neat)/cm-1 1464, 1378, 1049 
(C-0); OH (400.00 MHz, CDCh) 3.88 (lH, dt, J 12.9, 2.5 Hz, CH\ 3.71-3.79 (2H, 
m, CH2'), 3.59-3.60 (lH, m, CH'), 2.26 (IH, s, br, OH), 1.59-1.63 (2H, m, CH2ct), 
1.51 (6H, s, CH3"), 1.25-1.40 (18H, m, CH2'-m), 0.86 (3H, t, J 7.0 Hz, CH/); c 
(67.9 MHz, CDC13) 109.0 (C), 82.0 (CH), 77.8 (CH), 62.5 (CH2), 33.5 (CH2), 32.4 
(CH2), 30.1 (CH2), 30.0 (CH2), 29.8 (CHz), 28.7 (CHz), 27.4 (CH2), 27.1 (CHJ), 26.4 
(CH1), 23.1 (CHz), 21.4 (CHz), 18.4 (CHz), 14.6 (CH1); mlz (CI) 287 (MH+ 100%) 
[HRMS (CI) calcd. for C 17H35 0 3 (MH-), 287.2586, found: 287.2590. (1.4 ppm 
error) J. CDW 7 /49/2a. 
Ethyl 3-(2,2-dimethyl-5-undecyl-1 ,3-dioxolan-4-yl)-2-propenoate (130) 
s 
p n h b 
.6- a o-....../' 
a m k c q 
0 
Manganese dioxide (4.97 g, 57.2 mmol) m three equal portions, ethyl 2-
(triphenylphosphoranylidene)acetate (1.52 g, 4.56 mmol) and 4A molecular sieves 
( 1.0 g) were added to 2,2-dimethyl-5-undecyl-[ I ,3 ]-dioxalan-4-yl)methanol (129) 
(1.09 g, 3.81 mmol) in DCM (28 ml) under N2. The mixture was heated at reflux 18 
h. It was filtered through Celite" and the cake washed well with excess DCM. The 
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solvent was removed in vacuo and the residue was purified by column 
chromatography (PE:EtOAc, 4: I) to give the title compound 130 (with E:Z ratio of 
3:1) (1.175 g, 87 %) as a yellow oil, Rr 0.68 (PE:EtOAc, 3:1); vm, (neat)/cm·r 1725 
(C=O), 1465, 1370, 1172 (C-O), ethyl (E)-3-{2,2-dimethyl-5-undecyl-1,3-dioxolan-
4-yl)-2-propenoate (130 E), Orr (400.00 MHz, CDCh) 6.88 (IH, dd, J 15.6, J 5.8 
CH'), 6.13 (IH, dd, J 15.6, 1.2 Hz, CHb), 4.12-4.18 ( 1 H, m, overlapping with CH2q, 
CHct), 4.15 (2H, q, J 7.0 Hz, overlapping with CHct, CH2q), 3.71-3.73 (JH, m, CH'), 
1.58-1.61 (2H, m, CH/), 1.57 (3H, s, CH/), 1.54 (3H, s, CH3'), 1.25-1.40 (21H, m, 
CHz'-o + CH/), 0.86 (3H, t, J 7.0 Hz, CH/). 
Ethyl (Z)-3-(2,2-dimethyl-5-undecyl-1,3-dioxolan-4-yl)-2-propenoate (130 Z), 611 
(400.00 MHz, CDCh) 6.15 (IH, dd, J 11.6, 8.8 Hz, CH'), 5.93 (JH, dd, J 11.6, 0.9 
Hz, CH\ 4.12-4.18 (I H, m, overlapping with CH2 4, CHd), 4.15 (2H, q, J 7.0 Hz, 
overlapping with CHct. CH2°), 3.71-3.73 (I H, m, CH'), 1.58-1.61 (2H, m, CH2r), 1.57 
(3H, s, CH/), 1.54 (3H, s, CH/), 1.25-140 (21H, m, CHr+ CH/), 0.86 (3H, t, J 
7.0 Hz, CHJP); .c (100.0 MHz, CDCI3) 166.6 (C), 165.9 (C), 145.0 (CH2), 144.7 
(CH), 123.5 (CH), 123.l(CH), 109.8 (C), 109.6 (C), 81.5 (CH), 81.1 (CH X 3), 61.0 
(CHz), 61.0 (CH2), 32.6 (CH2 x 2), 32.5 (CH2 x 2), 32.4 (CH2 x 2), 30.1 (CH2), 30.1 
(CHz), 30.1 (CH2), 30.1 (CHz), 30.0 (CH2), 30.0 (CHz), 30.0 (CH2), 29.9 (CHJ), 29.8 
(CH1), 27.9 (CH3), 27.8 (CH3), 27.7 (CH2), 27.5 (CH 2), 27.1 (CH2), 26.5 (CH2), 264 
(CH2), 26.1 (CH2), 23.1 (CH2), 14.7 (CH1 x 2), 14.6 (CHJ x 2); mlz (CI) 355 (MH+ 
20 %) [HRMS (CI) calcd. for C2rH390 4 (MH\ 355.2849, found: 355.2843. (1.5 
ppm error)]. CDW 7/51/la. 
Ethyl (E)-4,5-dihydroxy-2-hexadecenoate (I 09) 
p n h 
OH 
e 









Ethyl 3-(2,2-dimethyl-5-undecyl-1 ,3-dioxolan-4-yl)-2-propenoate (130) (0.467 g, 
1.32 mmol) and p-TsOH (0.174 g, 0.90 mmol) in MeOH (18 ml) was stirred for 18 h 
at rt under N2 and then diluted with Et20 (20 ml). The Et20 solution was washed 
with brine (10 ml), dried with MgS04 and filtered. The solvent was removed in 
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vacuo and the residue was purified by column chromatography (DCM:MeOH, 
20:0.5) to give the title compound 109 (0.207 g, 50 %) as a white powder, Rr 0.25 
(DCM:MeOH, 6:0.5); m.p. 68 oc; Vm, (neat)/cm'1 3280 (OH), 1714 (C=O); i5H 
(270.01 MHz, CDCI3) 6.94 (IH, dd, J 15.9, J 4.9 CH'), 6.13 (IH, dd, J 15.9, 1.9 Hz, 
CHb), 4.12 (2H, q, J 7.0 Hz, Cthq), 3.72-3.74 (IH, m, Clld), 3.57-3.59 (IH, m, 
CH'), 3.17 (I H, s, br, OH), 2.55 (1 H, m, OH), I 47-148 (2H, m, CH/), 1.29 (3H, t, J 
7.0 Hz, CH1'), 1.25-140 (ISH, m, CHr). 0.86 (3H, t, J 7.0 Hz, CHl); mlz (CI) 
332 (MNH/ 40 %). CDW 7/52/Ia. The spectroscopic data were consistent with 
those reported in the literature.41 
Ethyl (E)-4,5-dioxo-2-hexadecenoate (II 0)41 
0 p n h b a r 
~ 0--..__/ e 
0 m k g d c q 0 0 
Ethyl (E)-4,5-dihydroxy-2-hexadecenoate (109) (0.047 g, 0.15 mmol) was dissolved 
in DCM (2.5 ml) and cooled to 0 "C. To the solution, TEMPO (I mg, 0.01 mmol), 
KBr (8.93 mg, 0.08 mmol) and lhO (0.2 ml) were added, followed by saturated 
NaHC03 (2 ml) and saturated NaOCI (2 ml). After stirring for 10 min, the phases 
were separated and the H20 phase was extracted with DCM (15 ml). The organic 
phase was dried with MgS04 and filtered. The solvent was removed in vacuo and the 
residue was purified by column chromatography (PE:EtOAc, 4: I) to give the title 
compound IIO (0.029 g, 62 %) as a yellow oil, Rr 045 (PE:EtOAc, 3:1); vm., 
(neat)/cm 1 1783, 1724 (C=O); i5 11 (400.00 MHz, CDC]]) 7.70 (I H, d, J 15.9 Hz, 
CH'), 6.94 (lH, d, J 15.9 Hz, CHb), 4.29 (2H, q, J 7.0 Hz, CHzq), 2.81 (2H, t, J 7.3 
Hz, CH/), 1.60-1.62 (2H, m, CHz"), 1.33 (3H, t, J 7.0 Hz, CH/), 1.25-1.29 (16H, m, 
CH,h-o), 0.86 (3H, t, J 7.0 Hz, CHl); c (100.0 MHz, CDC]]) 200.0 (C), 187.5 (C), 
1654 (C), 135.6 (CH), 132.9 (C), 62.1 (CH,), 37.0 (CH,), 324 (CH, ), 30.0 (CH2), 
29.9 (CH,), 29.8 (CH, X 2), 29.7 (CH,), 29.5 (CH,), 23.1 (CH,), 23.l(CH,), 14.6 
(CH1), 14.5 (CH3); mlz (CI) 328 (MNH4 ' 100 %). CDW 7/53/Ia. The spectroscopic 
data were consistent with those reported in the literature 41 
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5.5 Experimental Data for Chapter 3 
5.5.1 5-Membered Ring with One or Two Nitrogen Atoms 
5.5.1.1 General Method for Synthesis of Benzimidazoles and Related 
Heterocycles 
Manganese dioxide (0.652 g, 7.50 mmol) was added to a mixture of alcohol (0.50 
mmol), N-methyl-1,2-phenylenediamine (0.15 ml, 1.25 mmol), 2M HCl in Et20 
(0.04 ml, 15 mol %) and 4A molecular sieves (0.500 g) in toluene (12 ml). The 
mixture was reflux under N2 for 18 h. The mixture was hot filtered through a Celite® 
pad and the residue being washed with excess DCM. The solvent was removed in 
vacuo and the residue was purified with column chromatography on silica. 
1-Methyl-2-phenyl-benzimidazole (158) and N-methyl-2-{2-[2-
( methylamino )phenyl] diazenyl}aniline (159) 
158 
g 
CH3 I d 
H)O~ c 
a f ~ b 
b~N=N f I ~ e a 




The general experimental and work up procedure as described in the general method 
was carried out with benzyl alcohol (0.054 g, 0.50 mmol). Purification on column 
chromatography (PE:EtOAc, 3: I) gave the title compound 158 and the title 
compound 159. 1-Methyl-2-phenyl-benzimidazole (158) (0.094 g, 90 %) as a 
brown solid, Rr 0.3 (PE:EtOAc, 2:1); m.p. 96 oc (lit.76 m.p. 94-96 "C); Vm" 
(neat)/cm-1 3012 (Aryl CH), 1614 (C=N); 811 (400.00 MHz, CDCl3) 7.82-7.85 (IH, 
m, CH'), 7.74-7.76 (2H, m, CH'·'), 7.50-7.53 (3H, m, CHb,c,d), 7.39-7.41 (IH, m, 
CH1), 7.30-7.32 (2H, m, CHj,k), 3.85 (3H, s, CH3"); mlz (CI) 209 (MH+ 100 %); 
CDW 8/47/1 b. The spectroscopic data were consistent with those reported in the 
literature. 177 
N-methyl-2-{2-[2-(methylamino)phenyl]diazenyl}aniline (159) (0.015 g, 5 %) as a 
brown solid, Rr 0.5 (PE:EtOAc, 4:1); m.p. 178 "C; Vm" (neat)/cm-1 1563, 1511 
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(N=N); OH (400.00 MHz, CDCb) 7.56-7.58 (IH, m, CH'), 7.18-7.20 (IH, m, CHa), 
6.67-6.71 (2H, m, CHb·'), 2.86 (3H, m, CHg); i5c (100.0 MHz, CDCb) 142.0 (C), 
138.5 (C), 131.3 (CH), 127.4 (CH), 113.5 (CH), 111.3 (CH), 29.6 (CH1); mlz (EI) 
240 (M+ 75 %) [HRMS (EI) calcd. for C,4H,6N4(Min, 240.1375, found: 240.1375 
(0 ppm error)]. CDW 8/47/1a. 
2-( 4-Methoxy-phenyl)-1-methyl-benzimidazole (160) 
n . I . H,CDJ I h -N 
~ tr ~ ;,:: k n N m 1 H,c, 0 c 
d 
The general experimental and work up procedure as described in the general method 
was carried out with p-methoxybenzyl alcohol (0.069 g, 0.50 mmol). Purification on 
column chromatography (PE:EtOAc, 4:1) gave the title compound 160 (0.077 g, 65 
%) as a brown solid, Rr 0.1 (PE:EtOAc, 3:1 ); m.p. 122 °C (lit. 77 m.p. 118.5-119.5 
°C); vm., (neat)/cm-1 3002 (Aryl CH), 1608 (C=N); 811 (400.00 MHz, CDCb) 7.79-
7.82 (lH, m, CH'), 7.71 (2H, dd, 16.9, 2.1 Hz, CH'·'), 7.36-7.38 (IH, m, CH1), 7.29-
7.31 (2H, m, CHi.k), 7.23 (2H, dd, J 6.9, 2.1 Hz, CHb,ct), 3.88 (3H, s, CH3"), 3.85 
(3H, s, CH1"); mlz (CI) 239 (MH+ 1 00%). CDW 9/12/1a. The spectroscopic data 
were consistent with those reported in the literature. 77 
1-Methyl-2-( 4-nitro-phenyl)-benzimidazole (161) 
The general experimental and work up procedure as described in the general method 
was carried out with p-nitrobenzyl alcohol (0.077 g, 0.50 mmol). Purification on 
column chromatography (PE:EtOAc, 3:1) gave the title compound 161 (0.071 g, 56 
%) as a brown solid, Rr 0.15 (PE:EtOAc, 2:1); m.p. 215-216 °C (lit. 78 m.p. 214-215 
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"C); Vmax (neat)/cm·1 1633 (C=N); OH (400.00 MHz, CDCl3) 8.40 (2H, dd, J7.0, 1.8 
Hz, CHb.ct), 8.00 (2H, dd, J 7.0, 1.8 Hz, CH'·'), 7.85-7.87 (IH, m, CH\ 7.40-7.50 
(3H, m, CHJ,k,l), 3.94 (3H, s, CH 3"); lie (100.0 MHz, CDC13) 151.5 (C), 143.3 (C), 
137.2 (C), 136.8 (C), 130.7 (CH X 2), 124.4 (CH X 2), 123.6 (C), 120.7 (CH X 2), 
110.4 (CH x 2), 32.4 (CH3); m/z (Cl) 254 (MH+ 100%) [HRMS (CI) calcd. for 
CI4HizN20,(MH+), 254.0930, found: 254.0931 (0.8 ppm error)]. CDW 9/1/1c_a. 
2-( 4-Bromo-phenyl)-1-methyl-benzimidazole (163) 
The general experimental and work up procedure as described in the general method 
was carried out with p-bromobenzyl alcohol (0.094 g, 0.50 mmol). Purification on 
column chromatography (PE:EtOAc, 4: I) gave the title compound 163 (0.093, 65 
%) as a yellow solid, Rr 033 (PE:EtOAc, 3:1); m.p.IIO °C (lit. 79 m.p. 112-113 oC); 
vm, (neat)/cm 1 3050(Aryl CH), 1596 (C=N); OH (270.01 MHz, CDCh) 7.77-7.80 
(1H, m, CH'), 7.59-7.63 (4H, m, CH'·'·J.k), 7.30-7.35 (2H, m, CHb,d), 7.15-7.18 (IH, 
m, CH\ 3.82 (3H, s, CH3"); lie (100.0 MHz, CDCh) 145.0 (C), 132.5 (C), 132.1(C), 
131.4 (C), 129.0 (CH X 2), 123.7 (CH X 2), 123.3 (CH X 2), 121.1 (C), 120.2 (CH X 
2), 32.2 (CH3); mlz (CI) 287 (MH+ 100%) [HRMS (CI) calcd. for C14H12BrN2 
(MH\ 287.0184, found: 287.0174 (3.3 ppm error)]. CDW 9/6/1a. 
1-Methyl-2-naphthalen-2-yl-benzimidazole ( 165) 
The general experimental and work up procedure as described in the general method 
was carried out with naphthalene-1-methanol (0.079 g, 0.50 mmol). Purification on 
column chromatography (PE:EtOAc, 4:1) gave the title compound 165 (0.092 g, 71 
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%) as a brown solid, Rr 0.22 (PE:EtOAc, 3:1); m.p. 126 °C (lit. m.p. 128 °C); vm., 
(neat)/cm-1 1613 (C=N); 811 (400.00 MHz, CDCb) 8.12 (IH, d, J 8.1 Hz, CH\ 7.95 
(IH, d, J 8.1 Hz, CHh), 7.89-7.92 (lH, m, CH'), 7.73 (IH, d, J 7.5 Hz, CHP), 7.68 
(IH, dd, 17.01, 0.9 Hz, CHm), 7.60 (IH, d, J 8.2 Hz, CH'), 7.54 (lH, dd, J 8.0, 1.6 
Hz, CH1), 7.46-7.50 (2H, m, CHd''), 7.38-7.40 (2H, m, CH"'0 ), 3.61 (3H, s, CH1'); lie 
(100.0 MHz, CDCb) 151.5 (C), 143.0 (C x 2), 132.1 (C), 130.3 (C), 128.9 (C), 128.4 
(CH), 127.7 (CH), 127.2 (CH X 2), 126.3 (CH), 125.4 (CH), 125.0 (CH), 122.8 (CH), 
122.4 (CH), 120.0 (CH), 109.6 (CH), 31.0 (CH1); mlz (CI) 259 (MH+ 100%) [HRMS 
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The general experimental and work up procedure as described in the general method 
was carried out with £-cinnamyl alcohol (0.067 g, 0.50 mmol). Purification on 
column chromatography (PE:EtOAc, 6: I) gave the title compound 166 (0.029 g, 25 
%) as a pale yellow solid, Rr 0.15 (PE:EtOAc, 4:1); m.p. 111-112 oc (lit. 73 m.p. 113-
114 °C); Vmu (neat)/cm-1 3058 (Aryl CH), 1638 (C=N), 967 (H-C=C); 811 (400.00 
h . k MHz, CDCb) 8.02 (lH, d, J 15.9 Hz, CH ), 7.78-7.~0 (IH, m, CH ), 7.62-7.65 (2H, 
m, CH"·'J, 7.35-7.45 (6H, m, CHbc.d,l,m.n), 7.12 (lH, d, J 15.9 Hz, CHg), 3.90 (3H, s, 
CH3P); mlz (CI) 235 (MH+ 100%). CDW 9/3111c. The spectroscopic data were 
. . h h d' h 1' 178 consistent wit t ose reporte m t e Iterature. 
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1-Methyl-2-phenylethynyl-benzimidazole (167) 
p k H,cV' I J -
N ~ m 







The general experimental and work up procedure as in the general method was 
carried out with 3-phenyl-2-propyn-1-ol (0.066 g, 0.50 mmol). Purification on 
column chromatography (PE:EtOAc, 6:1) gave the title compound 167 (0.032 g, 28 
%) as a brown solid, Rr 0.22 (PE:EtOAc, 4:1); m.p. 136 oc; Vmox (neat)/cm'1 3056 
(Aryl CH), 2221 (C=C), 1663 (C~N); o11 (400.00 MHz, CDCh) 7.86 (IH, d, 17.3 
Hz, CH\ 7.65 (2H, dd, J 8.0, 1.5 Hz, CH'·'), 7.37-7.42 (6H, m, CHb.c.ct.r.m,o), 3.96 
(3H, s, CHl); oc (100.0 MHz, CDC13) 156.9 (C), 132.7 (C x 2), 130.4 (C), 129.1 
(CH), 128.8 (CH), 128.6 (CH), 128.5 (CH), 124.8 (C), 124.0 (CH X 2), 110.1 (CH X 
2), 91.8 (C), 84.3 (C), 31.4 (CH3); mlz (CI) 233 (MH+ 100%) [HRMS (CI) calcd. for 
Cr6ll13N2 (MH+), 233. I 079, found: 233.1077 (0.5 ppm error)]. CDW 9/30/1e. 
The general experimental and work up procedure as described in the general method 
was carried out with pyridine-3-methanol (0.055 g, 0.50 rnrnol). Purification on 
column chromatography (PE:EtOAc, 6: I) gave the title compound 169 (0.058 g, 55 
%) as a yellow solid, Rr 0.33 (PE:EtOAc, 5:1); m.p. 141-142 °C (lit81 m.p. 143-145 
oC); Vmox (neat)/cm·1 1607 (C~N); o11 (400.00 MHz, CDC13) 7.68 (IH, dd, 17.8, 1.5 
d d c ' Hz,CH ), 7.67(1H, d,J8.1, 1.2Hz,CH), 7.27-7.31 (IH,m,CH), 7.18(1H,dd,J 
8.1, 1.2 Hz, CHb), 6.81-6.83 (4H, m, CHg-3), 3.00 (3H, s, CH31); m/z (CI) 227 
(MNH/ I 00%). CDW 9/10/1a. The spectroscopic data were consistent with those 
reported in the literature 81 
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1,2-Diphenyl-benzimidazole (171) 
d 
The general experimental and work up procedure as described in the general method 
was carried out on benzyl alcohol (0.054 g, 0.50 mmol) with N-phenyl- I ,2-
phenylenediamine (0.23 g, 1.25 mmol). Purification on column chromatography 
(PE:EtOAc, 3:1) gave the title compound 171 (0.103 g, 76 %) as a brown solid, Rr 
0.3 (PE:EtOAc, 2:1); m.p. 113 oc (lit. 82 m.p. 111-112 °C); Vma< (neat)/cm- 1 3061 
(Aryl CH), 1596 (C=N); 011 (400.00 MHz, CDCJ3) 7.85 (1H, d, J7.8 Hz, CH'), 7.50-
7.51 (2H, m, CHa''), 7.48-7.49 (3H, m, CHb,c,ct), 7.29-7.34 (6H, m, CH1'm), 7.20-7.24 
(2H, m, CHj,k); mlz (Cl) 271 (MH+ 100%). CDW 9/14/1ab. The spectroscopic data 
were consistent with those reported in the literature. 82 
2-Pheny1-benzoxazole (181) 
'f). 
b 0 m I 
c e 
d 
The general experimental and work up procedure as described in the general method 
was carried out on benzyl alcohol (0.054 g, 0.50 mmol) with 2-aminophenol (0. 17 
ml, 1.25 mmo1). Purification on column chromatography (PE:EtOAc, 35:1) gave the 
title compound 181 (0.071 g, 73 %) as a yellow solid, Rr 0.18 (PE:EtOAc, 30:1); 
m.p. 101-102 oc (Jit. 179 m.p. 99-101 °C); Vm, (neat)/cm'1 1625 (C=N); Of{ (400.00 
MHz, CDCh) 8.25-8.27 (2H, m, CHa''), 7.78-7.79 (1H, m, CH'), 7.59-7.61 (IH, m, 
CH1), 7.53-7.55 (3H, m, CHb,c,ct), 7.35-7.37 (2H, m, CHJ.k); mlz (EI) 195 (100%). 
CDW 9/16/2a. The spectroscopic data were consistent with those reported in the 
literature. 77 
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2-Phenyl-benzothiazole (180) 
The general experimental and work up procedure as described in the general method 
was carried out on benzyl alcohol (0.054 g, 0.50 mmol) with 2-mercaptoaniline. 
Purification on column chromatography (PE:EtOAc, 9:1) gave the title compound 
180 (0.069 g, 66 %) as a yellow solid, Rr 0.65 (PE:EtOAc, 4:1); m.p. 111-113 °C 
(lit. 180 m.p. 112-115 °C); Vm" (neat)/cm 1 1586 (C=N); 811 (400.00 MHz, CDCb) 
8.10-8.12 (3H, m, CH"·'·'), 7.91 (lH, d, J 7.9 Hz, CH\ 7.49-7.50 (4H, m, CHb.ct,J,k), 
7.39-7.42 (IH, m, CH'); mlz (EI) 211 (100 %). COW 9/17/la. The spectroscopic 
data were consistent with those reported in the literature. 181 
Methyl-2-phenyl-imidazolidine (189a) and N-Benzylidene-N'-methyl-ethane-1,2-
diamine (189b) 
a 9 h H j 
u.::-... /'-.. ,N b N' Y 'CH3 c 
d 
189a 189b 
The general experimental and work up procedure as described in the general method 
was carried out with benzyl alcohol (0.054 g, 0.50 mmol) and N-methyl-
ethylenediamine (0.09 ml, 1.25 mmol). Work up gave the title compound 189a and 
189b (6: I ratio) (0.057 g, 70 %) as a yellow oil, Rr 0.37 (PE:EtOAc, 6: I); v""' 
(neat)/cm·' 3363 (NH), 1663 (C=N), 1578 (NH), 1-methyl-2-phenyl-imidazolidine 
(189a), oH (400.00 MHz, CDCh) 7.38-7.40 (2H, m, CH'·'), 7.31-7.34 (3H, m, 
CHb.c.ct), 3.80 (IH, s, CHg), 3.22-3.32 (II!, m, CH2'), 2.98-3.03 (I H, m, CH2h), 2.68-
2.74 (IH, m, CH2h), 2.55-2.57 (IH, m, Cl!2'), 2.36 (3H, s, CH3J). The spectroscopic 
data were consistent with those reported in the literature.90 
N-Benzylidene-N'-methyl-ethane-1,2-diamine (189b), liH (400.00 MHz, CDCb) 
8.26 (IH, s, CHg), 7.66-7.67 (2H, m, CH''), 7.31-7.38 (3H, m, CHb,c,ct), 3.70 (2H, t,J 
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5.6 Hz, CH/), 2.85 (2H, t, J 5.6 Hz, CH2'), 2.41 (3H, s, CH1\ mlz (CI) 163 (MH" 
100% ). CDW 9/13/3. The spectroscopic data were consistent with those reported in 
the literature90 
5.5.2 6-Membered Ring with One Nitrogen Atom 










To a solution of2-iodonitrobenzene (0.249 g, 1.00 mmol) and ethyl propiolate (0.41 
ml, 4.00 mmol) in THF (3 ml) were added Pd(PPh3)4 (0.014 g, 2 mol%), Cui (0.076 
g, 4 mol%) and K2C03 (0.276 g, 2.00 mmol) under N2. The mixture was stirred at 65 
°C for 24 h. The solvent was removed in vacuo and EtzO ( 10 ml) and saturated 
NH4Cl (10 ml) was added. The organic layer was separated and concentrated in 
vacuo. Purification on column chromatography (PE:EtOAc, 6:1) gave RSM (0.100 
g, 40 %) as a yellow solid followed by the title compound 210 (0.046 g, 22 %) as a 
yellow solid, Rr 0.33 (PE:EtOAc, 5:1); m.p. 60-61 oc (lit. 182 m.p. 60-62 °C); Vm, 
(neat)/cm-1 3106 (Aryl CH), 2233 (C:C), 1712 (C=O); 8H (400.00 MHz, CDCh) 
8.16 (JH, d, J 7.8 Hz, CHd), 7.78-7.79 (IH, m, CH'), 7.62-7.67 (2H, m, CHb·'), 4.33 
(2H, q, J 7.1 Hz, CH2i), 1.37 (3H, t, J 7.1 Hz, CH/); m/z (CI) 227 (MNH; 100%). 
CDW 9/25/3b. The spectroscopic data were consistent with those reported in the 
literature.m 
N-(2-Iodo-phenyl)-acetamide (215) 
2-lodoaniline (0.438 g, 2.00 mmol) was dissolved in Et20 (II ml) and the solution 
cooled to 0 oc under N2. To the solution, Et3N (0.21 ml, 2.05 mmol) was added 
followed by AcCl (0.15 ml, 2.05 mmol). The reaction mixture was stirred at 0 °C for 
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30 min and then warmed to rt and stirred for 18 h. The amine salts were removed by 
filtration, the filtrate diluted with EhO (1 0 ml) and washed with H20 (2 x 10 ml) and 
brine ( 1 x 10 ml). The organic extract was dried over MgS04, concentrated in vacuo 
to give the title compound 215 (0.454 g, 87 %) as a brown solid, m.p. 111-113 °C 
(1it. 183 m.p. 109-111 °C); Vm" (neat)/cm I 3273 (Aryl CH), 1662 (CO-NH); OH 
(400.00 MHz, CDC13) 8.21 (lH, d, 17.6 Hz, CHd), 7.77 (IH, d, 17.9 Hz, CH'), 7.36 
(lH, s, br, NH), 7.33-7.36 (lH, m, CH'), 6.84-6.86 (IH, m, CHb), 2.25 (3H, s, CH3h); 
mlz (CI) 262 (MH+ 100%). CDW 9/33/3. The spectroscopic data were consistent 
with those reported in the 1iterature. 183 
Ethyl (Z)-3-(tributylstannyl)-2-propenoate (216Z)103 and Ethyl (E)-3-
(tributylstannyl)-2-propenoate (216£) 103 
b c f 
~0'-./ 
n Bu3Sn II e 
a 0 
216Z 
A mixture of ethyl propiolate (2.50 ml, 24.68 mmol), tributylstannane (7.530 g, 
25.87 mmol) and AIBN (0.10 g) was heated to 55 oc over a period of 2 h. The 
mixture was left heating at 55 oc under N2 for 24 h. Purification on column 
chromatography (PE) gave the title compound 216Z followed by 216£. Ethyl (Z)-3-
(tributylstannyl)-2-propenoate (216Z) (2.49 g, 26 'Yo) as a colourless oil, R1 0.68 
(PE:EtOAc, 95:5); Vmax (neat/em'), 1712 (C=O), 960 (H-C=C); OH (400.00 MHz, 
CDC13) 7.15 (1 H, d, J 13.0 Hz, CH'), 6.73 (lH, d, J 13.0 Hz, CHb), 420 (2H, q, 17.0 
Hz, CH2'), 1.27-1.44 (12H, m, CH/), 0.96-0.98 (611, m, CH2'), 0.85-0.89 (12H, m, 
CH2' + CH31); m/z (CI) 390 (MH+ 100%). CDW 9/36/la. The spectroscopic data 
. . h h d . h 1' !OJ were consistent w1t t ose reporte m t e 1terature. 
Ethyl (E)-3-(tributylstannyl)-2-propenoate (216£) (4.03 g, 42 %) as a colourless 
oil, Rr 0.53 (PE:EtOAc, 95:5); vm, (neat/em·'), 1712 (C=O), 730 (H-C=C); OH 
(400.00 MHz, CDCh) 7.73 (lH, d, J 19.2 Hz, CH'), 6.29 (IH, d, J 19.2 Hz, CHb), 
4.09 (2H, q, J 7.0 Hz, CH2'), 1.33-1.49 (12H, m, CH/), 1.30-1.32 (6H, m, CH/), 
0.85-0.90 (12H, m, CHz" + CH11j; mlz (Cl) 390 (MH+ 100%). CDW 9/36/lb. The 
spectroscopic data were consistent with those reported in the literature. 103 
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Ethyl (Z)-3-(2-(acetylamino)phenyl]-2-propenoate (214Z) and Ethyl (E)-3-(2-
( acetylamino )phenyl]-2-propenoate (214£) 
a 9 h . k 
b~o'-./ 
c~,)"o j 
d ~ 1 m 
214Z 
N-(2-lodo-phenyl)-acetamide (215) (0.111 g, 0.42 mmol) and ethyl (Z)-3-
(tributylstannyl)-2-propenoate (216Z) (0.198 g, 0.51 mmol) were dissolved in toluene 
(6 ml) underN2. Pd(PPh3) 4 (0.010 g, 2 mol%) was added and the mixture was stirred 
at rt for 24 h. Saturated aqueous KF (2 ml) was added to the reaction and the mixture 
was stirred vigourously for 1 h. It was then diluted with Et20 ( 10 ml), washed with 
H20 (2 x 10 m1) and brine (10 ml). The organic extract was dried over MgS04 and 
concentrated in vacuo. Purification on column chromatography (PE:EtOAc, 4:1) 
gave the title compounds 214Z followed by 214£. Ethyl (Z)-3-(2-
(acetylamino)phenyl]-2-propenoate (214Z) (0.041 g, 42 %) as a colourless oil that 
solidified at rt, Rr 0.50 (EtOAc:PE, 9:1 ); vm, (neat)/cm 1 1709 (C=O), 1657 (C=O), 
969 (H-C=C); 8H (400.00 MHz, CDCI3) 11.37 (1H, s, br, NH), 7.80 (JH, d, 19.5 Hz, 
CHg), 7.58 (lH, d, J 7.6 Hz, CHd), 7.50-7.52 (lH, m, CH'), 7.35 (lH, d, J 8.1 Hz, 
CH"), 7.23-7.7.25 (1H, m, CHb), 6.71 (lH, d, J 9.5 Hz, CHh), 4.10 (2H, q, 17.1 Hz, 
CHh 2 01 (3H, s, CH1m), 1.26 (3H, t, J 7.1 Hz, CH/); i\ (100.0 MHz, CDCb) 
169.4 (C), 167.2 (C), 139.7 (CH), 131.2 (C), 129.5 (CH), 128.8 (C), 127.6 (CH), 
125.7 (CH), 121.1 (CH), 120.2 (CH), 61.1 (CH2), 24.6 (CH1), 14.4 (CH1); mlz (CI) 
234 (Mtt 100%) [HRMS (Cl) calcd. for CllH 15 N01 (Mt(), 234.1130, found: 
234.1129 (0.3 ppm error)]. COW 9/34/la. 
Ethyl (E)-3-(2-(acetylamino)phenyl]-2-propenoate (214£) (0.041 g, 42 %) as a 
colourless oil that solidified at rt, Rr 0.33 (EtOAc:PE, 9:1); Vmo.< (neat)/cm-1 1709 
(C=O), 1657 (C=O), 969 (H-C=C); oH (400.00 MHz, CDC11) 11.37 (lH, s, br, NH), 
g d c 8.00 (lH, d, J 16.0 Hz, CH ), 7.80 (lH, d, 17.6 Hz, CH ), 7.60-7.62 (lH, m, CH ), 
d 8 C a b h 7.40 (lH, , J .I Hz, H), 7.08-7.10 (lH, m, CH ), 6.40 (JH, d, J 16.0 Hz, CH ), 
4.26 (2H, q, J 7.1 Hz, CH2J), 2.35 (3H, s, CH1m), 1.34 (3H, t, J 7.1 Hz, CH/); lie 
(100.0 MHz, CDCb) 168.8 (C), 166.5 (C), 140.5 (CH), 1363 (C), 129.6 (CH), 128.4 
(C), 128.1 (CH), 126.3 (CH), 124.3 (CH), 123.7 (CH), 61.1 (CH2), 24.6 (CH3), 14.4 
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(CH3); m/z (CI) 234 (MH 100%) [HRMS (CI) calcd. for CllHrbNOz (MH ), 
234.1130, found: 234.1129 (0.3 ppm error)]. COW 9/34/lb. 
Ethyl (Z)-3-[2-nitro-phenyl]-2-propenoate (217Z) and Ethyl (E)-3-[2-nitro-
pheny1]-2-propenoate (217b) 
a 9 h . k 
b oc=gf I 0-....._/ 
I e 0 j c .& 
N02 d 
217Z 
a g h 
b ~~ 





(a) 2-Iodonitrobenzene (0.248 g, 0.99 mmol) and ethyl (Z)-3-(tributylstannyl)-2-
propenoate (216Z) (0.464 g, 1.19 mmol) were dissolved in toluene (6 ml) under N2. 
Pd(PPh3)4 (0.023 g, 2 mol %) was added and the mixture was stirred at rt for 24 h. 
Saturated aqueous KF (2 ml) was added to the reaction and the mixture was stirred 
vigorously for I h. It was then diluted with EtzO (I 0 ml), washed with HzO (2 x 10 
ml) and brine (10 ml). The organic layer was separated, dried over MgS04 and then 
concentrated in vacuo. Purification on column chromatography (PE:EtOAc, 6:1) 
gave the title compound 217Z followed by 217£. Ethyl (Z)-3-[2-nitro-phenyl]-2-
propenoate (217Z) (0.024 g, 11 %) as a brown solid, Rr 0.23 (PE:EtOAc, 4: I); m.p. 
38 oc; Vmox (neat)/cm'1 1715 (C=O), 1573 (C-NOz), 974 (H-C=C); 811 (400.00 MHz, 
CDCh) 8.20 (IH, d, J 8.2 Hz, CHd), 7.59 (lH, t, J 7.6 Hz, CH'), 7.48 (lH, t, J 7.6 
Hz, CH6), 7.40-7.48 (2H, m, CH''g), 6.10 (1H,d,JI2.0 Hz, CH\ 4.00 (2H, q,J7.2 
Hz, CH2J), 1.10 (3H, t, J 7.2 Hz, CH/); 8c (100.0 MHz, CDCh) 166.0 (C), 149.5 
(CH), 139.8 (C), 133.5 (CH), 131.5 (C), 130.2 (CH), 129.1 (CH), 124.9 (CH), 123.3 
(CH), 61.1 (CH2), 14.2 (CH1); mlz (CI) 222 (MH+ 100%) [HRMS (CI) calcd. for 
C 11 H 12N04 (MH+), 222.0766, found: 222.0766 (2.5 ppm error)]. COW 9/42/la. The 
spectroscopic data were consistent with those reported in the literature. 184 
Ethyl (E)-3-[2-nitro-phenyl]-2-propenoate (217£) (0.086 g, 39 %) as a brown 
solid, Rr 0.25 (PE:EtOAc, 4:1); m.p. 40-42 oc (lit.'" m.p. 42 °C); Vmox (neat)/cm'1 
1715 (C=O), 1573 (C-N02), 974 (H-C=C); 8H(400.00 MHz, CDCh) 8.20 (lH, d,J 
16.0 Hz, CHg), 8.15 (IH, d, J7.6 Hz, CHd), 7.54-7.65 (2H, m, CH"·6), 7.45-7.52 (IH, 
c h j 
m, CH ), 6.35 (lH, d, J 16.0 Hz, CH ), 4.30 (2H, q, J 7.2 Hz, CHz ), 1.36 (3H, t, J 
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7.2 Hz, CH/); mlz (CI) 222 (MH+ 100%). CDW9/42/1b. The spectroscopic data 
. . h h d. h ,. 1 ~ 1' were cons1stent w1t t ose reporte m t e 1terature. 
(b) A mixture of 2-nitrobenzeneboronic acid (0.167 g, 1.00 mmol), ethyl acrylate 
(0.13 ml, 1.20 mmol), Pd(0Ac)2 (0.328 g, 4.00 mmol) and Cu(OAch (O.DlO g) was 
stirred in DMF (11 ml) at 100 "C under N2 for 24 h. The mixture was diluted with 
DCM (10 ml) and washed with NaHC01 (10 m1). The organic layer was extracted, 
dried over MgS04 and concentrated in vacuo. Purification on column 
chromatography (PE:EtOAc, 6:1) gave the title compound 217E (0.071 g, 32 %) as a 
brown solid, Rr 0.25 (PE:EtOAc, 4:1); m.p. 40-42 °C (lit. 185 m.p. 42 "C); vm, 
(neat)/cm-1 1715 (C=O), 1573 (C-N02), 974 (H-C=C). CDW 9/35/1b. Spectral data 





(a) To ethyl (Z)-3-[2-(acetylamino)phenylj-2-propenoate (214Z) (0.084 g, 0.36 
mmol) in toluene (4 ml) under N2 at 0 "C, was added DIBAL-H in toluene, ca. I M 
(0.8 ml, 0.8 mmol) dropwise via syringe for 15 min. After addition was complete, 
stirring was continued for 1 h. It was then quenched with 20 % w/v Rochelle salt ( 10 
ml). The mixture was left to stir at rt until clear separation of two layers. The organic 
layer was separated and was dried over MgS04 and concentrated in vacuo. 
Purification on column chromatography (EtOAc:PE, 9:1) gave the title compound 
218 (0.033 g, 72 %) as a white solid, Rr 0.25 (EtOAc:PE, 9:1 ); m.p. 199-200 °C 
(lit. 187 m.p. 200-200.5 "C); Vm, (neat)/cm·1 3583 (Nll), 1655 (C=O), 945 (H-C=C); 
6H (400.00 MHz, CDC~]) 11.50 (Ill, s, br, NH), 8.25 (1H, d, J 8.6 Hz, CH1), 8.00 
(1H, d, J 8.5, CH8), 7.85 (1H, d, J 8.5 Hz, CH'), 7.71-7.74 (1H, m, CH'), 7.52-7.58 
(lH, m, CH/), 7.00-7.23 (IH, m, CH'\ m/z (CI) 146 (MNH/ 100%). CDW 
9/46/2b. The spectroscopic data were consistent with those reported in the 
literature. 1' 8 
(b) Ethyl (Z)-3-[2-(acetylamino)phenyl]-2-propenoate (214Z) (0.084 g, 0.36 mmol) 
in Et20 (4 ml) under N2 at 0 "C, was subjected to with lithium aluminium hydride 
(0.030 g, 0.8 mmol). After 1 h, MeOH (5 ml) was added to quench the excess 
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lithium aluminium hydride. The organic layer was separated and was dried over 
MgS04 and concentrated in vacuo. Purification on column chromatography 
(EtOAc:PE, 9:1) gave the title compound 218 (0.036 g, 78 %) as a white solid, Rr 
0.25 (EtOAc:PE, 9: I); 199-200 oc (lit187 m.p. 200-200.5 °C); Vm, (neat)/cm-1 3583 
(NH), 1655 (C=O), 945 (H-C=C). CDW 9/51/la. Spectral data are as above. 
Z-N-[2-(3-Hydroxy-propenyl)-phenyl]-acetamide (213Z) 
To ethyl (Z)-3-[2-(acetylamino)phenyl]-2-propenoate (214Z) (0.0839 g, 0.36 mmol) 
in toluene (4 ml) under N2 at -78 oc, was added DIBAL-H in toluene, ca. I M (0.8 
ml, 0.8 mmol) dropwise via syringe for 15 min. After addition was complete, stirring 
was continued for I h. It was then quenched with 20% w/v Rochelle salt (10 ml). 
The mixture was left to stir at rt until clear separation of two layers. The organic 
layer was separated, dried over MgS04 and concentrated in vacuo. Purification on 
column chromatography (EtOAc:PE, I 0: I) gave the title compound 213Z (0.029 g, 
42 %) as a white solid, Rr 0.25 (EtOAc:PE, 9:1); m.p. 101 oc; Vm" (neat)/cm-1 3280 
(OH), 1666 (C=O); oH (400.00 MHz, CDC]j) 8.02 (I H, d, J 8.2 Hz, CHct), 7.28-7.31 
(2H, m, CH' + NH), 7.07-7.13 (2H, m, CHb·'), 6.80 (I H, dt, J 11.4, 6.9 Hz, CHh), 
6.52 (IH, dd, J 11.4, 1.5 Hz, CHg), 4.19 (2H, dd, J 6.9, 1.5 Hz, CH,'), 2.17 (3H, s, 
CH3k); oc (100.0 MHz, CDCI3) 169.0 (C), 135.5 (C), 134.2 (CH), 130.9 (CH), 129.0 
(C), 127.9 (CH), 127.8 (CH), 124.8 (CH), 122.8 (CH), 59.9 (CH,), 25.0 (CH1); mlz 
(CI) 192 (MH+ 100%). [HRMS (CI) calcd. for C11H14NO, (MH+), 192.1024, found: 
192.1026 (1.1 ppm error)]. CDW 9/46/3d. 
3-(2-Amino-phenyl)-prop-2-en-1-ol (207) 




To Z-N-[2-(3-hydroxypropenyl)-phenyl]-acetamide (213Z) (0.039 g, 0.21 mmol) in 
MeOH (2 ml) under N2, was added K2C03 (0.22 g, 1.58 mmol). The mixture was 
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heated at 50 °C for 2 days. It was then diluted with Et20 (2 ml) and washed with 
saturated NH4Cl (2 ml). The organic layer was separated and dried over MgS04, 
concentrated and dried in vacuo. Purification on column chromatography 
(EtOAc:PE, 10:1) gave the title compound 207 (with Z,E ratio of0.6: 1) (6 mg, 20% 
%) as a yellow oil that solidified at rt, Rr 0.38 (EtOAc:PE, 9: I); Vma., (neat)/cm·1 3401 
(OH), 1651 (C-NH2); Z-3-(2-amino-phenyl)-prop-2-en-1-ol (207Z), i5H (400.00 
MHz, CDCI3) 7.10 (IH, dd, 17.6, 1.21lz, CH"), 6.95 (IH, d, 17.3 Hz, CHct), 6.73-
6.76 (2H, m, CHb''), 6.48 (IH, dd, 1 11.3, 1.5 Hz, CHg), 6.00 (IH, dt, 111.3, 6.7 
Hz, CHh), 4.23 (2H, dd, 1 6. 7, 1.5 Hz, CH2'), 2.58 (2H, s, br, NH2); mlz (Cl) !50 
(MH' 100%). The spectroscopic data were consistent with those reported in the 
literature. 189 
E-3-(2-Amino-phenyl)-prop-2-en-1-ol (207£), OH (400.00 MHz, CDCb) 7.05-7.10 
(2H, m, CH"·ct), 6.68-6.73 (3H, m, CHb.o,g), 6.24 (IH, dt, 116.0, 5.6 Hz, CHh), 4.34 
(2H, dd, 1 5.6, 1.5 Hz, CH2;), 2.58 (2H, s, br, NHz); m/z (Cl) !50 (MH+ 100%). 
CDW 1 O/l/4c. The spectroscopic data were consistent with those reported in the 
literature. 190 
Z-3-(2-Amino-phenyl)-prop-2-en-1-ol (207Z) and Z-N-[2-(3-Hydroxy-propenyl)-
phenyl]-acetamide (213Z) 
a g h 
bccYf OH 




a g h 
b~f OH I o . 
c ~ e )l' 
N J CH3 d H k 
213Z 
To ethyl (Z)-3-[2-(acetylamino)phenyl]-2-propenoate (214Z) (0.408 g, 1.75 mmol) in 
Et,O (12 ml) under N2 at -78 °C, was added DIBAI.-H in toluene, ca. I M (3.9 ml, 
3. 9 mmol) drop wise via syringe for 30 min. After addition was complete, stirring 
was continued for I h. It was then quenched with 20 % w/v Rochelle salt (I 0 ml). 
The mixture was left to stir at rt until clear separation of two layers. The organic 
layer was separated, dried over MgS04 and concentrated in vacuo. Purification on 
column chromatography (EtOAc:PE, I 0: I) gave the title compound 207Z followed 
by 213Z. Z-3-(2-Amino-phenyl)-prop-2-en-1-ol (207Z) (0.068 g, 26 'Yo) as a 
colourless oil that solidified at rt, Rr 0.38 (EtOAc:PE, 9: I); Vm"' (neat)/cm·' 3401 
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(OH), 1651 (C-NH2). CDW 10/8/1c. Spectral data is as the Z-isomer of CDW 
10/1/4c. 
Z-N-12-(3-Hydroxy-propenyl)-phenyl]-acetamide (213Z) (0.066 g, 20 %) as a 
white solid,, Rr 0.25 (EtOAc:PE, 9:1); m.p. 101 °C; Vm"' (neat)/cm-1 3280 (OH), 
1666 (C=O). CDW 10/8/1d. Spectral data is as provided in CDW 9/46/3d. 
£-3-(2-Amino-phenyl)-prop-2-en-1-ol (207 E) and £-N-12-(3-Hydroxy-propenyl)-
phenyl]-acetamide (213E) 
i 
a g h 
b OH 
c 
N j CH3 d H k 
207E 213E 
To ethyl (E)-3-[2-(acetylamino)phenyl]-2-propenoatc (214£) (0.408 g, 1.75 mmol) in 
Et20 (12 ml) under N2 at -78 "C, was added DJBAL-H in toluene, ca. 1M (3.9 ml, 
3.9 mmol) dropwise via syringe for 30 min. After addition was complete, stirring 
was continued for I h. It was then quenched with 20 % w/v Rochelle salt (1 0 ml). 
The mixture was left to stir at rt until clear separation of two layers. The organic 
layer was separated, dried over MgS04 and concentrated in vacuo. Purification on 
column chromatography (EtOAc:PE, 10:1) gave the title compound 207£ followed 
by the title compound 213£. £-3-(2-Amino-phenyl)-prop-2-en-1-ol (207E) (0.083 
g, 32 'Yo) as a white solid, R1 0.38 (EtOAc:PE, 9:1); m.p. 77-79 °C (lit190 m.p. 78-80 
"C); Vm" (neat)/cm-1 3401 (OH), 1651 (C-NH2). CDW 10/8/2a. Spectral data is as 
the £-isomer of CDW 1 0/1!4c. 
£-N-12-(3-Hydroxy-propenyl)-phenyl]-acetamide (213E) (0.100 g, 30 %) as a 
white solid, Rr 0.12 (EtOAc:PE, 9:1); m.p. 142 °C; Vmo., (neat)/cm-1 3280 (OH), 1666 
(C=O); oH (400.00 MHz CDCI3) 7.79 {lH, d, J 7.9 Hz, CHct), 7.40-7.42 (1H, m, 
CII'), 7.28-7.30 (1 H, m, CH'), 7.18-7.24 (2H, m, Cllb + NH), 6. 70 (lH, dd, J 15.6, 
1.5 Hz, CHg), 6.29 (lH, dt, J 15.6, 5.8 Hz, CHh), 4.36 (2H, dd, J 5.8, 1.5 Hz, CH21), 
2.18 (3H, s, CH3k); 6c (100.0 MHz, CDCI3) 169.6 (C), 134.8 (C), 128.8 (CH), 130.2 
(CH), 128.8 (C), 127.5 (CH), 126.0 (CH), 125.9 (CH), 124.5 (CH), 63.9 (CH2), 24.8 
(CH1); m/z (CI) 192 (MH+ 100%). [HRMS (CI) calcd. for C11Ht4N02 (M!·t}, 
192.1024, found: 192.1026 ( 1.1 ppm error)]. CDW 1 0/8/2b. 
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Manganese dioxide (0.222 g, 2.55 mmol) and 4A molecular sieves (0.170 g) were 
added to a solution of Z-3-(2-amino-phenyl)-prop-2-en-1-ol (207Z) (0.026 g, 0.17 
mmol) in DCM (3 ml). The mixture was stirred at rt under N2 for I h. It was filtered 
through a Celite® pad and the cake being washed with excess DCM. The solvent was 
removed in vacuo and the residue was purified by column chromatography 
(PE:EtOAc: 3:1) to give the title compound 200 (8 mg, 38 %) as a yellow oil, Rr 0.50 
(PE:EtOAc:l:l); vm, (neat)/cm-1 1620 (C=N), 1573, 1502, 1432, 1135, 1372, 942 
(quinoline ring stretching modes); 8H (400.00 MHz, CDCI3) 8.92 (IH, dd, J 4.0, 1.8 
Hz, CH\ 8.21 (IH, d, J 8.5 Hz, CH'), 8.17 (IH, J 8.5 Hz, CH\ 7.88 (I H, d, J 8.2 
Hz, CH'), 7.77 (IH, dd, J 8.5, 7.2 Hz, CH'), 7.60 (IH, dd, J 8.2, 7.2 Hz, CH3"), 
7.45 (IH, dd, J 8.5, 4.0 Hz, CH'); mlz (CI) 130 (MH+ 100";1,). COW 10/5/la. The 
spectroscopic data were consistent with those reported in the literature. 107 
Tetrahydroquinoline (221) 
c a 
b d(JDI i 
e ~ h 
g N 
f H 
Manganese dioxide (0.170 g, 1.95 mmol) and NaBH• (0.020 g, 0.54 mmol) were 
added to a solution of Z-3-(2-amino-phenyl)-prop-2-en-1-ol (207Z) (0.020g, 0.13 
mmol) and 4A molecular sieves (0.134 g) in DCM (3 ml). After 1 h, MeOH (1 ml) 
was added to the mixture. The mixture was stirred at rt for 18 h, then filtered through 
a Celite® pad and the cake being washed with excess DCM. The solvent was 
removed in vacuo and the residue was purified by column chromatography 
(PE:EtOAc: 3:1 with 0.01% Et3N) to give the title compound 221 (5 mg, 30 %) as a 
yellow oil, R1 0.38 (PE:EtOAc: 1:1 ); vm, (neat)/cm- 1 3402 (NH), 1583, 1503, 1356, 
1354, 1309, 1267, 1094, 745 (tetrahydroquinoline ring stretching modes); Ott (400.00 
MHz, CDCh) 6.94-6.98 (2H, m, CH'·'), 6.59-6.62 (lH, m, CH1), 6.48 (IH, d, J 7.6 
Hz, CH"), 3.28-3.31 (2H, m, CHh), 2.75-2.78 (2H, m, CH'), 1.93-1.96 (2H, m, CH'); 
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mlz (CI) 134 (MH 100%). CDW 10/6/1a. The spectroscopic data were consistent 




e~.)h g N 
f H 
DIBAL-H in 1.0 M toluene (0.55 ml, 0.55 mmol) was added to quinoline (200) 
(0.064 g, 0.50 mmol) in THF (2 ml) at 0 °C. The mixture was stirred for I h. It was 
then quenched with 20% w/v Rochelle salt (1 0 ml). The mixture was left to stir at rt 
until clear separation of two layers. The organic layer was separated, dried over 
MgS04 and concentrated in vacuo. Purification on column chromatography 
(EtOAc:PE, 2:3) gave the title compound 222 (0.037 g, 56%) as a yellow solid, m.p. 
71-73 oc (lit. 191 m.p.72-74.5 °C); Rr 0.75 (PE:EtOAc:l:l); Vm" (neat)/cm·1 3393 
(NH); 811 (400 MHz, CDCb) 6.92 (IH, ddd, J 7.8, 7.5, 1.3 Hz, CH'), 6.80 (IH, dd, 
J 7.7, 1.3 Hz, CH'), 6.57 (1H, ddd, J 7.7, 7.5, 1.5 Hz, CHct), 6.38 (IH, d, J 7.8 Hz, 
CI-rf), 6.29 (1H, d, J 10.0 Hz, CH"), 5.65 (IH, dt, J 10.0, 4.0 Hz, CH\ 4.18 (2H, 
dd, J 4.0, 2.1 Hz, CH\ mlz (CI) 132 (MH' 100%). CDW 10/10/1a. The 
spectroscopic data were consistent with those reported in the literature. 192 
5.5.3 6-Membered Rings with Two Nitrogen Atoms 
1-(2-Furyl)-2-hydroxy-1-ethanone (55) 
c b dna e!. 
"o/ n 'oH 
0 
2-Acctylfuran (0.276 g, 2.50 mmol) was added to a stirred solution of CF3C02H 
(0.38 ml, 5.00 mmol), H20 (2.5 ml) and CH3CN (12.4 ml). Ph!(OCOCF3)2 (2.13 g, 
5.00 mmol) was added and the solution was heated at reflux for 3 h. When the 
reaction was completed, the reaction mixture was concentrated in vacuo to remove 
CH3CN. The residue was partitioned between DCM (5 ml) and lhO (5 ml), and the 
aqueous phase was extracted with DCM (2 x 5 ml). The combined organic extracts 
were then washed with a saturated solution of NaHC03 (5 ml), dried with MgS04 
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and filtered. The solvent was removed in vacuo and the residue was purified by 
column chromatography (PE:EtOAc, 3:1) to give the title compound 55 (0.189 g, 60 
%) as a pale yellow solid, Rr 0.25 (PE:EtOAc, 2:1); m.p. 81-82 oc (Iit. 193 m.p. 82-83 
°C); Vm" (neat)/cm' 1 3390 (OH), 1681 (C=O); 8H (270.01 MHz, CDCh) 7.59-7.60 
(1H, m, CHct), 7.27-7.29 (1H, m, CHb), 6.54-6.56 (111, m, CH'), 4.74 (2H, s, CH21), 
3.25 (1H, s, br, OH); mlz (CI) 127 (MH+ 100%). CDW 6/45/ta. The spectroscopic 
data were consistent with those reported in the literature. 193 
1-Cyclohexyl-2-hydroxy-1-ethanone (238) 
b 
c(la n h 
d*OH 
0 
The a-hydroxylation was repeated on 1-cyclohexyl-1-ethanone (0.315 g, 2.50 mmol) 
as in the above procedure. The reaction was heated at reflux for 4 h, then the 
reaction mixture was concentrated in vacuo to remove CH1CN and worked up in a 
similar manner. The residue was purified by column chromatography (PE:EtOAc, 
3:1) to give the title compound 238 (0.160 g, 45 %) as a white solid, Rr 0.38 
(PE:EtOAc, 2:1); m.p. 27 oc (lit. 194 m.p. 27-28 °C); Vm"' (neat)/cm' 1 3444 (OH), 1713 
(C=08H (270.01 MHz, CDC}j) 4.24 (211, s, CH2h), 3.26 (lH, s, br, OH), 2.36 (lH, tt, 
J 11.3, 3.4 Hz, CH1), 1.79-1.80 (4H, m, CHt'), 1.39-1.43 (6H, m, CH2b,c,ct); m/z (CI) 
160 (MNH/ 100 %). CDW 6/41/la. The spectroscopic data were consistent with 
those reported in the literature. 195 
1-Hydroxy-2-heptanone (53) 
9 e c a 
b ~OH 
r d II 
0 
The a-hydroxylation was repeated on 2-heptanone (0.285 g, 2.50 mmol) as in the 
above procedure. The reaction was heated at reflux for 2 h, then the reaction mixture 
was concentrated in vacuo to remove CII3CN and worked up in a similar manner. 
The residue was purified by chromatography (PE:EtOAc, 3:1) to give the title 
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compound 53 (0.107 g, 33 %) as a yellow oil, Rr 0.45 (PE:EtOAc, 2:1); Vm, 
(neat)/cm 1 3400 (OH), 1679 (C=O); 8H (270.01 Ml!z, CDCh) 4.02 (2H, s, CH2'), 
3.52 (IH, s, br, OH), 2.45 (2H, t, J 6.5 Hz, CH/), 1.30-1.34 (6H, m, CH2d,e,r), 0.89 
(3H, t, J 6.8 Hz, CH3g); (EI) 130 (M+). CDW 6/46/la. The spectroscopic data were 
consistent with those reported in the literature 48 
5.5.3.1 Quinoxalines-General Procedure A 
To a mixture of a-hydroxyketone (0.50 mmol), aryl diamine (1.00 mmol) and 4A 
molecular sieves (0.50 g) in DCM (25 ml) was added manganese dioxide (5.00 
mmol) and the mixture heated at reflux under N2 until the a-hydroxyketone was 
consumed as indicated by TLC (15 min- 3 h). The mixture was then cooled tort and 
filtered through a Celite® pad and the cake being washed with excess DCM. The 
solvent was removed in vacuo and the residue was purified by column 
chromatography on silica to give the quinoxaline product. 
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2-Methyl-quinoxaline (234) and 2-[(2-Aminophenyl)diazenyl]aniline (235) 
i h g 
H,CYN~f 
b~~e N c 
d 
234 
e d H 2N~c 
a f ~ b b~N=N f a 
c~ d NH 2 
235 
a-Hydroxyacetone (0.037 g, 0.50 mmol), 1,2-phenylenediamine (0.108 g 1.00 mmol) 
and 4A molecular sieves (0.50 g) were added to DCM (25 ml). To the mixture, 
manganese dioxide (0.435 g, 5.00 mmol) was added and the mixture heated at reflux 
under N 2 for I h. Work up was carried out as in general procedure A and purification 
was carried out on column chromatography (PE:EtOAc, 3: I) to give the title 
compound 234 and 235. 2-Methyl-quinoxaline (234) (0.057 g, 79 %) as a orange 
oil, Rr 0.23 (PE:EtOAc, 2:1); Vmox (neat)/cm-1 3062 (Ar), 1491 (C=N); OH (270.01 
MHz, CDCh) 8.72 (IH, s, CH\ 7.98-8.03 (2H, m, CHd,g), 7.65-7.75 (2H, m, CH'.r), 
2.78 (3H, s, CH31); m/z (EI) 144 (M+ 100 %). CDW 6/31/lb. The spectroscopic data 
were consistent with those reported in the literature. 1'" 
2-[(2-Aminophenyl)diazenyl]aniline (235) (0.013 g, 6 %) as a brown solid, Rr0.33 
(PE:EtOAc, 2:1); m.p. 133-135 °C (lit. 197 m.p. 134-136 'C); Vmox (neat)/cm-1 1568 
(N=N); oH (400.00 MHz, CDCh) 7.67-7.70 (IH, m, CH"), 7.18-7.21 (IH, m, CHd), 
6.76-6.81 (2H, m, CHb·'), 5.49 (2H, s, br, NH2); mlz (EI) 212 (M+ 75 %). CDW 




l~j I h g m~ i a::;---N~f 
b "'-~e N c 
d 
a-Hydroxyacetophenone (0.068 g, 0.50 mmol), 1,2-phenylenediamine (0.108 g 1.00 
mmol) and 4 A molecular sieves (0.50 g) were added to DCM (25 ml). To the 
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mixture, manganese dioxide (0.435 g, 5.00 mmol) was added and the mixture heated 
at reflux under N2 for 30 min. Work up was carried out as in general procedure A 
and purification was carried out on column chromatography (PE:EtOAc, 4:1) to give 
the title compound 236 (0.081 g, 79 %) as a orange solid, Rr 0.32 (PE:EtOAc, 3:1); 
m.p. 81 oc (lit. 117 m.p. 79-80 °C); VmO< (neat)/cm"1 1492 (C=N); 811 (270.01 MHz, 
CDC13) 9.45 (JH, s, CHb), 8.14-8.19 (2H, m, CHct.g), 8.08-8.10 (2H, m, CHc.f), 7.75-
7.81(211, m, CHl"), 7.49-7.77 (3H, m, CH2k.l.m); m/z (EI) 206 (M+ 100%). CDW 





"'-~e N c 
d 
1-(2-Furyl)-2-hydroxy-1-ethanone (55) (0.063 g, 0.50 mmol), I ,2-phenylenediamine 
(0.108 g 1.00 mmol) and 4 A molecular sieves (0.50 g) were added to DCM (25 ml). 
To the mixture, manganese dioxide (0.435 g, 5.00 mmol) was added and the mixture 
heated at reflux under N2 for 30 min. Work up was carried out as in general 
procedure A and purification was carried out on column chromatography 
(PE:EtOAc, 3: I) to give the title compound 237 (0.087 g, 89 %) as an orange solid, 
Rr 0.55 (PE:EtOAc, 2:1); m.p.IOI oc (lit117 m.p 103 °C); VmO< (neat)/cm"1 1496 
(C=N); 811 (270.01 MHz, CDCh) 9.20 (lH, s, CHb). 8.01-8.03 (2H, m, CHct.g), 7.68 
(IH, d, J 3.2 Hz, CH1), 7.64-7.66 (211, m, CH'\ 7.31 (IH, d, 12.9, CHi), 6.58 (lH, 
dd, J 3.2, 2.9 Hz, CHk); m/z (El) !96 (M+ 100%). CDW 6/47/la. The spectroscopic 
d . . h h d . h 1' I9H ata were consistent wit t ose reporte m t e Iterature. 
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2-Cyclohexyl-quinoxaline (239) 
1-Cyclohexyl-2-hydroxy-1-ethanone (238) (0.071 g, 0.50 mmol), I ,2-
phenylenediamine (0.1 08 g 1.00 mmol) and 4 A molecular sieves (0.50 g) were 
added to DCM (25 ml). To the mixture, manganese dioxide (0.435 g, 5.00 mmol) 
was added and the mixture heated at reflux under N2 for 30 min. Work up was 
carried out as in general procedure A and purification was carried out on column 
chromatography (PE:EtOAc, 3:1) to give the title compound 239 (0.0827 g, 78 %) 
as a brown solid, Rr 0.63 (PE:EtOAc, 2: I); m.p. 46 oc (lit117 m.p. 48 °C); Vma> 
(neat)/cm· 1 3018 (Ar), 1491 (C=N); oH (270.01 Mllz, CDCI3) 8.67 (IH, s, CH\ 
7.97-7.98 (2H, m, CH"·8), 7.62-7.73 (2H, m, CH'\ 2.84 (IH, tt, J 11.8, 3.1 Hz, CH1), 
1.32-1.94 (IOH, m, CH/"); mlz (Cl) 213 (MH+ 100%). CDW 6/43/la. The 





~Y b N c e 
d 
Benzoin (0.106 g, 0.50 mmol), 1,2-pheny1enediamine (0.108 g 1.00 mmol) and 4 A 
molecular sieves (0.50 g) were added to DCM (25 ml). To the mixture, manganese 
dioxide (0.435 g, 5.00 mmol) was added and the mixture heated at reflux under N2 
for 15 min. Work up was carried out as in general procedure A and purification was 
carried out on column chromatography (PE:Et0Ac,l2:1) to give the title compound 
241 (0.106 g, 75 %) as a white solid, R1 0.25 (PE:EtOAc, 9:1); m.p. 127-128 oc 
(lit118 m.p. 125 °C); Vma> (neat)/cm I 1477 (C=N); 011 (270.01 MHz, CDCIJ) 7.99-
8.00 (2H, m, CHd·8), 7.75-7.78 (2H, m, CH'·\ 7.43-7.44 (4H, m, CHJ·'), 7.33-7.39 
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(6H, m, CH'·'·m); mlz (EI) 282 (M'). CDW 6/35/4a. The spectroscopic data were 
. . h h d . h ]' 200 consistent w1t t ose reporte m t e 1terature. 
2-Phenyl-6,7-dimethyl-quinoxaline (242) 
I h g o l~kj 
m ~ . a Nul CH3 
n ' ::--- I "-':: 
b0- ~ N c e CH3 d p 
a-Hydroxyacetophenone (0.0681 g, 0.50 mmol), 4,5-dimethyl-1 ,2-phenylenediamine 
(0.136 g, 1.00 mmol) and 4 A molecular sieves (0.50 g) were added to DCM (25 ml). 
To the mixture, manganese dioxide (0.435 g, 5.00 mmol) was added and the mixture 
heated at reflux under N2 for 45 min. Work up was carried out as in general 
procedure A and purification was carried out on column chromatography 
(PE:EtOAc, 4:1) to give the title compound 242 (0.077 g, 66 %) as a orange solid, Rr 
0.48 (PE:EtOAc, 3: I); m.p. 126 "C (lit.96 m.p. 124 °C); Vm, (neat)/cm'1 164l(C=N); 
8H (270.01 MHz, CDCI3) 9.22 (IH, s, CHb), 8.14-8.18 (2H, m, CHct,g), 7.85-7.90 
(2H, m, CI-Il·"J, 7.50-7.56 (3H, m, CHkl,m), 2.51 (6H, s, CH3°'P); mlz (EI) 234 (M+). 
CDW 6/33/2a. The spectroscopic data were consistent with those reported in the 
literature 96 
2-Cyclohexyl-6, 7-dimethyl-quinoxaline (243) 
'4kj g 0 
m n i a ::---N~CH3 
b0-~ N c e CH3 d p 
1-Cyclohexyl-2-hydroxy-1-ethanone (238) (0.071 g, 50 mmol), 4,5-dimethyl-1 ,2-
phenylenediamine (0.136 g, 1.00 mmol) and 4 A molecular sieves (0.50 g) were 
added to DCM (25 ml). To the mixture, manganese dioxide (0.435 g, 5.00 mmol) 
was added and the mixture heated at reflux under N, for 3 h. Work up was carried 
out as in general procedure A and purification was carried out on column 
chromatography (PE:EtOAc, 5:1) to give the title compound 243 (0.107 g, 89 %) as 
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an orange solid, Rr 0.40 (PE:EtOAc, 4:1 ); m.p. 66 "C; vm, (neat)/cm· 3055 (Ar), 
1496 (C=N); 8 11 (270.01 MHz, CDC13) 8.59 (1H, s, CHb), 7.72 (2H, s, CHd.g), 2.90 
(IH, tt, J 11.9, 3.3 Hz, CH,i), 2.40 (6H, s, CH3°'P), 1.32-1.94 (IOH, m, CH/"); 8c 
(67.9 MHz, CDCh) 160.1 (C), 143.9 (CH), 141.0 (C), 140.3 (C), 140.2 (C), 139.1 
(C), 128.1 (CH X 2), 45.0 (CH), 32.3 (CH2), 26.4 (CH, X 2), 25.8 (CH2 X 2), 20.3 
(CH1), 20.2 (CH1); m/z (CI) 241 (MH+ 100%) [HRMS (CI) calcd. for C16H21N2 
(MH+), 241.1705, found: 241.1703 (0. 9 ppm error)]. CDW 6/44/1 a. 
2-Pentyl-6, 7 -dimethyl-quinoxaline (244) 
m k i h g n 
::---Nul CH3 
I 
"' ~ N c e CH 3 d 0 
1-Hydroxy-2-heptanone (53) (0.0652 g, 0.50 mmol), 4,5-dimethyl-1 ,2-
phenylenediamine (0.136 g, 1.00 mmol) and 4 A molecular sieves (0.50 g) were 
added to DCM (25 ml). To the mixture, manganese dioxide (0.435 g, 5.00 mmol) 
was added and the mixture heated at reflux under N2 for 30 min. Work up was 
carried out as in general procedure A and purification was carried out on column 
chromatography (PE:EtOAc, 3:1) to give the title compound 244 (0.071 g, 62 %) as 
an orange oil, Rr 0.58 (PE:EtOAc, 2:1); vm, (neat)/cm·1 1488 (C=N); 811 (270.01 
MHz, CDCh) 8.57 (1H, s, CHb), 7.71-7.73 (2H, m, CHd'), 2.91 (2H, t, J 7.6 Hz, 
CH2), 2.40 (6H, s, CH3"'0), 1.31-1.32 (6H, m, CH{k 1), 0.82 (3H, t, 16.8 Hz, CHn; 
8c (67.9 MHz), CDCh) 157.3 (C), 145.5 (CH), 141.7 (C), 141.0 (C), 140.7 (C), 
139.2 (C), 128.7 (CH), 128.5 (CH), 37.0 (CH2), 32.2 (CH2), 30.0 (CH2), 23.1 (CH2), 
20.9 (CHJ), 14.6 (CH3 x 2); m/z (CI) 229 (MW 100%) [HRMS (CI) calcd. for 
C 15H21N2 (MH+), 229.1705, found: 229.1699 (2.6 ppm error)]. CDW 6/48/Ia. 
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Methyl glycolate (0.045 g, 0.50 mmol), I ,2-phenylenediamine (0.108 g, 1.00 mmol) 
and 4 A molecular sieves (0.50 g) were added to DCM (25 ml). To the mixture, 
manganese dioxide (0.435 g, 5.00 mmol) was added and the mixture heated at reflux 
under N2 for I h. Work up was carried out as in general procedure A and purification 
was carried out on column chromatography (EtOAc) to give the title compound 246 
(0.032 g, 44 %) as a white solid, Rr 0.38 (EtOAc); m.p. 268-269 °C (lit. 119 m.p. 270-
271 oq; Vmax (neat)/cm"1 1637 (N-C=O), 1458 (C=N); OH (270.01 MHz, CDCh) 8.29 
(IH, s, CHd), 7.71-7.73 (IH, m, CH'), 7.48-7.52 (IH, m, CH'), 7.23-7.25 (2H, m, 
CHg.h); mlz (EI) 146 (M+ 95 %). CDW 6/38/lb. The spectroscopic data were 
consistent with those reported in the literature.201 
5.5.3.2 Dihydropyrazines-General Procedure B 
To a mixture of a-hydroxyketone (0.50 mmol), ethylene diamine (1.00 mmol), 2M 
HCl in Et20 (1.00 mmol) and 4 A molecular sieves (0.50 g) in DCM (25 ml) was 
added manganese dioxide (5.00 mmol) and the mixture heated at reflux under N2 
until the a-hydroxyketone was consumed as indicated by TLC (I - 2.5 h). The 
mixture was then cooled to rt, filtered through a Celite® pad and the cake being 
washed with excess DCM. The solvent was removed in vacuo and the residue was 
purified by column chromatography on neutral alumina deactivated with I·hO (6 % 
w/w) to give the dihydropyrazine product. 
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5-Furan-2-yl-2,3-dihydropyrazine (252) and N-[2-(formylamino)ethyl] 
benzamide (253) 
h~~ ~aN 
o e v )d 
b 0- c 
N 
252 253 
1-(2-Furyl)-2-hydroxy-1-ethanone (55) (0.063 g, 0.50 mmol), ethylenediamine (0.07 
ml, 1.00 mmol), HCl (0.50 ml, 1.00 mmol) and 4 A molecular sieves (0.50 g) were 
added to DCM (25 ml). To the mixture, manganese dioxide (0.435 g, 5.00 mmol) 
was added and the mixture heated at reflux for 2 h. Work up was carried out as in 
general procedure B and purification was carried out on column chromatography 
(EtOAc) to give the title compounds 252 and 253. 5-Furan-2-yl-2,3-
dihydropyrazine (252), (0.028 g, 38 %) as a yellow oil, Rr 0.15 (EtOAc); Vm.x 
(neat)/cm-1 1597 (C=N); 811 (400.00 MHz, CDC13) 8.27 (!H, s, CHb), 7.49-7.58 (lH, 
m, CHh), 7.46-7.47 (!H, m, CHI), 6.52-6.54 (!H, m, CHg), 3.62-3.70 (4H, m, CHz"d); 
8c (100.0 MHz, CDC13) 163.8 (C), 160.1 (CH), 147.9 (C), 144.8 (CH), 115.1 (CH), 
112.7 (Cil), 39.7 (CH2), 39.7 (CH2); mlz (CI) 149 (MH+ 50%) [HRMS (CI) calcd. 
for C8H9N20 (MH\ 149.0715, found: 149.0715 (0.3 ppm error)]. CDW 7/50/4a. 
N-[2-(Formylamino)ethyl]benzamide (253), (0.016 g, 18 %) as a yellow oil, R1 
0.08 (EtOAc); Vm.x (neat)/cm-1 3300 (NH), 1650 (C=O); 811 (400.00 MHz, CDCh) 
8.20 (lH, s, CH'), 7.45-7.48 (!H, m, CHh), 7.09-7.11 (lH, m, CH\ 6.99 (lH, s, br, 
NH), 6.58 (lH, s, br, NH), 6.48-6.50 (lH, m, CHg), 3.47-3.60 (4H, m, CH/'d); 8c 
(100.0 MHz, CDCh) 165.3 (C), 162.6 (C), 147.9 (C), 144.8 (CH), 115.1 (CH), 112.7 
(CH), 39.7 (CH,), 39.7 (CH2); mlz (Cl) 183 (MW 100%) [HRMS (CI) calcd. for 
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1-Cyclohexyl-2-hydroxy-1-ethanone (238) (0.071 g, 0.50 mmol), ethylenediamine 
(0.07 ml, 1.00 mmol), HCl (0.50 ml, 1.00 mmo1) and 4 A molecular sieves (0.50 g) 
were added to DCM (25 ml). To the mixture, manganese dioxide (0.435 g, 5.00 
mmol) was added and the mixture heated at reflux under N2 for 2.5 h. Work up was 
carried out as in general procedure B and purification was carried out on column 
chromatography (EtOAc) to give the title compound 254 (0.025 g, 31 %) as a 
yellow oil, Rr 0.75 (EtOAc); Vma., (neat)/cm·' 1665 (C=N); bH (400.00 MHz, CDCh) 
7.71 (1H, s, CHb), 3.43-3.45 (4H, m, CH{ct), 2.21-2.25 (lH, m, CH'), 1.69-1.85 (4H, 
m, CH/·j), 1.32-1.94 (6H, m, CH2g.h,i); lie (100.0 MHz, CDCb) 165.0 (C), 156.0 
(CH), 61.2 (CH2), 50.1 (CH2), 47.5 (CH), 46.7 (CH2), 41.4 (CH2 ), 29.2 (CH2), 29.1 
(CHz), 26.5 (CHz); mlz (CI) 165 (MH+ 100) [HRMS (CI) ca1cd. for C 1oH 17N2 




_,;:. a N 
. e v )d 
J b~ N c 
4-Bromophenyl-2-hydroxyethanone (0.119 g, 0.50 mmol), ethylenediamine (0.07 ml, 
1.00 mmol), HC1 (0.50 ml, 1.00 mmo1) and 4 A molecular sieves (0.50 g) were added 
to DCM (25 ml). To the mixture, manganese dioxide (0.435 g, 5.00 mmol) was 
added and the mixture heated at reflux under N2 for 1 h. Work up was carried out as 
in general procedure B and purification was carried out on column chromatography 
(PE:EtOAc; 4:1) to give the title compound 256 (0.045 g, 39 %) as a yellow solid, Rr 
0.15 (PE:EtOAc; 3:1); m.p. 80 "C; Vm"' (neat)/cm- 11667 (C=N), 1590 (Ar); 811 
(400.00 MHz, CDCb) 8.34 (1H, s, CHb), 7.70 (2H, d, J 8.7 Hz, CHg·'), 7.59 (2H, d, J 
8.7 Hz, CHI:1), 3.56-3.67 (41-1, m, CH2'.ct); 8c (100.5 MHz, CDC13) 155.8 (C), 152.3 
(CH), 135.1 (C), 132.5 (CH x 2), 128.5 (CH x 2), 125.9 (C), 45.1 (CH2), 45.1 (CH2); 
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mlz (El) 236 (M" 35%); m/z (CI) 237 (M4 - I 33%), 235 (M"- I 32%) (HRMS calcd. 
for C10H8N281 Br, 236.9850 (M·-1), found: 236.9858 (3.1 ppm error), (HRMS (CI) 
calcd. for C 10H8N279Br, 234.9871 (M+-1), found: 234.9874 (1.5 ppm error)]. CDW 
8/4/la. 
5,6-Diphenyl-2,3-dihydro-pyrazine (258) 
Benzoin (0.1 06 g, 0.50 mmol), ethylenediamine (0.07 ml, 1.00 mmol), HCI (0.50 ml, 
1.00 mmol) and 4 A molecular sieves (0.50 g) were added to DCM (25 ml). To the 
mixture, manganese dioxide (0.435 g, 5.00 mmol) was added and the mixture heated 
at reflux under N2 for I h. Work up was carried out as in general procedure B and 
purification was carried out on column chromatography (PE:EtOAc, 4:1) to give the 
title compound 258 (0.049 g, 42 %) as a yellow solid, Rr 0.53 (PE:EtOAc, 2: I); m.p. 
163-164 'C (lit. 123 m.p. 162.5-164.5);vm"' (neat)/cm·' 1610 (C=N); 8H (400.00 MHz, 
CDC1 3) 7.38-7.40 (4H, m, CHfj), 7.21-7.32 (6H, m, CHg.h.'), 3.70 (4H, s, CH'"ct); m/z 
(EI) 234 (M+ 65 %). CDW 8/33/la. The spectroscopic data were consistent with 
h d . h ]" 120 t ose reporte m t e Iterature. 
5.5.3.3 Pyrazines-General Procedure C 
To a mixture of a-hydroxyketone (0.50 mmol), ethylenediamine (1.00 mmol), 2M 
HCI in Et,O (1.00 mmol) and 4 A molecular sieves (0.50 g) in DCM (25 ml) was 
added manganese dioxide (5.00 mmol) and the mixture heated at reflux under N2 
until the a-hydroxyketone was consumed as indicated by TLC (1 - 2.5 h). The 
mixture was then cooled to rt and ca. 0.4 M KOH in MeOH (5 ml) was added and 
was returned to reflux for 18 h. The mixture was filtered through a Celite® pad and 
the cake being washed with excess DCM. The solvent was removed in vacuo and the 
residue was purified by column chromatography on neutral alumina deactivated with 
H20 (6% w/w) to give pyrazine. 
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2-Furan-2-yl-pyrazine (264) 
1-(2-Furyl)-2-hydroxy-1-ethanone (55) (0.063g, 0.50 mmol), ethylenediamine (0.07 
ml, 1.00 mmol), HCl (0.50 ml, 1.00 mmol) and 4 A molecular sieves (0.50 g) were 
added to DCM (25 ml). To the mixture, manganese dioxide (0.435 g, 5.00 mmol) 
was added and the mixture heated at reflux under N2 for 2 h. The mixture was then 
cooled to rt and ca. 0.4 M KOH in MeOH (5 ml) was added and was returned to 
reflux for 18 h. Work up was carried out as in general procedure C and purification 
was carried out on column chromatography (PE:EtOAc; 4:1) to give the title 
compound 264 (0.044 g, 60 %) as a yellow oil, Rr 0.67 (PE:EtOAc; 2:1); vm, 
(neat)/cm· 1 1470 (C=N); 611 (270.01 MHz, CDCh) 8.97 (1H, s, CHb), 8.53 (IH, d, J 
' d d h 2.7 Hz, CH ), 8.42 (1H, , 12.7 Hz, CH ), 7.53-7.54 (1H, m, CH2 ), 7.07-7.08 (IH, 
m, CH21), 6.50-6.52 (1H, m, CH'); oc (67.9 MHz, CDCI3) 147.9 (C), 145.0 (CH), 
144.7 (CH), 143.1 (CH), 141.2 (C), 138.3 (CH), 112.9 (CH), ll!J (CH); mlz (Cl) 
147 (MH+ 100%) [HRMS (CI) calcd. for C8H7N20 (Min, 147.0558, found: 
147.0558 (0 ppm error)]. CDW 7/39/4a. 
2-Cyclohexyl-pyrazine (265) 
1-Cyclohexyl-2-hydroxy-1-ethanone (238) (0.071 g, 0.50 mmol), ethylenediamine 
(0.07 m1, 1.00 mmol), HCl (0.50 ml, 1.00 mmol) and 4 A molecular sieves (0.50 g) 
were added to DCM (25 ml). To the mixture, manganese dioxide (0.434 g, 5.00 
mmol) was added and the mixture heated at reflux under N2 for 2.5 h. The mixture 
was then cooled to rt and ca. 0.4 M KOH in MeOH (5 ml) was added and was 
returned to reflux for 18 h. Work up was carried out as in general procedure C and 
purification was carried out on column chromatography (PE:EtOAc; 4:1) to give the 
title compound 265 (0.027 g, 33 %) as a yellow oil, Rr 0.38 (PE:EtOAc; 3:1); vm, 
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(neat)/cm 1 1643 (C=N); oil (400.00 MHz, CDCh) 8.47-8.48 (IH, m, CH}), 8.46 
(IH, d, J2.4 Hz, CH2'), 8.37 (IH, d, J2.4 Hz, CH,''), 2.75 (IH, dt, J 11.9, 3.4 Hz, 
CHz'), 1.32-1.94 (IOH, m, CH/j); 8c (100.0 MHz, CDC13) 161.0 (C), 143.9 (CH), 
143.6 (CH), 142.2 (CH), 44.0 (C), 32.4 (CH, x 2), 26.3 (CH, x 2), 25.8 (CH,); m/z 
(EI) 162 (M+ 100%) [HRMS (EI) calcd. for Crollr4N, (M+), 162.1157, found: 
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4-Bromophenyl-2-hydroxyethanonc (0.118 g, 0.50 mmol), ethylenediamine (0.07 ml, 
1.00 mmol), HCI (0.50 ml, 1.00 mmol) and 4 A molecular sieves (0.50 g) were added 
to DCM (25 ml). To the mixture, manganese dioxide (0.435 g, 5.00 mmol) was 
added and the mixture heated at reflux under N2 for I h. The mixture was then cooled 
to rt and ca. 0.4 M KOH in MeOH (5 ml) was added and was returned to reflux for 
18 h. Work up was carried out as in general procedure C and purification was carried 
out on column chromatography (PE:EtOAc; 4: I) to give the title compound 266 
(0.067 g, 57 %) as a yellow solid, Rr 0.29 (PE:EtOAc; 3:1); m.p. 121 'C; vm, 
(neat)/cm· 1 1470 (C=N); 8H (400.00 MHz, CDCI3) 9.04 (IH, s, CHb), 8.63 (IH, s, 
CHct), 8.53 (I H, s, CH'), 7.90 (2H, d, J 8.9 Hz, CH1'J), 7.64 (2H, d, J 8.9 Hz, CH"''); 
8c (100.0 MHz, CDCI1) 152.3 (C), 144.8 (CH), 143.7 (CH), 142.5 (CH), 135.8 (C), 
132.9 (CH x 2), 129.2 (CH x 2), 125.2 (C); m/z (EI) 234 (M+ 100 %). [HRMS (EI) 
calcd. for CroH7BrN,, 233.9792, found: 233.9796 (I A ppm error)]. CDW 8/2/2a. 
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a-Hydroxyacetophenone (0.068 g, 0.50 mmol), ethylenediamine (0.07 ml, 1.00 
mmol), HCI (0.50 ml, 1.00 mmol) and 4 A molecular sieves (0.50 g) were added to 
DCM (25 ml). To the mixture, manganese dioxide (0.435 g, 5.00 mmol) was added 
and the mixture heated at reflux under N2 for 2.5 h. The mixture was then cooled tort 
and ca. 0.4 M KOH in MeOH (5 ml) was added and was returned to reflux for 18 h. 
Work up was carried out as in general procedure C and purification was carried out 
on column chromatography (PE:EtOAc; 4: I) to give the title compound 260 (0.044 
g, 57%) as a colourless solid, Rr 0.29 (PE:EtOAc; 3: I); m.p. 74 "C (lit. 124 m.p. 72-73 
"C); vm" (neat)/cm-1 1464 (C=N); 811 (400.00 MHz, CDC~]) 9.03 (lH, d, J 1.5 Hz, 
CHb), 8.63 (1 H, dd, J 2.4, 1.5 Hz, CH'), 8.50 (1 H, d, 12.4 Hz, CHct), 7 98-8.04 (2H, 
m, CHLJ), 7.49-7.52 (3H, m, CHg.h.r); mlz (Cl) 157 (MH+ 100 %). CDW 3/2/la, The 
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Benzoin (0.106 g, 0.50 mmol), ethylenediamine (0.07 ml, 1.00 mmol), HCI (0.50 ml, 
1.00 mmol) and 4 A molecular sieves (0.50 g) were added to DCM (25 ml). To the 
mixture, manganese dioxide (0.435 g, 5.00 mmol) was added and the mixture heated 
at reflux under N2 for I h. The mixture was then cooled tort and ca. 0.4 M KOH in 
MeOH (5 ml) was added and was returned to reflux for 18 h. Work up was carried 
out as in general procedure C and purification carried out on column chromatography 
(PE:EtOAc; 3:1) to give the title compound 267 (0.061 g, 52%) as a yellow solid, Rr 
0.50 (PE:EtOAc; 2:1); m.p. 116-118 "C (lit. 126 m.p. 112-115 "C), Vm" (neat)/cm- 1 
1633 (C=N); 811 (270.01 MHz, CDCI3) 8.61 (2H, s, CH'·d), 7.44-7.46 (4H, m, CHLJ), 
7.30-7.34 (6H, m, cW·h,r); m/z (CI) 233 (MH- 100%). CDW 8/34/lb. The 
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a-Hydroxyacetophenone (0.068 g 0.50 mmol), 1 ,2-diphenyl-ethane-1,2-diamine 
(0.212 g, 1.00 mmol), HCI (0.50 ml, 1.00 mmol) and 4 A molecular sieves (0.50 g) 
were added to DCM (25 ml). To the mixture, manganese dioxide (0.435 g, 5.00 
mmol) was added and the mixture heated at reflux under N2 for I h. The mixture was 
then cooled tort and ca. 0.4 M KOH in MeOH (5 ml) was added and was returned to 
reflux for 18 h. Work up was carried out as in general procedure C and purification 
was carried out on column chromatography (PE:EtOAc; 6:1) to give the title 
compound 268 (0.080 g, 52%) as a yellow solid, Rr 0.60 (PE:Et0Ac;4:1); m.p. 152-
154 "C (lit. 127 m.p. 154-155 °C),vm, (neat)/cm-1 3057 (Ar), 1419 (C=N); o11 (270.Dl 
MHz, CDCh) 9.03 (IH, s, CHb), 8.17-8.18 (2H, m, CH1'j), 7.48-7.60 (6H, m, 
CHm,o,o), 7.31-7.34 (7H, m, CHg.h,l,t.p); m/z (CI) 309 (MH+ 100%) CDW 9/20//lc. 






Chapter 5: Experimental 
1-Cyclohexyl-2-hydroxy-1-ethanone (238) (0.071 g, 0.50 mmol), ethylenediamine 
(0.07 ml, 1.00 mmol), HCl (0.5 ml, 1.0 mmol), NaBH4 (0.08 g, 2.00 mmol) and 4 A 
molecular sieves (0.50 g) were added to DCM (25 ml). To the mixture, manganese 
dioxide (0.435 g, 5.00 mmol) was added and the mixture heated at reflux under N2 
for 2.5 h. After complete consumption of cyclohexyl-2-hydroxyethanone, MeOH (6 
ml) was added and stirred at rt for 18 h. The mixture was filtered through a Celite® 
pad and the residue being washed with excess DCM. Et20 (1 0 ml) was added to the 
filtrate and it was extracted with 2 M HCl (3 x 10 ml). The aqueous layer was 
basified with 5M KOH (20 ml) and extracted with DCM (20 ml). The combined 
organic layers was dried over MgS04, filtered and concentrated in vacuo to give the 
title compound 278 (0.028 g, 34 %) as a white solid, m.p.l28 oc; Vma., (neat)/cm- 1 
1540 (NH), 1448 (NH); 811 (400.00 MHz, CDC13) 2.98-3.01 (2H, m, CHb), 2.90 (lH, 
d, J 11.2 Hz, CH2'), 2.72-2.75 (2H, m, CH,'), 2.48-2.50 (2H, m, CH2d), 1.53-1.80 
(7H, m, CH/J, CH' + 2NH), 1.03-1.34 (6H, m, CH2"·h·'); &c (1 00.0 MHz, CDC13) 
61.2 (Cl!,), 50.1 (CH2), 47.5 (CH,J, 46.7 (CH2), 41.4 (CH), 29.2 (CH2 X 2), 26.4 
(CI!, x 2), 26.2 (Cl!,); mlz (CI) 169 (MH' 100'/'o) [HRMS (CI) calcd. for C 1oH2 1N2 
(MH\ 169.1705, found: 169.1704 (0.7 ppm error)]. CDW 7/36/3f. 
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5.6.1 Preparation of Aromatic Nitriles via TOP 
4-Bromonitrohenzene (304) 
Chapter 5: Experimental 
General procedure: Manganese dioxide (1.40 g, 16.10 mmol) was added to a stirred 
solution of 4-bromobenzyl alcohol (0.200 g, 1.07 mmol) and NH3 (2 M in 2-
propanol) (2.1 ml, 4.3 mmol) in THF (4 ml) with MgS04 (1.93 g, 16.10 mmol). The 
mixture was stirred at rt under N2 for 18 h. The manganese dioxide was removed by 
filtration through Celite®, the cake washed well with THF and the combined organic 
portions were concentrated in vacuo. The residue was purified by column 
chromatography (PE:EtOAc, 5:1) to afford the title compound 304 (0.157 g, 81 %) 
as a white solid, Rr 0.25 (PE:EtOAc, 4: l ); m.p. 113 °C (lit145 m.p.l14-114.5 °C); 
vm" (neat)/cm-1 2224 (C=:N); 611 (270.01 MHz, CDCl3) 7.62-7.66 (2H, m, CH"''), 
7.51-7.54 (2H, m, CHct,r); mlz (EI) 181 (M+, 90%). CDW 2/3/1. The spectroscopic 
d . . h h d . h l' 146 ala were consistent w1t t ose reporte m t e 1terature. 
4-Cyanonitrobenzene (305) 
As in the general procedure, manganese dioxide ( 4.26 g, 49.10 mmol) was added to a 
stirred solution of 4-nitrobenzyl alcohol (0.500 g, 3.27 mmol) and NH3 (2M in 2-
propanol) (6.5 ml, 13.1 mmol) in THF (13 ml) with MgS04 (5.91 g, 49.10 mmol). 
Work up, followed by column chromatography ((PE:EtOAc, 5:1) afforded the title 
compound 305 (0.392 g, 81 %) as a yellow solid, Rr 0.35 (PE:EtOAc, 4:1); m.p. 
147-148 °C (1it. 147 m.p. 148°C); Vma.< (neat)/cm-1 2233 (C=N); OH (270.01 MHz, 
CDC]j) 8.35-8.37 (2H, m, CH'·'), 7.87-7.91 (2H, m, CHct.t); m/z (EI) 148 (M+, 
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1 00%). CDW2/l/1. The spectroscopic data were consistent with those reported in the 
literature 205 
2-Hydroxybenzonitrile (307) 
c b ~N d~ e~OH 
f 
As in the general procedure, manganese dioxide (2.16 g, 24.60 mmol) was added to a 
stirred solution of 2-hydroxybenzyl alcohol (0.203 g, 1.64 mmol) and Nth (2 Min 
2-propanol) (3.3 ml, 6.6 mmol) in THF (7 ml) with MgS04 (2.96 g, 24.60 mmol. 
Work up, followed by column chromatography ((PE:EtOAc, 3:1) afforded the title 
compound 307 (0.170 g, 87 %) as a white solid, Rr 0.58 (PE:EtOAc, 2: 1); m.p. 94-
96 °C (lit. 148 m.p. 97-98 °C); vm" (neat)/cm-1 2229 (C:N); 811 (270.01 MHz, CDCh), 
7.44-7.52 (21-1, m, CH'·\ 7.00-7.03 (21-1, m, CH"·'), 6.16 (IH, s, br, OH); mlz (EI) 
119 (M+, 100%). CDW 2/5/1. The spectroscopic data were consistent with those 
d . h l" 206 reporte m t e Iterature. 
Terephthalonitrile (308) 
As in the general procedure, manganese dioxide (3.90 g, 44.40 mmol) was added to a 
stirred solution of 1 ,4-benzenedimethanol (0.204 g, 1.48 mmol) and NH3 (2 Min 2-
propanol) (5.8 ml, 11.8 mmol) in THF (6 ml) with MgS04 (5.23 g, 44.4 mmol). 
Work up, followed by column chromatography ((PE:EtOAc, 4: I) afforded the title 
compound 308 (0.148 g, 78 %) as a white solid, Rr 0.30 (PE:EtOAc, 3:1 ); m.p. 224-
225 oc (lit149 m.p. 227 °C); vm"' (neat)/cm- 1 2358 (C:N); 811 (270.01 MHz, DMSO) 
7.80 (41-1, s, CHa.o.d. 1); mlz (EI) 128 (M', 100%) CDW 2/15/1. The spectroscopic 
data were consistent with those reported in the literature 207 
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1-N apthalenecarbonitrile (309) 
a h 




As in the general procedure, manganese dioxide (4.16 g, 47.40 mmol) was added to a 
stirred solution of 1-napthalenemethanol (0.484 g, 3.16 mmol) and NH3 (2 Min 2-
propanol) (6.3 ml, 12.6 mmol) in THF (13 ml) with MgS04 (5.71 g, 47.40 mmol). 
Work up, followed by column chromatography ((PE:EtOAc, 6:1) afforded the title 
compound 309 (0.398 g, 82 %) as a white solid, Rr 0.35 (PE:EtOAc, 4:1); m.p. 76-
77 oc (lit. 150 m.p. 78 °C); Vm, (neat)/cm"1 2222 cc=N); 8H (270.01 MHz, CDClJ) 
8.26 (IH, dd, J 6.5, 0.7 Hz, CHg), 8.12 (lH, d, J 7.8 Hz, CHa), 7.92-7.95 (2H, m, 
CH'·1), 7.51-7.65 (3H, m, CHb.c,ct); m/z (El) 153 (M+ 100%). CDW 2/2/1. The 
spectroscopic data were consistent with those reported in the literature 208 
5.6.2 Preparation of Heterocyclic Nitriles via TOP 
2-Furancarboxamide (315) 
c b 
d~a e NH 
'o,.-y ' 
0 
As in the general procedure, manganese dioxide (2.68 g, 30.60 mmol) was added to a 
stirred solution of 2-furanmethanol (0.196 g, 2.04 mmol) and NH3 (2 M in 2-
propanol) (4.1 ml, 7.3 mmol) in THF (7 ml) with MgS04 (3.69 g, 30.60 mmol). The 
mixture was stirred at rt under N2 for 18 h. Work up, followed by column 
chromatography (EtOAc:PE, 70:30) afforded the title compound 315 (0.1 00 g, 44 
%) as a white solid, Rr 0.33 (EtOAc: PE, 95:5); m.p.142-144 oc (lit. 152 m.p.142 "C); 
Vma., (neat)/cm· 1 3354 (NH2), 1677 (C=O); OH (270.01 MHz, CDCI3) 7.46 (IH, dd, J 
d b 3.1, 0.8 Hz, CH ), 7.16 (lH, dd, J 3.5, 0.8 Hz, CH ), 6.52 (1H, dd, J 3.5, 3.1 Hz, 
CH'), 6.23 (2H, s, br, NH2); mlz (CI) 112 (MH+ 100%). CDW2/4/4. The 
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As in the general procedure, manganese dioxide (2.68 g, 30.60 mmol) was added to a 
stirred solution of 3-furanmethanol (0.196 g, 2.04 mmol) and NH3 (2 M in 2-
propanol) (4.1 ml, 7.3 mmol) in THF (7 ml) with MgS04 (3.69 g, 30.60 mmol). 
Work up, followed by column chromatography (EtOAc:PE, 70:30) afforded the title 
compound 317 (0.109, 48 %) as a white solid, Rr 0.40 (EtOAc PE, 95:5); m.p.166-
167 "C (lit153 m.p. 169 "C); Vm,_, (neat)/cm 1 3340 (NHz), 1670 (C=O); 811 (270.01 
MHz, CDCI3) 7.97 (IH, dd, J 1.6, 0.7 Hz, CH'), 7.45 (IH, dd, J 1.7, 1.6 Hz, CH0), 
6.62 (IH, dd, J 1.7, 0.7 Hz, CH'), 5.66 (2H, s, br, NH2); lie (100.0 MHz, CDCI3) 
171.0 (C), 145.3 (CH), 143.5 (CH), 117.0 (C), 108.6 (CH); mlz (Cl) 129 (MNH/ 
I 00%) [HRMS (CI) calcd. for C5H,N20 2 (MNH/), 129.0664, found: 129.0663 (0.6 




's/ Y ' 
0 
As in the general procedure, manganese dioxide (2.28 g, 26.40 mmol) was added to a 
stirred solution of 2-thiophenemethanol (0.200 g, 1.76 mmol) and NH3 (2M in 2-
propanol) (3.50 ml, 7.04) in THF (7 ml) with MgSO. (3.16 g, 26.40 mmol). Work 
up, followed by column chromatography (EtOAc:PE, 70:30) afforded the title 
compound 319 (0.180 g, 80 %) as a white solid, Rr 0.45 (EtOAc:PE, 95:5); mp 
179-180 "C (lit. 154 m.p. 179-180 "C); Vmn (neat)/cm 1 3352 (NHz), 1649 (C=O); 8H 
(270.01 MHz, CDCl3) 7.51-7.53 (2H, m, CH 6), 6.87-7.11 (2H, m, CH''ct), 5.75 (2H, s, 
br, NHz); m/z (EI) 128 (M+ 100 %). COW 2/16/2. The spectroscopic data were 
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Chapter 5: Experimental 
As in the general procedure, manganese dioxide (2.28 g, 26.40 mmol) was added to a 
stirred solution of 3-thiophenemethanol (0.200 g, I. 76 mmol) and NH3 (2 Min 2-
propanol) (3.5 ml, 7.0 mmol) in THF (7 ml) with MgSO. (3.16 g, 26.40 mmol). 
Work up, followed by column chromatography (EtOAc:PE, 70:30) afforded the title 
compound 321 (0.208 g, 93 %) as a white solid, R1 0.45 (EtOAc:PE, 95:5); mp 177-
179 oc (lit. I 55 m.p.l79-180 °C); Vm"' (neat)/cm'1 3553 (NHz), 1459 (C=O); i5H (270.0 I 
MHz, CDC1J) 7.93 (IH, dd,J3.1, 1.2 Hz, CH'), 7.40-7.42 (IH, m, CH'), 7.26-7.28 
(IH, m, CHd), 6.02 (2H, s, br, NH2); m/z (CI) 128 (MH' 100). CDW 2/19/2. The 
spectroscopic data were consistent with those reported in the literature209 
2-Pyridinecarbonitrile (323) and 2-Pyridinecarboxamide (324) 
c c dAb 
e I ~ a 




As in the general procedure, manganese dioxide (2.39 g, 27.45 mmol) was added to a 
stirred solution of 2-pyridinemethanol (0.200 g, 1.83 mmol) and NHJ (2M in 2-
propanol) (4.0 ml, 7.3 mmol) in THF (7 ml) with MgS04 (3.31 g, 27.45 mmol). The 
mixture was stirred at rt under N2 for 18 h. Work up, followed by column 
chromatography (EtOAc:PE, 70:30) afforded the title compound 323 followed by 
324. 2-Pyridinecarbonitrile (323) (0.057 g, 30 %) as a white solid; R1 0.50 
(EtOAc:PE, 95:5); mp 47-48 oc (lit. 156 m.p. 48-50 °C); Vm, (neat)/cm I 2224 cc=N); 
811 (270.Dl MHz, CDCh) 8.80 (IH, ddd, J 4.8, 1.7, 0.9 Hz, CH'), 7.92 (lH, ddd J 
7.8, 7.6, 1.7 Hz, CH'), 7.68 (lH, dd, J 7.8, 1.2 Hz, CH6), 7.55 (IH, ddd, J 7.6, 4.8, 
1.2 Hz, CHd; m/z (EI) 104 (M+, 100%). CDW2/24/1a. The spectroscopic data were 
. . h h d . h 1' 210 consistent wit t ose reporte m t e 1terature. 
2-Pyridinecarboxamide (324) (0.136 g, 60 %) as a white solid, Rr 0.38 (EtOAc: 
PE, 95:5); m.p. 110-111 oc (lit. 157 107-109 °C); Vm"' (neat)/cm' 1 3419 (NHz), 1662 
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(C=O); 8H (270.Ql MHz, CDCh) 8.50 (JH, ddd, J 4.8, 1.7, 0.9 Hz, CH'), 8.21 (JH, 
dd, J7.8, 0.9 Hz, CHb), 7.86 (JH, ddd, J7.8, 7.6, 1.7 Hz, CH'), 7.45 (lH, ddd, J7.6, 
4.8, 1.2 Hz, CHd), 5.99 (2H, s, br, NH2); m/z (CI) 123 (MH+ 100). CDW2/24/lb. 
The spectroscopic data were consistent with those reported in the literature. 211 
3-Pyridinecarboxamide (325) 
0 
d~NH2 J~.J:' N 
As in the general procedure, manganese dioxide (2.39 g, 27.45 mmol) was added to a 
stirred solution of 3-pyridinemethanol (0.200 g, 1.83 mmol) and NH3 (2 M in 2-
propanol) (3.6 ml, 7.3 mmol) in THF (7 ml) with MgS04 (3.31 g, 27.45 mmol). 
Work up, followed by column chromatography (EtOAc:PE, 70:30) afforded the title 
compound 325 (0.145 g, 65 %) as a white solid, Rr 0.50 (EtOAc:PE, 95:5); m.p. 
132-134 °C (lit. 158 m.p. 131 °C); Vm" (neat)/cm-1 3392 (NHz), 1697 (C=O); OH 
(270.01 MHz, CDCh) 9.02 (1H, dd, J2.3, 1.7 Hz, CH'), 8.74 (IH, dd, J 4.8, 1.7 Hz, 
C ' dd c d H), 8.16 (I H, , J7.6, 2.0 Hz, CH ), 746 (IH, dd, J7.6, 4.8 Hz, CH ), 6.18 (2H, 
br, s, NH2); mlz (EI) 122 100%. CDW 2/25/2. The spectroscopic data were 
consistent with those reported in the literature.212 
3-Cyanoindole (327) 
As in the general procedure, manganese dioxide (2.39 g, 20.40 mmol) was added to a 
stirred solution of indole-3-methanol (0.200 g, 1.36 mmol) and NH3 (2 M in 2-
propanol) (2.7 ml, 5.4 mmo1) in THF (5 ml) with MgS04 (2.46 g, 20.40 mmol). 
Work up, followed by column chromatography (EtOAc:PE, 70:30) afforded the title 
compound 327 (0. 148 g, 77 %) as a white solid, R1 0.63 (EtOAc:PE, 95:5); m.p. 
180 oc (lit159 m.p. 180 °C); Vm"' (neat)/cm·l 2227 (C=N); OH (270.01 MHz, DMSO) 
8.34 (IH, s, br, NH), 7.51-7.62 (2H, m, CH'-'), 7.24-7.35 (3H, m, CH'.d.c); m/z (CI) 
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160 (MNH4 I 00%). CDW 2/26/1. The spectroscopic data were consistent with those 
d . h ,. 211 reporte m t e 1terature. · 
Tetrahydro-2-furancarboamide (329) 
c b 
dn.a 8 NH 
'o,.y ' 
0 
As in the representive procedure, manganese dioxide (2.60 g, 29.40 mmol) was 
added to a stirred solution of 2-tetrahydrafuranmethanol (0.200 g, 1.96 mmol) and 
NHJ (2 Min 2-propanol) (4.0 ml, 7.8 mmol) in THF (8 ml) with MgS04 (3.60 g, 
29.40 mmol). Work up, followed by column chromatography (EtOAc:PE, 1 :1) 
afforded the title compound 329 (0.099, 44 %) as a white solid, Rr 0.21 
(PE:EtOAc, 1 :2); m.p.76-77 oc (lit160 m.p. 78.5-81.5 °C); Vmex (neat)/cm'1 3448 
(NH2), 1673 (C=O); 8H (270.01 MHz, CDCh) 4.32-4.34 (lH, dd, J 8.4, 6.1 Hz, 
CH'), 3.43-3.54 (2H, m, CHct), 2.72 ( 2H, s, br, NH2), 1.80-1.85 (2H, m, CH6), 1.51-
1.55 (2H, m, CH'); ); 8, (100.0 MHz, CDCh) 164.0 (C), 85.8 (CH), 69.5 (CH), 30.1 
(CH), 29.7 (CH); m/z (CJ) 116 (MH' 100%) [HRMS (CI) calcd. for C5H10N10 2 
(MH\ 116.0712, found: 116.0711 (0.7 ppm error)]. CDW 2/6/1. 
N-Furfurylidienebenzylamine (335) 
g 
c b fnh 
d~N~; 
0 a e j 
As in the representive procedure, manganese dioxide (2.29 g, 26.25 mmol) was 
added to a stirred solution of 2-furfurylmethanol (0.171 g, 1.75 mmol) and 
benzylamine (0.75 g, 7.01 mmol) in THF (7 ml) with MgS04 (3.15 g, 26.25 mmol). 
The mixture was stirred at rt under N2 for 18 h. Work up, followed by column 
chromatography (EtOAc:PE, 70:30) afforded the title compound 335 (0.130, 40 %) 
as a colourless oil, R1 0.30 (EtOAc PE, 95:5); vm"' (neat)/cm-1 1647 (C N); 8H 
(27001 MHz, CDC13) 8.17 (JH, s, CH'), 7.51 (lH, d, 13.1 Hz, CHct), 7.28-7.35 (5H, 
m, CH1;g,h,'-'), 6.77 (lH, d, J 3.4 Hz, CH\ 6.45 (Ill, dd, J 3.4, 3.1 Hz, CH'), 4.79 
1 5 I 
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(2H, s, CH2'); mlz (CI) 186 (MH 100%). CDW 2/2111. The spectroscopic data were 
consistent with those reported in the literature.214 
5.6.3 Preparation of Aliphatic Nitriles via TOP 
(E)-2-Nonenenitrile (337) 
h, ~ ~ ~, i0N 
'-.._/ '-.._/ '-.._/ ~ ?' 
g e c a 
As in the general procedure, manganese dioxide (1.84 g, 21.00 mmol) was added to a 
stirred solution of (E)-2-nonen-1-ol (0.200 g, 1.40 mmol) and NH3 (2 M in 2-
propanol) (3.0 ml, 5.6 mmol) in THF (6 ml) with MgS04 (2.99 g, 21.00 mmol). The 
mixture was stirred at rt under N2 for 24 h. Work up, followed by column 
chromatography ((PE:EtOAc, 1 :2) afforded the title compound 337 (0.157 g, 82 %) 
as a colourless oil, Rr 0.50 (PE:EtOAc, 1:3); Vmc..• (neat)/cm·' 2211 (C:N); OH 
(270.01 MHz, CDCh) 6.50 (lH, dt, J 16.1, 6.8 Hz, CHb), 5.26 (lH, dt, J 16.1, 1.5 
Hz, CH3), 2.19-2.22 (2H, m, CH2'), 1.16-1.53 (8H, m, CH2ct.c.f.g), 0.90 ((3H, t, J 6.7 
Hz, CH3h); m/z (CI) 155 (MNH/ 100%). CDW 2/13/2. The spectroscopic data were 
consistent with those reported in the literature. 215 
(Z)-2-Nonenenitrile (339) 
h f d b a 
~N 
As in the general procedure, manganese dioxide ( 1.83 g, 21.00 mmol) was added to a 
stirred solution of (Z)-2-nonen-1-ol (0.203 g, 1.40 mmol) and NH3 (2 M in 2-
propanol) (3.0 ml, 5.6 mmol) in THF (6 ml) with MgS04 (2.99 g, 21.00 mmol). The 
mixture was stirred at rt under N2 for 24 h. Work up, followed by column 
chromatography (PE:EtOAc, I :2) afforded the title compound 339 (with Z:£ ratio 
of 5:1) (0.155 g, 81 %) as a colourless oil, Rr 0.50 (PE:EtOAc, I :3); vm, (neat)/cm·' 
2237 (C:N); (Z)-2-nonenenitrile (337), oH (270.01 MHz, CDCI3) 6.72 (lH, dt, J 
10.9, 6.8 Hz, CHb), 5.23 (IH, dt, J 10.9, 1.5 Hz, CH'), 2.19-2.22 (2H, m, CH2'), 
1.16-1.53 (8H, m, Clhct.erg), 0.90 (3H, (3H, t, J 6.7 Hz, CH/); m/z (CI) 155 
!52 
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(MNH4 100%). CDW 2/23/2. The spectroscopic data were consistent with those 
d . h l' 216 reporte m t e 1terature. 
2-Nonynenitrile (346) 
d b 




As in the general procedure, manganese dioxide (1.88 g, 21.40 mmol) was added to a 
stirred solution of 2-nonyn-1-ol (0.200 g, 1.43 mmol) and NH3 (2M in 2-propanol) 
(2.9 ml, 5.7 mmol) in THF (7 ml) with MgS04 (2.58 g, 21.40 mmol). The mixture 
was stirred at rt under N2 for 18 h. Work up, followed by column chromatography 
((EtOAc:PE, 70:30) afforded the title compound 346 (0.168 g, 87 %) as a colourless 
oil,217 Rr 0.63 (EtOAc:PE, 95:5); Vm"' (neat)/cm- 1 2268 (C:N); 011 (270.01 MHz, 
CDCh) 2.34 (2H, t, J 6.6 Hz, CH/), 1.25-1.55 (8H, m, CH,h,c,d,e), 0.87 (3H, t, J 7.0 
f Hz, CH1 ); oc (100.0 MHz, CDCI1) 105.2 (C), 87.5 (C), 55.1 (C), 31.0 (CH2), 28.3 
(CH,), 26.9 (CH2), 22.3 (CH,), 18.7 (CHz), 13.9 (CH,); m/z (Cl) 153 (MNH/ 100%) 
[HRMS (CI) calcd. for C9H17N2 (MNH/), 153.1392, found: 153.1388 (2.2 ppm 








c ~ e 
d 
As in the general procedure, manganese dioxide (2.05 g, 23.50 mmol) was added to a 
stirred solution of 3-phenyl-2-propyn-1-ol (0.207 g, !.57 mmol) and NH3 (2M in 2-
propanol) (3.2 ml, 6.3 mmol) in THF (6 ml) with MgS04 (2.84 g, 23.5 mmol). The 
mixture was stirred at rt under N2 for 2 h. Work up, followed by column 
chromatography ((PE:EtOAc, 4:1) afforded the title compound 347 (0.163 g, 82 %) 
as a white solid, R1 0.55 (PE:EtOAc, 3:1); m.p. 37-38 oc (lit. 164 m.p. 40 °C); Vm"' 
(neat)/cm- 1 2185 (C:N); 011 (270.01 MHz, CDCh) 7.58-7.64 (2H, m, CH"-'), 7.51-
7.57 (lH, m, Cll'), 7.37-7.47 (2H, m, CHb.d); mlz (CI) 145 (MNH; 100%). 
153 
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CDW2/11/4a. The spectroscopic data were consistent with those reported in the 
literature. 218 




a fd h NH 2 a ~g by- by- ~g 
c """' e c """' e 
d d 
347 348 
As in the general procedure, manganese dioxide (2.05 g, 23.50 mmol) was added to a 
stirred solution of 3-phenyl-2-propyn-1-ol (0.207 g, !.57 mmol) and NH3 (2M in 2-
propanol) (3.2 ml, 6.3 mmol) in THF (6 ml) with MgS04 (2.84 g, 23.50 mmol). 
The mixture was stirred at rt under N2 for 18 h. Work up, followed by column 
chromatography ((PE:EtOAc, 4: I) afforded the title compound 347 followed by 348. 
3-Phenyl-2-propynenitrile (347) (0.060 g, 30 %) as a white solid, Rr 0.55 
(PE:EtOAc, 3:1); m.p. 37-38 °C (lit 164 m.p. 40 °C). CDW 2/II/4a_l. Spectral data 
is as above. 
3-Pheny1-propyn-amide (348) (0.136 g, 60 %) as a white solid, R10.28 (PE:EtOAc, 
3:1); m.p.104-106 "C (lit165 m.p. 107-108 'C); Vme., (neat)/cm-1 3376 (NH2), 1635 
(C~O); OH (270.01 MHz, CDCI1) 7.55-7.62 (2H, m, CH"'), 7.34-7.40 (3H, m, 
CH6·'·d), 5.79 (2H, s, br, NH2); mlz (Cl) 146 (MH+ 100%). CDW 2/11/4b_l. The 
spectroscopic data were consistent with those reported in the literature. 219 
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bstract: The direct conversion of primary alcohols into nitrites is 
ported (RCH20H into RCN) using manganese dioxide and am-
onia in 2-propanol-THF, containing magnesium sulfate at room 
mperature. This transformation, which proceeds via an in situ ox-
ation-imination-aldimine oxidation sequence, has been applied to 
range of benzylic, heterocyclic, ally lie and propargylic alcohols. 
cy words: oxidation. imines, nitrilcs, cyanides, one-pot 
.s part of a programme to investigate tandem manganese 
ioxide-mediated alcohol oxidation followed by in situ 
apping of the resulting aldehydes, we have studied the 
se of stabilised phosphoranes, 1 non-stabilised phospho-
mes,2 stabilised phosphonate anions2 and aminesJ as 
apping agents. 4 By including a polymer-supported re-
ucing agent in the amine trapping process, the sequence 
·as extended so that the intermediate imine was reduced 
1 situ: this oxidation-imination-reduction sequence thus 
rovides a one-pot route from alcohols to amines (Equa-
on 1).3 Inspired by a recent publication by Lai et al., 5 we 
ecided to investigate the related oxidation-imination-ox-
lation sequence shown in Equation 2. 
\1nO, I IIHI 1 rCH OH ---...- ArCHO ---+- ArCH=NR 1 ---+- ArCH2NHR 2 R1NH:: 
PCSBH 
CSBH =polymer supponed cyanoborohydride 
quation 1 
:quation 2 
. ai 's group showed that aromatic aldehydes could be con-
ertcd into the corresponding nitriles by treatment with 
mmoma in 2-propanol (IPA) and THF containing mag-
esium sulfate and manganese dioxide at room tempera-
Jre (r.t.) for 16-22 hours. 5 This transformation 
,resumably involves conversion of the aldehyde into the 
orresponding aldimine followed by in situ oxidation by 
ynlett 2002. No.8, Print: 30 07 2002. 
.rt !d. t437-2096.E;2002.0,08, I 291, 1292.ftx,cn;D08802ST.pdf. 
) Georg Thieme Verlag Stuttgart· New York 
SSN 0936-5214 
the manganese dioxide. We hoped to illustrate that this 
transformation could be canied out directly from primary 
alcohols (Equation 2). 
Initial studies were carried out using 4-bromobenzyl alco-
hol under Lai's conditions (Equation 3) 5 To our delight 
the procedure gave the corresponding benzonitrile in 81% 





THF, r.L. 18 h 
We therefore investigated the in situ oxidation-nitrile for-
mation reaction with a range of benzylic alcohols under 
these conditions (Table 1). They all underwent smooth 
transformation to give the corresponding nitriles in good 
yields. The reaction was compatible with electron with-
drawing or donating substituents (entries i-iii), and effi-
ciently converted 1,4-benzenedimethanol into 
terephthalomtrile (entry iv). One naphthalene example 
was studied and proceeded smoothly (entry v), as did the 
conversion of indole-3-methanol into 3-cyanoindole (en-
try vi). In the last example it is noteworthy that N-protec-
tion was not required. 
We next looked at similar reactions with allylic and prop-
argylic alcohols (Table 2). BothE- and Z-non-2-en-l-ol 
underwent efficient conversion into the corresponding un-
saturated nitriles (entries i and ii), although in the latter 
example there was a small amount of alkene isomerisation 
(ZE = 5:1). Propargyl alcohols were also studied (entries 
iii and iv); both non-2-yn-1-ol and 3-phenylprop-2-yn-l-
ol gave the corresponding nitriles in good yields, the latter 
reaction taking only 2 hours . 
If the reaction with 3-phenylprop-2-yn-1-ol was left for 
longer than 2 hours, increasing amounts of phenylpropar-
gylamide were observed, presumably by nitrile hydration 
occurring in situ. R A similar result was obtained with py-
ridine-2-methanol (Equation 4) 89 A fair yield (30%) of 
the nitrile was ohtained under the standard (18 h) condi-
tions, but the main product was the corresponding carbox-
amide. 
Attempts to extend this methodology to unactivated alco-
hols such as decanoJlb were unsuccessful. 
~92 G. D. McAllister ct al. 






























Jsing ammonia m IPA, MgSO~, manganese dioxide (15 equiv) in 
-IF at r.t. for 18 h, 1 30 equiv of MnOc was used in example (iv). 
1ble 2 In Situ Oxidation-lmination-Oxidation Giving Nitriles: Al-
lie and Propargyli<.: Examples' 
!try Alcohol Product Product 
(isolated 
yield) 
Cr,Hil~OH <-N 821/(· (24 ~C' h) Cr,HII ~ 
CrJl11~ 'l~ 82% (24 
- OH Cr,Hit........_____.,c .... h)Z£=5 I 
i) /011 Cr.H11 ~ C=:N 87% (18 
Cr,Htl h) 
>) OH Ph ~ c=N 82% (2 h)1" --~'~"~~~~-------------· - ------
Jsing ammonia in lPA, MgS04 , manganese diox1de (15 equiv.) in 
-IF at r.t. for the time indicated. 
Vhen the reaction was left for 3 h, some phenylpropargylamide was 
1served by TLC. If the reaction was left for 24 h, phenylpropargyl-
lide was the only product (62Wr). 
conclusion, we have successfully developed a one-pot 
ocedure for the conversion of activated primary alco-






THF r.t .. 18h 
30'~ 
Equation 4 
oxidant is heterogenous and can be removed by simple fil-
tration, evaporation of the solvent then giving the product. 
Given the importance of nitriles for the synthesis of fine 
chemicals, pharmaceuticals and agrochernicals, 10 we feel 
that this new methodology will be of general interest. 
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u-Hydroxyketoncs undergo MnOrmediated oxidation fol-
lowed by in situ trapping with aromatic or aliphatic 
1,2-diamines to give quinoxalines or dihydropyrazines, 
respe(.tively, in a one pot procedure which avoids the need to 
isolate the highly reactive 1,2-dicarbonyl intermediates. 
Modifications of the procedure allow the formation of 
pyrazines and piperazin~. 
Quinoxa!ines const!tute the basis of many insecticides, fungi-
cides, herbicides and anthe!mintics, as well as being important 
in human health and as receptor antagonists.!.Z Dihydropyr-
azines, piperazines and pyrazines are also of great importance in 
natural products and chemotherapeutic agents.2a.J 
We have recently developed a number of manganese dioxide-
Jased tandem oxidation processes (TOPs) for the elaboration of 
:tlcohols.4-6 As part of this programme, we discovered an in situ 
)Xidation-amine trapping process leading to imines.5 In 
1ddition. we recently established that a-hydroxyketones un-
lergo in situ oxidation-trapping when treated with manganese 
iioxide in the presence of stabilised Wittig reagents. 6 We 
herefore decided to investigate the conversion of LY-hydrox-
lketones 1 into quinox;:dines 2 or dihydropyrazines 3 by the use 
)f manganese dioxide along with suitable 1,2-diamino com-
Jounds (Scheme I). 
H2Ny~-~~ / 
H,N//// 
2a Ro::Ph7:a 79% 
2b R=C6H11 7b 78% 
H R 
3a R=Ph 64% 
Jb R=~H 11 53% 
4a R"'-Ph 14% 
4b R=CeH11 
Scheme I Formation of quinoxalines and dihydropyn1zines_R.<J 
We have shown these processes to be effective for a range of 
-hydroxyketones l and I ,2-diamines (Scheme I ).1 o The 
ihydropyrazines 3 were sometimes accompanied by N~acyl­
"-formy!-trans-1 ,2-diaminocyclohexane byproducts 4. There 
an isolated example of the oxidative cleavage of bis-
~miaminaJsll and we propose a similar Mn0 2-mediated 
~ocess leading to 4.12 
Having shown that it is possible to produce dihydropyrazines 
in situ using TOP methodology, attention moved to extended 
1e-pot procedures. We recently reported the production of 
:condary and tertiary amines from activated alcohols using a 
ln02 mediated one-pot oxidation imine-formation reduction 
·quence.5 We envisaged a similar sequence leading from a-
tdroxyketones I to piperazines 5 (Scheme 2). Thus, the 
hydropyrazine-fonning reactions described above were re-
;ated using Mn0iNaBH4 . No piperazine formation was 
observed under these conditions, but the addition of excess 
methanol to the reaction mixture after dihydropyrazine forma-
. tion gave the corresponding piperazines 5a-f in good yields 
(Table I). 
As can be seen (Table I), the procedure gave good to 
excellent yields with aromatic (entries i-iii) and aliphatic 
(entries iv~vi) a-hydroxyketones. In the reactions using 
(:::)-trans-] ,2-diaminocyclohexane (entries ii-iv, vi), only one 
Mn02, Na8H4 • 
CH2CI2, reflux, 
then MeOH 
Scheme 2 In slfu formation of piperazines. 1 3 
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" Yields refer to chromatographically pure product.9 n Compound Sc proved 
sensitive to acid/base extraction; it was therefore ISOlated as the correspond-
ing diacetate. ~Formed as a mixture (ca. I: I) ofdiastereomers. 
This JOUtnai IS © The Royal Soc1ety of Chemistry 2003 
diastereomeric product was isolated and we have tentativelv 
assigned these as the all-equatorial adducts shown.1 4 ~ 
Finally, we investigated a TOP-aromatisation sequence 
leading to pyrazines 6. To this end, the original dihydropyrazine 
fonnation was repeated in THF and toluene at extended reflux 
in the presence of excess Mn02 in order to effect the 
aromatisation. However, under these conditions, only trace 
amounts of pyrazines 6 were observed in the toluene reaction. 
The use of co-oxidants, such as DDQ and CAN, in these 
reactions resulted in complete degradation of the dihydropyr-
azines 5. We eventually established that the addition of- 0.4 M 
KOH in methano! 15 to the refluxing reaction mixture after the 
formation of dihydropyrazines 5 resulted in production of the 
corresponding pyrazines 6 (Scheme 3). lt should be noted that 
the addition of methanol alone did not achieve the desired 
transformation. The results are summarised in Table 2. As is 
apparent, the presence of an aromatic substituent facilitates 
aromatisation. 
Scheme 3111 situ fonnation ofpyrazines.16 
fable 2 In situ pyrazine fonnation 16 
R R' 
Ph H 



















[n conclusion, we have developed novel methodology for the 
wersion of a-hydroxyketones I into the corresponding 
noxalines 2 and dihydropyrazines 3 via a tandem oxidation 
'cedure with in situ trapping using I ,2-diamines. This 
thodo!ogy has been successfully extended to allow the direct, 
:~pot conversion of the dihydropyrazines into the corre~ 
nding piperazines and pyrazines in fair to good yields. 
ther work is continuing to optimise and apply this new 
mistry. 
We are grateful to the EPSRC for postdoctoral support 
(ROPA, S.A.R.) and to Universiti Teknologi, Petronas. Ma~ 
laysia for a Ph. D. Scholarship (C. D. W.). 
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1xy ketones undergo manganese dioxide-mediated oxidation follOwed by in situ trapping with aromatic or 
~ 1,2-diamines to give quinoxalines or dihydropyrazines, respectively, in a one-pot procedure which avoids 
to isolate the highly reactive dicarbonyl intermediates. The scope and limitations of these procedures are 
and modifications to this procedure are discussed in which reduction is carried out in the same reaction 
~nerating piperazines, or oxidation, leading to pyrazines. 
1ction 
1-containing heteroarornatic and heterocyclic com-
ue indispensable structural units for both the chemist 
biochemist. Quinoxalines constitute the basis of many 
les, fungicides. herbicides and anthelmintics, as well as 
portant in human health and as receptor antagonists. 1•1 
re numerous methods of preparing quinoxalines 
double condensation of a 1.2-dicarbony! compound 
-diaminoaromatic is commonly employed. l-l Similarly, 
yrazines, piperazines and pyntzines are of great 
tce in natund products and as chemotherapeutic 
1 and can be prepared from the corresponding I .2-
yl compound and an aliphatic 1,2-diam'tne, 1 a,~.s 
by reduction or oxidation of the resulting dihydro-
;, if required. 
re recently developed a number of mang<mese dioxide-
tandem oxidation processes (TOPs) for the elabor-
tkohols.~>-8 As part of this programme. we established 
dro:o;yketones undergo in situ oxidation-trapping when 
rith nwnganese dioxide in the presence of stabilised 
!agents, giving y-ketocrotonates (Scheme !a).7 In 
we have also developed a TOP-amine trapping 
leading lo imines (Scheme I b). 8 We therefore decided 
I these procedures and investigate the conversion of 
iketones l into diamino heterocycles. 9 
0 
~OH Mn02, Ph3PCHC02Et CH20 2, reflux 
Mn01, R'NH2, 
4A mol. sieves 




~e I TOP approaches to 7-ketocrotonates and imine~. 
and discussion 
tudied the preparation of quinoxalines 4 and related 
ies employing a manganese dioxide-mediated TOP 
lble 1,2-diaminoctromatics 2 avoiding the need to 
e "hyper-reactive" 10 1,2-dicarbonyl intermediate 3 
). 
1ary studies were carried out using hydroxyacetone 
:) and a-phenylenediamine 2a (R'=H), and are sum-
l Table I. On the first attempt we were delighted to 
1e formation of 2-methylquinoxaline 4a 11" but the 
: r(YNH, 
IR·~N'N~R' 
'5 ~ I H,N 
Scheme 2 Propo~ed TOP synthe:;i~ of quinoxalines. 
yield of 43 1!1,, was disappointing (Table I, entry i). Addition of 
acid or base (entries ii and iii), or changing the solvents (entries 
iv omd v) gave no improvement. The major by-product was 
isolated and identified as the known 1 ~ diazobenzene Sa result-
ing from oxidative coupling of 2a. We therefore investigated 
batcJ1wise ;1ddition of the reagent:; and the usc or different 
stoichiometries (entries vi and vii). The optimum conditions 
involved the use of a two fold excess of diamine 2a (entry vii); 
in this case the reaction was complete in just one hour and 
2-methylquinoxaline 4a was isolated in 79% yield (after 
Table I Optimi.';lation of :V!n01-mediated TOP leading to quinoxaline 
4•" 
Me,(+ H2N1) Mn02 Me~ND l / ~ 
OH H2N N ,, 2a <a 
Yield 
Entry Reagents Conditions Timelh (%) 
!5 eq. Mn02, l I eq. 2a CH2CI!,t:,. 20 43 
ii 15 eq. MnO!, I I eq. 2a. CH!Cl::, t:,. 20 10 
1'/\,AcOH 
iii ·1Seq. Mn02, I I eq. 2a. CHzCI 2• D. 20 10 
I'Yn K2CO] 
;, 15 eq. Mn02, 1 I eq. 2a Et20, .-1 20 12 
' 
15 eq. Mn02, 1.1 eq. 2a THF,6 20 15 
v• !5 eq. Mn0 2, 3.0 eq. 1a. CH 2CI2, 6. 20 51' 
l.Oeq.2a 
"' 
10 eq_ Mn0 1, 2.0 eq. 
4 A moL sieves 
2a, CH2CI2, D. 79' 
• Based on I eq. alcohol 1a unless otherwise stated; the diazo com~ 
pound Sa was also formed (up to 15%). "Yield based on diamine 2a. 
'The i~olated yield of diazo compound in this case was 6% based on 2a. 
1iomol. Chem., 2004,2,788-796 Thrs JOurnal is Q Tile Royal SoC'ety of Chemistry 2004 
. ' 
' 
.1n02-mediated TOP quinoxa!lne formation n 
Entry a-Hydroxy ketone I Amine 2 ProJuct 4 Yield ('Yro) 
lo ,, 43 lin 79 
"( ll:N~ ~c::o OH H,J~ 
ii lb 2• 4bll0 78 
C\o 
H,NX) 
C\N:o ll~N ~ OH N 
iii lc ,, 4cllc 79 
~0 H,NX) ~ H~N :NX) OH N 
,, ld ,, 4d lie 89 Yto H,NX) 0 "' 0A(X) H~N ~ OH N 
,, ,, 4e lid 75 gxo H,NX) ONX) H1N oxN~I OH 
_., 
,; lc 2b 4fl< 66 
~ H,Nxx (\ . I H2N ~ "'0 "'NXX OH ""!'J ~ ...._, 
vii lb lb 4g 89 
C\o 
H,Nxx 
C\Nxx H2N ~ 
OH N 








"' ~I N 
;, ,, 2c 4ill, 66' 
~c:H H,Nt) rNX) Me- I '- I 
""' ""' H,N N N 
X lc 2c 4jl<llf G9' 
Oyo H0Nt) O(X) " I c, ""' I H2N N N 
'--oH 
\1n02 and 2 eq. diamine in CH 2C/7 at reflux; diazo and polymeric byprnducts were removed during chromatography. Yield refers to 
atographically and spectroscopically pure product." Isolated as a mixture of regia isomers, -7 . I in favour of the 3-methylpyrido[2.3-
~tennined by 1H NMR spectroscopy r Isolated as a mixture of regioisomers, -2 : I in favour of the 3-pheny!pyrido[2,3-b]pyntzine as 
'H NMR spectroscopy. 
'hY to remove Sa and polymeric by-products). The 
mplicity of this process is noteworthy: after the 
nplete the remaining oxidant and its by-products 
'Y filtration and concentration in vacuo followed 
·aphy gives the pure product. 
ccessful optimisation results in hand, we moved 
te the scope of the process (Table 2), first in terms 
of a-hydroxyketone substrate (entries t-v). As can be seen, in 
addition to a-hydroxyacetone Ja, the related I -cyc!ohexyl-
2-hydroxyethanone Ib 13 also gave an excellent yield of the 
corresponding quinoxaline 4b on treatment with manganese 
dioxide and J .2-diaminobenzene. Substrates I a and Ib were 
of particular interest as the intermediate a-keto aldehydes 




the aldehyde function. 10 We next moved on to examine aryl 
substituted a-hydroxyketones (entries iii and iv), both 
hydroxyacetophenone lc and the related fury! system ld 11 
giving the expected adducts 4c and 4d, respectively. The 
secondary alcohol benzoin le was also shown· to react well 
under these oxidative-trapping conditions with 1.2-diamino-
benzene 2a giving 2,3-diphenylquinoxa!ine 4e in 751X, yield 
(entry v). 
We next studied the use of otherdiamines (entries vi-x). Thus, 
I ,2-diamino-4,5-dimethyfbenzene 2b was also shown to work 
well in these reactions giving the desired 2,6,7-trisubstituted . 
quinoxa!ines 4f, 4g and 4h in good to excellent yields with 
u-hydroxyketones 1c, lb and lf, respectively (entries vi-viii). 
Finally, 2J-diaminopyridine 2c was investigated as a coupling 
partner with Ia and lc. giving the corresponding 2/3-substituted 
pyrido(2J-h]pyrazines 4i and 4j as mixtures of regioisomers 
(entries ix and x). 
Finaf!y in this section of the research, we attempted to 
apply this methodology to the synthesis of quinoxalin-2-ones. 
Hence, methyl glycolate {1.20 equivalents) and 1)-phenylene 
diamine 2a were reacted under the standard conditions. 
Unfortunately, oxidation of the glycolate is much slower than 
for the a-hydroxyketones and therefore, production of diazo-
benzene is much faster than formation of the quinoxalinone 4k, 
which was isolated in a disappointing yield of 36% (Scheme 3). 
Even when the glycolate was used in two-fold excess with 
respect to phenylenediamine 2a, 1H NMR spectroscopy of the 
crude product, after complete consumption of 2a, showed the 
molar ratio of diazobenzene Sa to q uinoxaline 4k to be -1. I : I . 
With a facile and technically straightforward synthesis of 
quinoxalines and related heteroaromatlc compounds from the 
corresponding a~hydroxyketones to hand, our attention turned 
to the development of related procedures for the preparation of 
pyrazines, dihydropyrazines and piperazines. 
H 
MeO 0 H,Nl) 0 ND Y + • ( .....::::: MnOl, 4A mar. sreves y ) '.":::: 
l_ .....:. CH2CI2, reflux ~ .....-:;. OH H,N N 
1g 2a 36% 4k 
Scheme 3 Synthesis of quinoxalin-2-ones. 
Initial studies concentrated on the preparation of dibydro-
pyrazines. using a-hydroxy-.tcetophenone lc as the mode! 
u-hydroxyketone with ethylenediamine 5a (Scheme 4). We 
quickly established that the process was viable under the 
optimum conditions as used for quinoxaline synthesis. The 
expected 2-phenyl-5,6-dihydropyrazine 6a was produced in 28% 
yield without contamination by diazo byproducts. However, 
somewhat surprisingly, the major product from this reaction 
was N-benzoyl-N'-formyl I ,2-diaminoethane 7a, obtained in 
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Ph ~ oxidatwe ?a 
8 cleavage 
Scheme 4 TOP approach to dihydropyrazines. 
We assume that a bis-hemi-aminal intermediate, such as 8, 5" 
1hich would give adduct 6a after dehydration, can also undergo 
xidative cleavage in the presence of manganese dioxide giving 
is-amide 7a. The oxidative cleavage of I ,2-dio/s using Mn02 is 
Org. Biomol. Chem., 2"004,2, 788-796 
well known 14 but, to our knowledge, it has not been reported 
with hemi-aminals before. An isolated example of the oxidative 
cleavage of a bis-hemiaminal using sodium perbromate has 
however been reported. 15 By varying the reaction conditions 
and solvent {Scheme 4). we found that it was possible to 
minimise formation of bis~amide 7a by the addition of 2.0 M 
HCI in Et10 (J equivalent with respect to the diamine) to 
the reaction mixture. Using this optimised procedure, dihydro· 
pyrazine 6a was obtained in 53(Y,, yield. The dihydropyrazines 
produced rn this manner are fairly sensitive, particularly 
in unpurified form, and were therefore chromatographed 
immediately after work up using deactivated, neutral alumina. 
We then went on to determine the scope of this procedure, 
particulariy in terms of the u-hydroxyketone substrate 
(Table 3). When using a more hindered diamine, exemplified 
by (±)-trans·/,2-diaminocyc!ohexane Sb (entries ii-iv), the 
dihydropyrazines 6b-6d were obtained in fair to excellent 
yields, reflecting their greater hydrolytic stability. It should be 
noted that when using cyclohexanediamine Sb, the bis-amide 
by-products (corresponding to 9a) were formed in relatively 
low yields (<15'Y.,), and the addition of HCl in Et10 was not 
required. 
Having shown that it was possible to produce dihydro-
pyrazines 6:1-d in situ using TOP methodology, attention 
moved to the extended one-pot procedures. We recently 
reported the production of secondary and tertiary amines from 
<iClivated alcohols using a Mn02 mediated .one-pot oxidation 
imine-formation reduction sequence. 8 We e~visaged a similar 
sequence leading from a-hydroxyketones ,' I to piperazines 
9 (Table 4). Thus, the dihydropyrazine-Torming reactions 
described above were repeated using Mn01-NaBH 4 . No 
piperazine formation was observed under these conditions, but 
Table 3 MnOJ-111elliated TOP dihydmryrazine limnalion "·" 
Entry R R' 
Phenyl 1 c H 
Sa 
" 
Phenyl !c (CH,), 
Sb 
























.• Using Mn01 (1 0 eq.), diamine (1.2 eq.) and powdered 4 A moL sieves 
in CH-:.01 at reflux; when using diamine Sa, 2.0 eq. of diamine were 
employed along with 2.0 M HCI in Et10 (I eq. with respect to diamine). 
Yield refers to isolated, chromatogmphically and spectroscopically pure 
product. n The products were purified immediately after work up 
(chromatogrdphy on deactivated neutral alumina) in order to prevent 
degradation. 
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"Using Mn02 (10 eq.), diamine (1.2 eq.), NaBH4 (4.0 eq.) and pow-
dered 4 A mol. sieves in CH 1Cl2 at reflux; when u:;ing Ui;tmine Sa, 2.0 
eq. ofdiamine were employed along with 2.0 M HCJ in Et20 (I eq with 
respect to diamine. 'field refers to isolated, spectroscopically pure 
product. 
the addition of excess methanol to the reaction mixture after 
dihydropyrJzine formation gave the corresponding piperazines 
9a-d in good yields (Table 4). As can be seen, the procedure 
gave good to excellent yields with aromatic (entries i-iii) and 
aliphatic a-hydroxyketones (entry iv). In the reactions using 
(±)-trans-1 ,2-diaminocydohex.ane Sb (entries ii-iv), only one 
diastereomeric product was isolated and we have tentatively 
assigned these as the all-equatorial adducts shown. There is 
literature precendence for this selectivity 16 and, furthermore, 
pertinent coupling constants in the 1 H NMR spectra were in the 
region expected for trans-diaxial protons, e.g. for H-2 to H-Ja,.,1 
in compound 9b, the J value is 10.4 Hz. 
Finally. we investigated the TOP-dihydropyrazine formation-
aromatisation sequence leading to pyrazines IO (Table 5). To 
this end, the original dihydropyrazine formation was repeated 
in THF and toluene at reflux for extended periods of time in the 
presence of excess Mn0 1 to effect the aromatisation. However, 
under these conditions, only trace amounts of pyrazines 8 were 
observed in the toluene reaction. The use of co-oxidants, 
such as DDQ and CAN, in these reactions resulted in com-
plete degradation of the dihydropyrazines 6. We eventually 
established that the addition of -0.4 M KOH in methanol 3",Sh 
to the refluxing reaction mixture after the formation of dihydro~ 
pyrazines 6, resulted in production of the corresponding 
pyrazines 10. It should be noted that the addition of methanol 
alone did not achieve the desired transformation. The results 
are summarised in Table 5. As is apparent. the presence of an 
:tromatic substituent facilitates aromatisation (e.g. entries i and 
v t•ersus vi and vii). 
Finally, we examined the value of these methodologies with 
he complex, multifunctional substrate, hydrocortisone 11. 
~xposure of I I to the standard conditions for the formation 
Table 5 Mn02-mediated TOP-aromatisation pyrazine form<ltion" 
RVO ~R'(NyR'l 
i "Ci);-M;:;:;coo",-,-l , I j 
"-oH 'l..A..R, diamine 5 ,. 
R N R' 
(ii) 0.4 M KOH '( }( 
in MeOH N R' 
10 


















































"Using Mn0 2 (I 0 eq.), diamine (1.2 eq.) and powdered 4 A mol. sieves 
in CH 2CI2 at reftux; when using diamine Sa, 2.0 eq. of diamine were 
employed along with 2.0 M HCJ in Et20 ( l eq. with respect to diamine). 
After consumption of the hydroxy ketone, KOH in MeOH was added 
to complete aromatisation. Yield refers to isolated, chromato-
graphically and spectroscopically pure product 
of quinoxalines, dihydropyrazines, piperazines or pyrazines 
gave the novel derivatives 12-17 in moderdte to excellent 
unoptimised yields (Scheme 5). 
Conclusion 
In conclusion, we have developed a novel methodology for the 
conversion of a-hydroxy ketones 1 into the corresponding 
quinoxalines 4 and dihydropyrazines 6 ~·ia Mn02~mediated 
tandem oxidation processes with in situ trapping using I ,2-
diamines. This methodology has been extended to allow the 
direct synthesis of piperazines 9 and pyrazines 10 in related 
TOP sequences from the corresponding a-hydroxy ketones I 
·in fair to good yields. These Mn01.-TOPs offer the synthetic 
chemist significant time-cost benefits and, hence, we expect 
them to find applications in both academic and industrial 
environments. Further work is continuing to optimise and 
apply this new chemistry to more complex targets and 
compound-library synthesis. 
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13, R"'H, 40% 
14, R=(CH2)4, 82% 
"X" 0 
N R / 
H ~n02, Sa or Sb, Hydrocort'isone 11 ~ 
0 
15, R=H, 59% 
16, R=(CH2)"', 87% 
NaBH4 , 4A mol. sieves, 
CH20 2, reflux 
ii) MeOH, rt 
-lA mot. sieves, 
CH 20 2, reflux 
ii) KOH in MeOH, 
reflux 
Scheme 5 Hydrocortisone as a viable substrate for Mn0 1-medi<tted TOP formation of heterocyclic and heteroaromatic functionality. 
Experimental 
General details: NMR spectra were recorded on Jeol EX~270 
and EX-400 instruments using CDCI 1 as solvent unless 
otherwise stated. Tetramethylsilane was used as an internal 
standard in all cases. IR spectra were recorded on an AT! 
Mattson Genisis FT-IR or a ThermoNicolet IRIOO spectro-
meter. Low resolution electron impact (EO mass spectra were 
recorded on a Kratos MS 25 spectrometer. Chemical ionisation 
(Cl) and high resolution mass spectra were recorded on a 
Micromass Autospec spectrometer. Flash column chromato-
graphy was carried out using Matrex silica gel 60 (70-200) 
or Brockmann grade I neutral alumina, deactivated by the 
addition of 6 wt% H 10. The a-hydroxy ketones Ib, ld and lf 
were synthesised from the corresponding methyl ketones using 
the method reported by Moriarty er a/. 13 All other reagents 
were purchased from commercial sources and used without 
further purification. Activated Mn02 was purchased from 
Aldrich chemical company, catalogue number 21,764-6. PE 
refers to petroleum ether (boiling point 40-60 °C). 
Representative procedure for quinoxalines 4 
2-i\llethylquinoxaline 4a. To a solulion or (I-hydroxyacctone 
Ia (0.50 mmol, 0.037 g) in dry CH 2Cl1 (25 mL) was added 
sequentially a-phenylenediamine 2a (1.00 mmol, 0.108 g), 
powdered 4 A molecular sieves (0.50 g) and activated MnO; 
(5.00 mmo!. 0.435 g) and the mixture heated to reflux. After 45 
min, TLC showed the reaction to be complete. The reaction 
mixture was cooled to RT, filtered through Cellte® and the 
solid residues washed well with CH1Cl2. The solvent was 
removed in mcuo and the product purified by column chrom-
atography (2 : I PE : EtOAc) to give the title compound 4a 
{0.056 g, 79%) as an orange oil: Rr 0.23 (2 : 1 PE: EtOAc); v .. ,... 
(film) 1560, 1492, 1435, 1409, 1369 em '; "" (270 MHz; 2.78 
(3 H, s, CH,), 7.65-7.75 (2 H, m, H-6.7). 7.98-8.03 (2 H, m, 
H-5,8), 3.72 (I H, s, H-3); ml::. (EI) 144 (M < ). Data consistent 
with literature values. 11" 
2-Cyclohexylquinoxaline 4b. Prepared by the procedure given 
for 4a using 1-cydohexyl-2-hydroxyethanone Ib 13 (0.50 mmol, 
0.106 g) and a-phenylenediamine 2a ( 1.00 mmo!, 0.108 g). 
Purified by column chromatography (2: 1 PE : EtOAc) to give 
the title compound 4b (0.083 g, 78%) as a brown solid: Rr 0.63 
(2: I PE: EtOAc); mp46 °C(lit'' 48 °C}; vm, (film) !559, 1490, 
1445, 1364 em ': "" (270 MHz) 1.32-1.94 (10 H, m. 
H-2' .]',4',5' ,6'), 2.84 (I H, tt, J 11.8 Hz, J 3.1 Hz, H-1'), 7.62 
(2 H, m, H-6,7), 1.97 (2 H, m, H-5,8), 3.67 (I H, s, H-3); ml: 
{CI) 21 J (MH' ). Data consistent with literature values. 1111 
2-Phenylquinoxaline 4c. Prepared by the procedure given for 
4a using a-hydroxyacetophenone lc (0.50 rnmol, 0.068 g) and 
~~ Org. Biomol. Chern., 2004,2, 788-796 
o-phenylenediamine 2a (1.00 mmol, 0.108 g). Purified by 
column chromatography (3 I PE : EtOAc) to give the title 
compound 4c (0.08 I g, 79(Y.,) as an orange solid: Rr 0.32 (J ; 1 
PE: EtOAc); mp 81 oc (lit'" 79-30 oq; 'm., (film) 1619, 1577, 
1560, 1531, 1492, 1436, 1410, 1374 em ': ,jH (270 MHz) 
7.49-7.75 (3 H, m, H-3',4',5'), 7.77-7.81 (2 H, m, H-1',6'), 8.10 
(2 H, m, H-6.7). 8.19 (2 H, m, H-5,8), 9.45 (I H, s, H-3); ml: 
(EI) 206 (M ').Data consistent with literature values.. 1k 
2-(2-Furanyl)quinoxaline 4d. Prepared by the procedure given 
for 4a using 1-(2-furanyl)-2-hydroxyethanone Hi 13 (0.50 mmol, 
0.063 g) and a-phenylenediamine 2a (1.00 mmol, 0.108 g). 
Purified by column chromatography (2: I PE: EtOAc) to give 
the title compound 4d (0.041 g, 89%) as an orange solid: R, 0.55 
(2: I PE: EtOAc): mp 101 oc (lit. 1H JO] °C): J'n•~· (!ilm) 1612. 
1536, 1560, I 552, 1496, 1459 em '; ''" (270 M Hz) 6.58 (I H, dd, 
J 3.2 Hz, J 1.9 Hz, H-4'), 7.31 (I H, d, J 3.2 Hz, H-3'), 7.64 
(2 H, m, H-6,7), 7.63 (I H, d, J 1.9 Hz, H-5'), 8.03 (2 H, m, 
H-5,8), 8.03 (I H, s, H-3); mlc (El) 196 (M '). Data consistent 
with literature values. 1tc 
2,3-Diphenylquinoxaline 4e. Prepared by the procedure given 
fOr 4a using benzoin le (0.50 mmol. 0.106 g) and a-phenyl-
enediamine 2a ( 1.00 mtnol, 0. !08 g). Purified by column 
chromatography (9 : I PE : EtOAc) to give the title compound 
4e (0.106 g, 75°/r,) as a white solid: R,0.25 (9: I PE: EtOAc); mp 
128"C (lit.'" 125°C); '~,(film) 1558, 1477, 1441,1395 em'; 
,j" (270 MHz) 7.33-7.39 (6 H, m, H-3',4',5'.3",4",5"), 7.50-7.54 
(4 H, m, H-2',6',2",6"), 7.72 (2 H, m, H-6,7), 8.08 (2 H, m, 
H-5,8); ml: (El) 282 (M 'l Data consistent with literature 
va!ues. 11 d 
2-Phenyl-6,7-dimethylquinoxaline 4f. Prepared by the 
procedure given for 4a using a-hydroxyacetophenone lc 
(0.50 mmol, 0.068 g) and 4,5-dimethyl-1,2-phenylenediamine 
2b ( 1.00 mmol, 0.136 g). Purifi"ed by column chromatography 
{3 : l PE: EtOAc) to give the title compound 4f (0.077 g, 66%) 
as an orange solid: Rr 0.48 (3 : I PE : EtOAc); mp 120 °C (Iit. 2< 
124 'C); 'm"' (film) 1533, 1485, 1449 em '; ''" (270 MHz) 2.51 
(6 H, s, 2 x CH,), 7.50-7.56 (3 H, m, H-3',4',5'), 7.33 (2 H, m, 
H-1',6'), 8.16 (2 H, m, H-5,8), 9.22 (I H, s, H-3); ml: (El) 234 
(M ').Data consistent with literature values.1~ 
2-Cyclohexyl-6,7-dimethylquinoxaline 4g. Prepared by the 
procedure given for 4a using 1-cyclohexy!-2-hydroxyethanone 
lbll (0.50 mmol, 0.106 gj and 4,5-dimethyl-!,2-phenylene-
diarnine 2b ( !.00 mmol, 0.136 g). Purified by column chromato-
graphy (4 · l PE: EtOAc) to give the title compound 4g (0.107 g, 
89%) as an orange solid: R( 0.40 (4: I PE: EtOAc); mp 66 oc; 
vm,. (film) 1542, 1485, 1454, 1369 em ': ,jH (270 MHz) 1.32-1.94 
(10 H. m, 11-2',3',4',5',6'), 2.90 (I H, tt, J 11.9 Hz, J 3.3 Hz, 
H-1'), 2.40 (6 H, s), 7.72 (2 H, m, H-5,8), 8.59 (I H, s, H-3); 
Oc (68 MHz) 20.2, 20.3, 25.8, 26.4, 32.3, 45.0, 128.1 (x2), 139.1, 
140.2, 140.3, 141.0, 143.9, 160.1; mh (CI) 241 (MWJ [HRMS 
(CD calcd. for C"H,N, 241.1705. Found 241.1703 (0.9 ppm 
error)]. 
2-Pentyl-6,7-dimethylquinoxaline 4h. Prepared by the 
procedure given for 4a using 1- hydroxypentan-2-one lf13 
(0.50 mmol, 0.065 g) and 4,5-dimethyl-1,2-phenylenediamine 
2b (1.00 =ol, 0.136 g). Purified by column chromatography 
(2: 1 PE: EtOAc) to give the title compound 4h (0.071 g, 62%) 
as an orange oil: R,0.58 (2: 1 PE: EtOAc); '=• (film) 1628, 
1552, 1488,1464, 1362 em·'; oH (270 MHz) 0.82 (3 H, t, 16.8 
Hz, H-5'), 1.32-1.37 (6 H, m, H-2',3' ,4'), 2.40 (6 H, s, 2 x CH,), 
2.90 (2 H, m, H-1 '), 7.72 (2 H, m, H-5,8), 8.57 (1 H, s, H-3); 
Jc(68 MHz) 14.6, 20.9, 23.1, 30.0, 30.3, 32.2, 37.0, 128.5, 128.8, 
139.9, 140.7, 141.0, 141.7, 145.5, 157.3; mh (Cl) 229 (MW) 
[HRMS (CD calcd. for C,H,N, 229.1705. Found 229.1699 
(2.6 ppm error)]. 
2-13-Methylpyrido[2,3-b]pyrazine 4i. Prepared by the 
procedure given for 4a using a-hydroxyacetone la (0.50 mmol, 
0.034 mL) and 2,3..ctiaminopyridine 2c (1.00 mmol, 0.109 gj. 
Purified by column chromatography (19; 1 CH2C12 : MeOH) to 
give the title compound 4i (0.048 g, 66%), a white solid, as 
a mixture of regioisomers (~7 1 3-methyJ 2-methyl as 
determined by 'H NMR spectroscopy): R,0.27 (I9: 1 CH,CI,: 
MeOH); JH (270 MHz) 3-methy/pyrido[2.3-bjpymzine 2.80 
(3 H, s, CH,), 7.61 (1 H, dd, J 8.2 Hz, 13.4 Hz, H-7), 8.37 (1 H, 
dd, J 8.2 Hz, J 1.7 Hz, H-8), 8.77 (1 H, s, H-2), 9.07 (I H, dd, 
J 3.4 Hz, J 1.7 Hz, H-6); 2-methylpyrido[2,3-bjpyrazine 2.76 
(3 H. s, CH,), 7.64 (1 H, m, H-7), 8.31 (1 H, dd, J 8.5 Hz, J 1.7 
Hz, H-8), 8.90 (1 H, s, H-3), 9.07 (1 H, m, H-6); Oc (68 MHz) 
3-methy/pyrido[2.3-bjpyrazine 22.9, 124.5, 136.0. 138.2, 147.2, 
150.7, 154.0, 157.7; mlz (Ef) 145 (M') [HRMS (EI) calcd. for 
C,H,N, 145.0640. Found I45.0639 (0.5 ppm error)]. The data 
for 2-methylpyridof2,3-bjpyrazine were consistent with those 
reported in the literature. !l .. 
2-13-Pheoylpyrido[2,3-b]pyrazine 4j. Prepared by the 
procedure given for 4a using a-hydroxyacetophenone lc 
(0.50 mmol, 0.068 g) and 1,3-diaminopyridine 2c (l.OO mmol, 
0.109 g). Purified by column chromatography (EtOAc; to 
give the title compound 4j (0.072 g, 69%), a yellow solid, as 
a mixture of regioisomers (-2 1 3-phenyl 2-phenyl as 
determined by 1H NMR spectroscopy): Rr 0.34 (EtOAc); 
,jH (270 MHz) 3-phenylpyrido[2.3-bjpyrazine 7.48-7.57 (3 H, m, 
H-3',4',5'), 7.65 (1 H, dd, J 8.3 Hz, J 4.1 Hz, H-7), 8.26--8.31 
(2 H, rn, H-1' ,6'), 8.43 (1 H, dd, J 8.3 Hz, J 1.5 Hz, H-8), 9. I 4 
:1 H, dd, J 4.1 Hz, J 1.5 Hz, H-6), 9.4I (1 H, s, H-2); 2-phenyl-
'yrido[2,3-bjpyrazine 7.48--7.57 (3 H, m, H-3' ,4' ,5'), 7.69 (1 H, 
ld, J 8. 7 Hz, 13.9 Hz, H-7), 8.15-8.19 (2 H, rn, H-1 ',6'), 8.46 
1 H, dd, J 8. 7Hz, J 1.5 Hz, H-8), 9.11 (I H, dd, 13.9 Hz, J 1.5 
l.z, H-6), 9.50 (I H, s, H-3); Jc (68 MHz) 3-phenylpyrido[2,3-
']pyrazine 124.8, I28.I, I29.3, I31.9,I35.7, 136.8, !38.2, 144.4, 
50.3, 154.5, 154.7; 2-phenylpyrido[2.3-b}pyrazine 125.7, 127.7, 
29.3, 130.8, 135.9, 137.6, 138.6, 146.3, 150.4, 153.5,158.7;m/: 
3!) 207 (M') [HRMS (EI) calcd. for C,H,N, 207.0796. Found 
07.0796 (0.2 ppm error)]. Data consistent with ilterature 
ilues.2c,Ilf 
Quinoxalin-2-one 4k. Prepared by the procedure given for 
1 using methyl glycolate lg (1.20 mmol, 0.093 mL), 1,2-
Ienylenediarnine 2a (J.OO mmol, 0.108 g) and manganese 
oxide (l 0.0 mmol, 1.043 g). Purified by column chromato-
aphy (EtOAc) to give the title compound 4k (0.052 g, 36%) 
a white solid: R, 0.38 (EtOAc); mp 267-268 oc (lit" 266--
rC); JH (DMSO-d,, 270 MHz) 7.25-7.34 (2 H, m), 7.54 
H, rn), 7.77 (1 H, m), 8.16 (I H, s, H-3); oc (DMSO-d,, 
MHz) 115.6, I23.1, 128.7, 130.6, 131.7, 132.0, 151.5. 154.8; 
z (CI) 147 (MH+). Data consistent with literature va1ues.20 
Representative procedure for dihydropyrazines 6 
2-Phenyl-S,6-dihydropyrazine 6a. To a solution of a-hydroxy-
acetophenone lc (0.50 mmol, 0.068 g) in dry CH2Cl2 (25 mL) 
was added sequentially ethylenediamine Sa (1.00 mmol, 0.07 
mL), powdered 4 A molecular sieves (0.50 g), 2.0 M HCJ in 
Et10 (1.00 mmol, 0.50 mL) and activated Mn02 (5.00 mmol, 
0.435 g) and the mixture heated to reflux. After 90 min, TLC 
showed the reaction to be complete. The reaction mixture was 
cooled to RT, filtered through Ce!ite® and the solid residues 
washed weJJ with CH2Cl 2 . The solvent was removed in vacuo 
and the product purified by column chromatography on neutral 
alumina deactivated with H 20 (6% w/w) (EtOAc to 19 · I 
EtOAc : MeOH) to give first the title compound 6a (0.042 g, 
53%) as a pale yellow oil: Rr 0.50 (EtOAc); v=~ (film) 3057, 
2939,2845, 1627, 1569, 1449,929.766,694 em ';JH (400 MHz) 
3.55~3.62 !2 H, m), 3.65--3.71 (2 H, m), 7.42-7.49 (3 H, m, 
H-3' ,4' ,5'). 7. 79-7.86 (2 H, m, H-I' ,6'), 8.37 (1 H, t, J 1.4 Hz, 
H-3); ,)c (I 00 MHz) 44.8, 44.9, 126.6, 128.8, 130. 7, 135.8, 152.4, 
156.2; mlz !CD 159 (MH') [HRMS (Cl) calcd. for C,,HuN, 
159.0922. Found 159.0920 (1.3 ppm error)]. This was followed 
by N-benzoyi-N -formylethylenediamine 7a (0.026 g, 26%): Rf 
0.12 (EtOAc); vm,. (film) 3064, 1651, 1539, 909, 733 em-•; 
JH (400 MHz) 3.46--3.52 (2 H, m), 3.53-3.60(2 H, m), 7.31 (1 H, 
t, J 6.9 Hz, NH, exchanged in a D 20 shake), 7.34-7.42 (2 H, m, 
H-3',5'), 7.44--7.51 (1 H, m, H-4'), 7.71 (1 H, t, J 4.4 Hz, NR, 
exchanged in a D 20 shake), 7.77-7.82 (2 H, m, H-1',6'), 8.15 
(1 H, s, NCHO); ,\ (100 MHz) 38.5, 40.5, 127.1, 128.6, 131.7, 
133.9, 162.8, 168.7; mlz (CI) 193 (MW), 210 (MNH;) [HRMS 
(CI) calcd. for C,H,N,O, 193.0977. Found 193.0976 (0.5 ppm 
error)]. 
2-Phenyl-4a,5,6,7,8,8a-hexabydoquinoxaline 6b. Prepared by 
the procedure given for 6a using a-hydroxyacetophenone lc 
(0.50 mmol, 0.068 g) and trans- I ,2-diaminocyclohexane 
Sb (0.60 mmol, 0.07 mL). With trans-1,2-diaminocyclohexane 
Sb no HCJ is necessary as the amount of bis-amide formed 
is much lower than for ethylenediamine Sa. The first eluting 
product was the tide compound 6b (0.068 g, 64%) as a pale 
yellow oil: R,O.SO (EtOAc); v~ (film) 293I, 2856,1681,1565, 
1447, 904, 762. 690 em '; JH (400 MHz) 1.22-1.55 (4 H, m), 
1.68-1.88 (2 H, m), 2.29-2.41 (2 H, m), 2.56--2.83 (2 H, rn, 
H-4a.8a), 7.28-7.44 (3 H, m, H-3' ,4' ,5'), 7.70--7.81 (2 H. rn, 
H-1 ',6'), 8.23 (I H, d, J 3.0 Hz, H-3); be (IOO MHz) 25.6, 33.4, 
33.8, 59.0, 59.2, 126.8, 128.9, 130.7, I35.9, 151.9, I56.0; mlz 
iCI) 213 (MH) [HRMS (CD calcd. for C,.H,N, 213.1392. 
Found 213.1384 (3.4 ppm error)]. This was followed by N-
benzoyl-N'-formyl-trans-1,2-diaminocyclohexane 7b (0.017 g, 
14%): R, 0.24 (EtOAc); vm .. (film) 3304, 1665, 1636, I554, 1536, 
1291, 721, 667 em ·•; J" (400 MHz) 1.08-1.39 (4 H, m), 1.72-
1.81 (2 H, m), 1.91-2.14 (2 H, m). 3.81 (2 H, br s, H-1,2), 6.36 
(] H, d, J 3.2 Hz, NH, exchanged in a D,O shake), 6.80 (1 H, d, 
J 3.8 Hz, NH, exchanged in a D,O shake), 7.28-7.45 (3 H, m, 
H-3',4',5'), 7.66-7.75 (2 H, m, H-1',6'), 8.05 (I H, s, NCHO); 
Oc (100 Jvlliz) 24.7, 24.8, 32.3, 32.4, 52.4, 54.5, I27.2, I28.7, 
I31.7, 134.1, 162.1, 168.0; mlz (Cl) 247 (MH') [HRMS (Cl) 
calcd. for C14H 19N:02 247.1447. Found 247.1446 (0.3 ppm 
error)j. 
2-(2-Furanyl)-4a,5,6, 7,8,8a-hexahydoquinoxaline 6c. Pre-
pared by the procedure given for 6a using l-(2-furanyl)-
2-hydroxyethanone ldn (0.22 mmol, 0.028 g) and trans-1,2· 
diaminocyclohexane Sb (0.30 mmol, 0.036 mL). With trcms-1 ,2-
diaminocyclohexane Sb no HCJ is necessary as the amount 
of bis-amide formed is much lower than for ethylenediamine 
Sa. The first eluting product was the title compound 6c (0.028 g, 
64%) as a pale yellow solid: R, 0.38 (EtOAc); mp 124--126 'C; 
'mu (nujol) 1584, 1408, 1297 em '; JH (400 MHz) 1.19--1.60 
(4 H, m), 1.80-1.92 (2 H, m), 2.34--2.49 (2 H, m), 2.67-2.89 
(2 H, m, H-4a,8a), 6.51 (I H, m, H-4'), 6_g9 (I H,m, H-3'), 7.56 
(1 H, s, H-5'), 8.I9 ( 1 H, d, J 2.4 Hz, H-3); be (100 MHz) 25.6, 
25.7, 33.5, 33.8, 58.6, 59.3, 111.9, !13.1, 145.4, 147.5, 150.5; m!~ 
(CI) 203 (MH') [HRMS (CI) caled. for C"H ,N,O 203.1184 
Found 203.1183 (0.5 ppm error)J. This was followed by 
N-furoyi-N' -formyl-trans- 1.2-diaminocyclohexane 7c (0.009 g. 
15%): R,O.I8 (EtOAe); v_, (nlm) 3246, 3048. 1650, 1640, I 575, 
15]8, 13]2 em ';c)" (400 MHz) 1.18-1.45 (4 H, mi. 1.70-1.8.1 
(2 H, m). 2.01-2.18 (2 H, m), 3.75-3.94 (2 H. m, H-1.2). (J.JU 
(I H, d. J 5.8 Hz, NH, exchanged in a 0 20 shake), 6.48 (I H, m. 
H-4' ), 6.64 (I H, d, J 6.7 Hz, NH. exchanged in a 0 20 shake). 
7.07 (I H. m, H-3'), 745 (I H, s, H-5'), 8.10 (I H, s, NCHO): 
r5c (100 MHz) 24.7, 24.9, 32.4, 32.5, 52.9, ~-3.2, 112.2, 114.6, 
144.5, 147.6, 159.2, 161.7; m/: (CI) 237 (MH'! [HRMS (Cl) 
calcd. for C 12 H 17N 20 1 237.1239. Found 237.1240 (0.5 ppm 
error)l. 
2-Cyclohexyl-4a,5,6,7 ,8,8a-hexahydoquinoxaline 6d. Pre-
pared by the procedure given for 6n using 1-cydohexyl-
2-hydroxyethanone Jb 0 (0.25 mmol, 0.036 g) and trans-/,2-
diaminocyclohexane Sb (0.30 mmol, 0.036 mL). With trans-1,2-
diaminocyclohexane Sb no HCJ is necessary as the amount of 
bis-amide formed is much lower than for ethylenediamine Sa. 
The only product isolated was the Iitle compound 6d (0.029 g, 
53%) as a pale yellow oil: Rr 0.43 (EtOAc); ~'rn.u (film) 2930, 
2856, 1587, 1449, 921, 733 em '; cl" (400 MHz) 1.09-1.51 (9 H, 
m), 1.51-1.68 (I H, m), !.70-1.81 (6 H, m), 2.22-2.36 (3 H, m1, 
2.45-2.64 (2 H, m, H-4a,8a), 7.75 (I H, d, J 2.7 Hz, h-3); 
c)c(IOO MHz) 25.6, 25 7, 25.9, 25.9, 26./. 29.3, 30.0, 33.4, 33.8, 
44.7, 58.5, 59.J, 153.2, 163.9; m/: (Cli 219 (MH') [HRMS (CI) 
calcd. for C14 H 23 N1 219.1361. Found 2!9.1854 (3.2 ppm error)]. 
Representative (lrocedure for piperazines 9 
2-Phenylpiperazine 9a. To a solution of a-hydroxy;.tceto-
phenone Ic (0.50 mmol, 0.063 g) in dry CH 1CI2 (25 mL) was 
added sequentially ethylenediamine Sa (!.00 mmol, 0.07 mL), 
powdered 4 A molecular sieves (0.50 g), 2.0 M HCI in Et10 
(1.00 mmol, 0.50 mL), NaBH, (2.00 mmol, 0.076 g) ;md 
activated Mn01 (5.00 mmol, 0.435 g) and the mixture heated to 
retl ux. After 75 min, TLC showed complete conversion to the 
dihydropyrazine. The reaction mixture was cooled to RT and 
MeOH (6 ml) was added. After a further 20 h at RT, the 
nixture was filtered through Celite® and the solid residues 
.vashed well with CH-:.Cl1 . The solvent was removed in mcuo 
tnd the product purified by acid/base extraction to give the title 
·ompotmd 6a (0.042 g, 52%) as a colourless oil: vm~• (film) 3198, 
'.930, 2828, 1650, 1539, 1454, 1326, 1137, 877, 754,699 em '; 
H (400 MHz) 1.95 (2 H, br s, 2 X NH), 2.55-3.16 (6 H, m, 
f-3,5,6), 3.67 (I H, dd, J 15.7 Hz, J 4.0 Hz, H-2). 7.12-7.39 
5 H, m. H-2',3',4',5',6'): clc (I 00 MHz) 46.1, 47.8, 54.3, 62.0, 
27.0, 127.5, 128.5, 142.7; m/c (CI) 163 (MH'J [HRMS (CI) 
1lcd. for C10H 15 N2 163.1235. Found 163.1234 (0.7 ppm error)]. 
2-Phenyl-1 ,2,3,4,4a,5 ,6, 7 ,8,8a-decahydoquinoxaline 9b. Pre-
'Ued by the procedure given for 9a using a-hydroxyaceto-
lenone lc (0.50 mmol, 0.068 g) and trans-1,2-diamino-
'clohexane 50 (0.60 mmol, 0.07 mL) With truns-1,2-
aminocydohe.xane Sb no HCJ was used. Acid/base extraction 
:ve the title co111pound 9b (0.081 g, 75%) as a colourless solid. 
p 82-83 oc: ''• .. (nlm) 3225, 3209, 2855. 2820. 1454, 1333, 
36,755,699,652 em '; c!" (400 MHz) 1.15-1.40 (4 H, m), 
il-1.85 (6 H. m), 2.26--2.48 (2 H, m, H4a,8a), 2.78 (I H, dd. 
11.8 Hz, J 10.4 Hz, f/-3,.,,,), 3.06 (I H, dd, J 11.8 Hz, J 2.9 
~. H-3equawm1), 3.85 (I H, dd, J 10.4 Hz. J 2.9 Hz, H-2axlal), 
7-7.40 (5 H, m, /!-2',3',4',5',6');Jc (100 MHz) 25.0, 25.2, 
0, 32.2, 54.5. 60.4, 62.4, 62.4, 127.0. 127.4, 128.5, 142.7; ml::. 
I) 217 (MH') [HRMS (Cl) calcd. for C,.H,N, 217.1705 
und 217.1698 (3.2 ppm error)]. 
,4-Diacetyl-2-(2-furany/)-1 ,2,3,4,4a,5,6, 7 ,S,Sa-decahydo-
noxaline 9c. Prepared by the procedure given for 9a using 
!-furanyl)-2-hydroxyethanone Jdll (0.25 mmol, 0.032 g) and 
Org. Biomol. Chem., 2004,2, 788-796 
/rans-1,2-diaminocyclohexane Sb (0.30 mmol, 0.036 ml). With 
trans- I ,2-Uiaminocyclohex<tne Sb no HCl was used. After 
filtration, the solvents were removed in vamo and the crude 
mixture taken up in CH 2Cl1 (5 mL). To this was added Et3N (1 ml) and acetyl chloride (1.00 mmol, 0.07 ml) and the 
mixture stirred at RT for 3 h. It was then poured into sat. 
NaHCOJ 115 m L) and extracted with CH 1Cl2 (J x 5 ml). The 
combined organics were dried (MgS04 ), filtered and con-
centrated in vacuo. Purification by column chromatogmphy 
(EtOAc) gci\--e the title compound 9c (0.044 g, 60'Y.,) as a colour-
less oil: Rr 0.14 (EtOAc)~ v"'a' (nUJOI) 1662, 1629, 1411, 1324. 
'1307, 1183. I 144, 751 em 1 ; rJH (270 MHz) 0.94-1.13 (J H, m), 
1.25-154 (3 H, m), 1.57-1.78 (2 H, m), 1.94 (3 H, s, CH,), 2.07 
(3 H, s, Cl-IJ, 2.44-2.83 (I H, m), 2.85 (I H, br d, J I 1.9 Hz), 
3.43 (I H, dt. 12.2 Hz. J 10.8 Hz), 3.72 (I H, dt, 12.6 Hz, J 10.8 
Hz). 3 99 (I H, m), 5.15 (I H, br' H-2), 6.28 (I H, m, H-3'), 
6.33 ( 1 H, m. H-4'), 7.35 (J H, s, H-5'); (5c (68 MHz, toluene-d8 , 
80 T) 22. I, 22.3, 25.6, 25.8, 32.2, 32.6, 47.7, 52.5, 58.0, 58.9, 
108.1, 111.0, 142.2, 154.7, 170.5, 171.7; m/: (Cl) 291 (MH') 
[HRMS (Ci) calcd. for C 16H-:.3 N10 1 291 1710. Found 291.!713 
(1.5 ppm error)J. 
2-Cyclohex yl-1 ,2,3,4,4a,5 ,6, 7 ,S,Sa-decahydoquinoxaline 9d. 
Prepared by the procedure given for 9a using l-cyc!ohexyl-
2-hydroxyethanone Jb n (0.25 mmol, 0.036 g) and trans-1,2-
dlaminocyclohexane Sb (0.30 m mol, 0.036 ml). With trans-! ,2-
diaminocyclohexane Sb no HC! was used. Acid/base extraction 
gave the title compound 9d (0.047 g, 84%) as a colourless solid: 
mp 78-80°C; '•" (film) 3362, 3290, 3226, 1341, 833 em '; 
,)" (400 MHz) 0.85-1 00 (2 H, m), 1.02-1.36 (8 H, m), 1.54--1.82 
(9 H, m), 2.09-2.41 (4 H, m), 2.41-2.51 (2 H, m), 2.99-3.11 
(I H, m); o0 ( 100 MHz) 24.9, 25.1, 26.2, 26.3, 26.5, 29.2, 29.4, 
.11.7, 32.2, 41.3. 50.1. 60.8. 61.4. 61.6: ml= tCI) 223 (MH') 
[HRMS (Cl) calcd. for C 1.H27 N1 223.2174. Found 223.2!67 
(3.2 ppm error-)]. 
Representative procedure for pyrazines 10 
2-Phenylpyrazine 10a. To a solution of a-hydroxyaceto-
phenone Jc (0.50 mmol, 0.068 g) in dry CH1Cf: (25 mL) was 
added sequentially ethylenediamine Sa (LOO mmoJ, 0.07 mL), 
powdered 4 A molecular sieves (0.50 g), 2.0 M HC! in Et20 
( 1.00 mmol, 0.50 mL) and activated Mn02 (5.00 mmol, 0.435 g) 
and the mixture heated to reflux. After 2.5 h, TLC showed 
complete conversion to the dihydropyrazine. The reaction 
rnixtl!re was cooled to RT and -0.4 M KOH in MeOH (5 mL) 
was added. The mixture was returned to reflux for a further 
20 h, then was fdtered through Celite® and the solid residues 
washed well with CH1Cl1 . The solvent was removed in vacuo 
and the product purified by column chromatography on neutral 
alumina deactivated with H::.O (6%, w/w) (3: 1 PE: EtOAc) to 
give the title compound lOa (0.035 g, 45"f.,) as a colourless solid: 
mp 74 "C (lit."o 72 °C); v.,. (film) 2904, 2854, 1728, 1464, 1379, 
1271 em ': ciH (270 MHz) 7.49-7.52 (3 H, m, H-Y,4',5'), 7.98-
8 0412 H, m, H-2',6'), 8.50 (I H, d, J 2.4 Hz, H-6), 8.63 (I H, 
dd, J 2.4 Hz, 'J I 5Hz, H-5), 9.03 (I H, d, 'J 1.5 Hz, H-3); clc 
(IIJOMHz) 127.11.129.2, 130.0, 136.4.142.3. 1430,144.3, 152.9; 
ml~ (C!) 157 (M f I'). Data consistent with literature values. 17" 
2-(4-Bromophenyl)pyrazine lOb. Prepared by the procedure 
given for 6a using 1-(4-bromophenyl)-2-hydroxyethanone lh 
(0.50 mmo!, 0. I 08 g) and ethylenediamine Sa ( J .00 mmol, 0.07 
ml). Column chromatography (3: l PE: EtOAc) gave the title 
compound lOb (0.067 g, 57%) as a yellow oil: Rr0.29 (3: 1 PE · 
EtOAe); '•" (film) 1555, 1470, 1412,1385 em ';JH (400 MHz) 
7.64 (2 H, d, J 8.9 Hz, H-3',5' J, 7.90 (2 H, d, J 8.9 Hz, H-1' ,6'), 
8.53 (I H, s, H-6), 3.63 (I H, s, H-5), 9.04 (I H, s, H-3); J 0 (IOO 
MHzJ 125.2, 1292. 132.9, 135.8, 142.5, 143.7, 144.8, 152.3;m/: 
(CI) 232/234 (MH ') [HRMS (Cl) calcd for C,H,N,"Br 
233.9792. Found ~.\3.9795 ( 1.1 ppm error)]. 
2-{2-Furanyl)pyrazine JOe. Prepared by the procedure given 
for 6a using l-(2-furanyl)-2-hydroxyethanone ld 12 (0.50 mmol. 
0.064 g) and ethylenediamine 5a (l_OQ mmol, 0.07 mL). Column 
chromatography (2. I PE: EtOAc) gave the title compound JOe 
(0.044 g, 60%) as a yellow oil: Rf 0.67 (2 : l PE : EtOAc); I' max 
(film) 1590,1470,1411, 1384cm ';JH(270MHz)6.57(1 H,m, 
H-4'), 7.15 (I H, m, H-3'), 7.60 (I H, rn, H-5'), 8.42 (I H. d, 
12.7 Hz, H-6), 8.53 (I H, d,J 2.7 Hz, H-5), 8.97 I I H, s. H-3);cic 
( 100 MHz) II IJ, 112.9, I 38.3, 141.2, 143.1, 144.7, 145 0, 147.9; 
ml: iCI) 147 IMH') [HRMS (Cl) calcd for C,H,N,O 147.0558. 
Found 147.0558 (0.0 ppm error)). 
2-Phenyl-5,6,7,8-tetrahydoquinoxaline !Od. Prepared by the 
procedure given for 6a using a-hydroxyacetophenone Jc (0.50 
mmol, 0.068 g) and trans-1,2-diaminocyc!ohexane 5b (0.60 
mmol, 0.07 mL). With trans- I ,2-diuminocyclohexane Sb no 
HCI was used. Column chromatography (3. 1 PE: EtOAc) gave 
the title compound JOd (0.069 g, 66%) as a colourless oil: Rr O.J I 
(2. I PE: EtOAc): •· ... (film) 2937, 2861, 1457, 1444. 1380, 
1142,775,694 em ': ci" (270 MHz) 1.78-1.94 (4 H, m, H-6,7), 
2.83-2.98 (4 H. m, H-5,8), 7.29-7.43 (3 H, m, H-3',4',5'), 7.82-
7.91 (2 H, m, H-1',6'), 8.64 (I H, s, /i-3); Jc (68 MHz) 22.7, 
22.7, 31.8, 32.8, 126.8, 129.0, 129.3, 137.0. 138.9, 149.8, 15IJ, 
1524: m/: (CI) 211 (MH') [HRMS (C[) calcd. for C,.H,N, 
211.1235. Found 211.1234 (0. 7 ppm error)]. 
2-(2-Furany/)-5,6,7 ,8-tetrahydoquinoxaline I Oe. Prepared by 
the procedure given for 6a using a-hydroxyacetophenone lc 
(0.50 mmol, 0.068 g) and trans-1,2-diaminocydohexane 5b 
(0.60 mmol, 0.07 mL). With trans- I ,2-diaminocyclohexane Sb 
no HCI was used. Column chromatography (3: I PE: EtOAc) 
gave the title compound 1 Oe (0.069 g, 66o;;,) as a colourless oil: Rr 
0.31 (L I PE: EtOAc); ''m,. (film) 2937. 2861, 1457, 1444, 1380, 
I 142, 775, 694 em '; ''" (270 MHz) 1.78-1.94 (4 H, m, H-6.7), 
2.83-2.98 14 H. m, H-5,8), 7.29-7.43 (3 H, m, H-3',4',5'), 
7.82-7.91 (2 H, m, !1-1',6'), 8.64 (I H, s, H-J): clc (68 .Y!Hz) 
22.7. 22.7, 31.8, 32.8. 126.8, 129.0, 1293. 137.0, 138.9. 1498. 
151.3. 152.4: m/: fCI) 211 (MH'I [HRMS (Cl) calcd for 
C 14H 15 N ~ 211 . 1235. Found 21 J.l2J4 (0. 7 ppm error)]. 
2-Cyclohexylpyrazine !Of. Prepared by the procedure given 
-or 6a using I -cydohexyl-2-hydroxyethanone I b 11 (0.50 mmoJ, 
).!06 g) and ethylenediamine Sa (1.00 mmol, 0.07 mL). Column 
:hromatography {J . 1 PE: EtOAc) gave the title compound 1Df 
0.027 g, 331%) as a yellow oiL Rr 0.38 (3 : I PE: EtOAcJ; vm.a, 
film) 1558, 1441, 1381 em ': JH (400 MHz) 1.32-1.94 (10 H, m. 
{-2' ,3' ,4' ,5' ,6'), 2. 75 (I H. dd, J 11.9 Hz, J2.4 liz. H-I'), 8.37 
I H, s, H-3), 8.39 12 H. m, H-5,6); iic (100 MHz) 25.8. 26.3, 
2.4, 44.0, 142.2. 143.6, 143.9, 161.0: m!: (El) 162 IM 'J [HRMS 
~!) calcd. for CwH 14 N1 162.1157. Found 162.1156 (0.8 ppm 
TOr)). 
I, 17 -Dihydroxy-1 0, 13-dimethyl-17-quinoxa/in-2-yl-
2,6,7,8,9,10,1 I ,12,13,14,15,16,17-tetradecahydocyclopenta-
1phenanthren-3-Qne J 2 
epared by the procedure given for 4a using hydrocortisone li 
20 mmol, 0.072 g) and a-phenylenediamine 2a (0_40 mmol, 
)43 g). Purified by column chromatography (EtOAc) to give 
: rifle compound I 2 (0.058 g, 67%) as an orange solid: Rf 0.50 
tOAc); mp 266-268 °C, ''••• (nujol) 3392, 1638, 1276, 123 I, 
27, 1112, 942. 865, 775 em ': JH (400 MHz) 0.86 (3 H, s, 
l;l, 101 (I H,dd,J 10.7 Hz,J3.1 Hz), 1.08-1.18(1 H.m). 
I (I H, dd, J 14.0 Hz, 12.1 Hz), l.37 (3 H, s, CH,), 1.50-1.64 
H, m). 1.77 (I H, dt. J 4.6 Hz. J 13.4 Hz), 1.86-2.51 (12 H. 
J.04 I I H, dd, J 12.5 Hz, J I 1.9 Hz), 4.41 (I H, s, OH), 4.61 
-I, s. OH), 5.61 II H, s, C=CH), 7.67-7.76 (2 H. m. H-6,7), 
\-8.07 (2 H, m, H-5,8), 9.01 (I H, s, H-3); <lc (100 MHzJ 
), 21.0, 243, 319. 32.2, 32.8, 33.8. 34.9, 35.0, 393, 39.4, 
'51.9. 56.1, 684, 84.8, 122.3, 129.0, 129.1, 129.8, 130.3, 
140.5, 141.2, 143.9, 157.0. 172.7, 199.8: m/: (Cl) 433 iMH'), 
415 (MH' ~ H,O) [HRMS (Cl) calcd. !Or CnH 13 N10J 
433.249 J Found 433.2497 ( 1.3 ppm error)}. 
I 7-(5,6-Dihydropyrazin-2-y 1)-ll, J 7 -dihydroxy- I 0, 13-dimethyl-
1 ,2,6, 7,8,9, 10, II ,12,13,14,15,1 6, 17-tetradecahydrocyclopenta-
[a]phenanthren-3-one 13 
Prepared by the procedure given for 6a using hydrocortisone li 
(0.20 mmc•J, 0.072 g) and ethylenediamine Sa (0.40 mmol, 0.027 
rrJL)_ Purified by column chromatography (25 l to 15 : J 
CH 2CI". MeOH) to g1ve the title compound l3 (0.030 g, 4011<,) as 
the only isolated product, a pale yellow solid: Rr 0.24 (9 : I 
CH,CI,: MeOH): mp I 30-132 oC; ''m,. (nuJOI) 3404, 1659, 1615, 
1590,1276, i233, 1189, 1119,950.926,868cm 1:0H(400MHz) 
096(3H,s,CH,), 1.01-104(1 H,m), 1.06-1.21 (I H,m), 1.42 
13 H,s,CH,J, 1.34-1.52(3 H,m). 1.54--1.65(1 H,m), 1.71-1.95 
(3 H, m). 1.96-2.09 (3 H, m), 2.12-2.28 (2 H, m), 2.33 (I H, m), 
2.39-2.53 !2 H, m), 2.73 (I H. m), 3.34-3.55 (4 H, m, DHP), 
l .87 (I H, br s, OH), 4.43 (I H, br s, OH), 5.66 (I H, s. C~CH), 
8.11 (I H,u,J 1.5 Hz. •mme);<ic (100 MHz) 18.5,21.1, 24.2, 
31 .5, 32.2, 32.8. 33.5, 33.9, 35.1, 39.3, 39.9, 43.9, 44.5, 48.5, 
51.7,56.1,68.5,84.7, 122.4, 152.6, 162.2, 172.4, 199.7:m/:(C[) 
385 (MH') [HRMS (Cl) calcd. for C,H,N,O, 385.2491. 
Found 385.2489 (0.5 ppm error)]. 
17-(4a,5,6,7 ,8,8a-Hexahydroquinoxalin-2-yl)-ll ,17-dihydroxy-
1 0,13-dimethyl-1 ,2,6,7 ,8.,9,10,11 ,12,13, 14, 15,16,17-tetradeca-
hydrocyclopenta[a}phenanthren-3-one 14 , 
Prepared by !he procedure given for 6a using hydrocortisone 1i 
(0.20 mmol, 0.072 g) and zrans-1,2-diaminocyc!ohexane Sb 
(0.24 mmo!, 0.028 mL). Purified by column chromatography 
(EtOAc to 19 l EtOAc : MeOH) to give the title compound 
14 (0.072 g, 82'Yr,) as an inseparable mixture of diastereomers 
r-1 l A: BJ. a colourless solid: Rr 0.19 (EtOAc); mp 123-
i 25 T; 'm., (nujol) 3393, [ 658, [ 615, I 584, 1233, 1118, 915, 730 
em ': ,)" (400 •vi Hz) 0.88 (3 H, s, CH,A), 0.93 (3 H, s, CH,B), 
0.94-1.00 (I H. m, A+ B), 1.02-1.18 (I H, m, A+ 8), 1.24--
1.57 (6 H, m, A + B), 1.19 (1 H, s, CH,A + B), 1.60-2.06 (II H, 
m.A + B),2.08-2.82(10H.m,A + B),J.68(1 H,brs,OH,A), 
4.3911 H,brs,OH,A + 8),4.52(1 H, brs.OH,B),562(1 H,s, 
C~CH A + B), 7.98 (I H, d, J 2.8 Hz, imine A), 8.04 (I H, d, 
J 2.7 Hz, •mine B); clc (100 MHz) 18.4/18.5 (CH,), 21.0/21.1 
(CH,), 24.0/24.3 (CH,), 25.4/25.5 (CH,), 25.5/25.5 (CH,), 31.4/ 
31.5 (CH), 32.2 (CH,), 32.7/32.8 ICH,), 32.9/33.7 (CH,), 33.0/ 
331 iCH,), 335133.5 (CH,), 33.8 (CH,), 34.9 (CH,), 39.2/39.3 
(C), 39.5/40.0 (CH,), 48.0/48.9 (C), 51.5/51.6 (CH), 56.1/56.1 
(CH), 58.1/58.3 iCH), 58.8/59.1 (CH), 68.2168.3 (CH), 84.1/84.5 
(C), 122.21122.3 iCH), 15151152.4 (CH), 161.711618 (C), 
17:2_6/l72.7 (C), 199.71!99_7 (C) [The pairs of signals were 
tentatively <ISsigned due to their similar chemical shift and type; 
however. this is by no means a definitive assignation]; m/: (CI) 
439 (MH') [HR.YIS iCI) calcd. for C,H,N,O, 439.2961. 
Found 439.2967 ( i A ppm error)}. 
11, 17-Dihydroxy-1 0,1 3-dimethyl-17-piperazin-2-yl-1 ,2,6,7 ,8,9 ,-
1 0, II, 12, I 3, 14,1 5, 16,17-tetradecahydocyclopenta[a]phenan-
thren-3-one 15 
Prepared by the procedure given lOr 9a using hydrocortisone lg 
(0.20 mmol. 0.072. g) and ethylenediamine Sa (0.40 mmol, 0.027 
mL). Acid/base extraction gave the title compound 15 (0.054 g, 
69'1(,) as <1 colourless solid: mp 104-106 "'C vn,, .. (CH 2Cl 2) 3445, 
)053. 2934, 1661, 1451, 1266. II 33, 909, 738, 704 ern ': o" (400 
Mfiz) 0.73-3.16 (28 H, m), 102 (3 H, s, CH,), 1.40 (3 H, s, 
CH,). 4.33 I I H, br s. OH). 5.63 (I H, s, C=CH): clc (100M Hz) 
169, 21.1, 23.4, JIJ, 32.3, 32.7, 33.9, 35.0, 37.3, )9.3, 41.5, 
45.5, 45.8, 46.6, 46.9. 52.1, 56.0, 61.5, 68.2, 83.6, 122.2, 173.0, 
199.9: m/: (Cl) 389 iMH ') [HRMS (C[) calcd. for C,H,N,O, 
389.2804. Found 389.2807 (0.8 ppm error)]. 
Org. Biomol. Chem., 2004,2,788-796 1M: 
ecahydroquinoxalin-2-yl)-11, 17-dihydroxy-1 O, 13-dimethy1-
7,8,9,10,11,12, 13,14,15, 16, 17-tetradecahydrocydopenta-
·nanthren-3-one 16 
red by the procedure given for 9a using hydrocortisone Jg 
mmo1, 0.072 g) and /rans-1,2-diaminocyclohexane Sb 
nmo!, 0.028 mL). With trans-1,2-diaminocyc!ohexane Sb 
:1 was used. Acid/base extraction gave the title compound 
.077 g, 89%) as a mixture of several diastereomers 
own by 1H and 13 C NMR spectroscopy), a colourless 
mp 112-113 oc ,_, (nujol) 3429,2870,2727,1657, 1461, 
749 em '; ml= (C[) 443 (MH') [HRMS (CI) calcd. for 
3N 20 3 443.3274. Found 443.3275 (0.4 ppm error)]. 
Dihydroxy-1 0, 13-dimethyl-17 -pyrazin-2-yl-
7,8,9,10, 11,12,13,14,15, 16, 17-tetradecahydocyclo-
a}phenanthren-3-one 17 
red by the procedure given for lOa using hydrocortisone 
20 mmo1, 0.072 g) and ethylenediamine Sa (0.40 mmo1, 
mL). Column chromatography (EtOAc to 4 : 1 EtOAc : 
-{)gave the tirle compound 17 (0.008 g, lQ'Y,,) as a co1our-
Jiid R, 034 (9 I CH,CI, EtOAc); mp 185-190oC 
np.); ~'mu (nujol) 3455, 2953, 1642, 1614, 1234, 1157, 
1915, 859 em '; .5" (400 MHz) 0.84 (J H, s, CH,), 1.08 (I 
, I.IJ-U4 (l H, m), 1.43 (J H, s, CH,), 1.50-1.64 (2 H, 
81-2.12 (6 H, m), 2.12-2.21 (I H, m), 2.23-2.30 (I H, m), 
'.40 (I H, m), 2.42-2.57 (2 H, m), 2.82 (I H, m), 4.18 (I H, 
lH), 4.49 (I H, br d, 11.8 Hz, OH), 5.70 (I H, s, C=CH), 
Z H, br s, H-pyraz.), 8.82 (I H, s, H-pyraz.); rlc( 100 MHz) 
21.2, 24.3, 32.2, 32.4, 33.0, 34.1, 35.0, 35.2, 39.5, 39.6, 
51.8, 56.], 68.8, 84.4, 122.6, 142.6, 143.1, 14] J, 157.2, 
199.8; ml: (CI) J8J (M H' J [HRMS (CI) calcd. for 
1N20 3 38:1.2321. Found 383 . .2331 (2.6 ppm error)]. 
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reparation of 2-Substituted Benzimidazoles and Related Heterocycles 
lirectly from Activated Alcohols Using TOP Methodology 
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liversity of York, Heslington, York, UK, YOlO SOD, l_IK 
x +44( 1904)434523; E-mail: 1jkt I @ynrk.ac.uk 
cei1•ed 3 March 2004 
•stract: A one-pot procedure for preparing 2-substitutcd benzim-
lzoles directly from activated alcohols in good to excellent yields 
ng a new Tandem Oxidation Process (TOP) is reported. The use 
this methodology to prepare 2-substitutcd benzoxazoles and 2-
)Stituted bcnzothiazoles is also described. 
~y words: 2-substituted benzimidazoles, 2-substitutcd bcnzox-
Jlcs, 2-substituted bcnzothiazoles, tandem oxidation procedure, 
e-pot 
Substituted benzimidazoles and their derivatives have 
en shown to exhibit fungicide, antitumour, immuno-
ppressant and anti-convulsant properties,1 and have re-
ntly been prepared as ligands for asymmetric catalysis.1 
1ere are many methods available for the synthesis of 
~se heterocycles, 1 although reaction of 1,2-phenylene-
:tmines with carbonyl reagents is one of the most impor-
n.1·-5 For example, condensation of 1,2-phenyl-
ediamines with carboxylic acids or derivatives in the 
~sence of polyphosphoric acid at 170----180 oc gives a 
1ge of 2-arylbenzimidazoles.3 More recently, polymer-
und esters have been treated with 1,2-phenylenedi-
lines and a Lewis acid in refluxing toluene in a solid-
pported route to benzimidazoles.4 As is evident from 
!Se examples, such transformations often require harsh 
nditions. An alternative approach utilises aldehydes, or 
rivatives, as the condensation partner with 1,2-phe-
lenediamines, followed by aromatisation of the inter-
!diate dihydrobenzimidazole. 2.5 In addition, there is one 
)Ort of the direct preparation of 2-substituted benzimi-
zoles from alcohols; Watanabe et al. prepared 2-substi-
ed benzimidazoles by the ruthenium-catalysed reaction 
1,2-phenylenediamines with alcohols which presum-
1eme 1 
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ably proceed by way of the corresponding aldehyde gen-
erated in situ.6 Again, very high temperatures (200 °C) 
and autoclave conditions were required. 
We have recently designed a range of transformations 
hased on manganese dioxide-mediated tandem oxidation 
processes (TOPs) of primary alcohols. 7·8 The resulting al-
dehydes have been trapped in situ with a range of Wittig 
reagents and amines. 7 Recently, this methodology has 
been extended to enable quinoxalines and related hetero-
cycles to be prepared directly from a-hydroxy ketones and 
1,2-diamines.8 We therefore decided to investigate the 
one-pot preparation 2-substituted benzimidazoles using a 
TOP method. Thus, the aim was to commence with anal-
cohol and carry out in situ the oxidation-double conden-
sation-aromatisation as shown in Scheme 1. The use of 
manganese dioxide to convert dihydrobenzimidazoles 
into benzimidazolcs has been previously reported. 2•9 
Initial studies were carried out using benzyl alcohol and 4 
equivalents of N-methyl 1,2-phenylenediamine in the 
presence of 15 equivalents of activated manganese diox-
ide in dichloromethane at reflux for 18 hours. We were 
delighted to obtain the desired 1-methyl-2-pheny !benzim-
idazole (la) in 35(1c yield. Carrying out the reaction in 
hcnzene improved the yield to 54% and changing to tolu-
ene resulted a further increase in yield to 78%. We then 
added various amounts of 2 M HCI in diethyl ether to as-
sist the condensation and found that addition of 15 mol% 
HCl with 2.5 equivalents of N-methyl 1,2-phenylenedi-
amine in toluene at retlux gave 1-methyl-2-phenylhenz~ 
imidazole (la) in an excellent yield (90%). 10 The 
methodology is simple and the spent oxidant is easily 




CH2C12, !l, 35% 
PhH, .'..54% 
PhMe. \, 78~'0 
PhMe.HCI, ."., 90'\ 
ETTER Preparation of 2-Substituted Benzimidazoles and Related Heterocycles 1629 
aving completed this optimisation study, we proceeded 
investigate the TOP sequence on a range of alcohols us-
g N-methyl 1,2-phenylenediamine (Table 1, entries i-
































ix). Thus, the same conditions gave reasonable yields (56--
65%) of the 2-substituted benzimidazoles (I b--<1) derived 
from p-methoxy, p-bromo and p-nitro-benzyl alcohols 











ith manganese dioxide ( 15 equiv), N-methyl or N-phenyl I ,2-phenylenediamine (2.5 equiv), 15 mol% HCI (w .r.t diamine) and 4 A mol 
'es, in toluene at 105 oc for 18 h. 
IJ products are known and gave data consistent with literature values 
J product was obtained after 18 h re11ux as above 
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PhMe . .1. 18 h 
:ntries ii-iv). This demonstrates that the TOP sequence is 
)plicable to 'neutral', electron rich and electron deficient 
~nzylic systems. Naphthalene-1-methanol also under-
ent the TOP sequence smoothly to give benzimidazole 
e, as did pyridine-3-methanol giving 1f (entries v and vi, 
·spectively). Next, propargylic and ally lie alcohols were 
(amined (entries vii and viii). In these cases, although 
1e desired products lg and lh were obtained, the yields 
ere lower, possibly due to the formation of Michael-ad-
Jets. An unactivated alcohol was also examined (entry 
), but conversion into the anticipated heterocyclic sys-
m was not observed in the usual reaction time period. Pi-
lily, we went on to determine the scope of this reaction 
1th respect to the dmmine. Thus, N-phenyl 1,2-phe-
(!enediamine and benzyl alcohol gave the corresponding 
onzimidazole li in 76% yield (entry x), although at-
mpts to use I ,2-phenylenediamine itself were unsuc-
:ssful. It therefore seems as if this methodology is ideal 
r preparing 1-alkylated-2-substituted benzimidazoles 
Jm activated alcohols but not for the direct preparation 
·the corresponding parent lH-benzimidazoles. 
'e briefly explored the use of aliphatic diamines, which 
ould lead to imidazolidine!imidazoline/imidazole de-
;atives. With N-methyl- and N-phenyl-ethylenediamine, 
:nzyl alcohol and manganese dioxide, the reaction gave 
mixture (ca. 70'il.) of !-methyl- and 1-pheoyl-2-phe-
'limidazolidine and the corresponding ring-opened im-
es, 11 but further dehydrogenation was not observed. 
nally, when the N-substituted 1,2-phenylenediamine 
1s replaced by 2-aminophenol or 2-aminothiophenol in 
e reaction with benzyl alcohol, the desired benzoxazole 
md benzothiazole 3 were produced in good, though un-
~timised, isolated yields (Scheme 2). These results indi-
te such TOPs should be of general utility for the 
nthesis of these types of heterocyclic systems, as long as 
:; 2-substituent is derived from an activated alcohol. 
summary, we have developed a simple method for the 
nversion of a range of activated alcohols directly into 2-
bstituted benzimidazoles and analogous heterocycles 
a TOP sequence involving oxidation-double conden-
tion-aromatisation. We are currently applying this 
~thodolgy and extending it to other heterocydic sys-
ns. 
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(I 0) Representative Experimental Procedure 
Activated manganese dioxide (Aldrich 21764-6, 0.653 g, 
7.50 mmnl) was added to a mixture of benzyl alcohol (0.054 
g, 0.50 mmol), N-methyl I ,2-phenylenediamine (0.15 mL, 
1.25 mmol), HCI in Etp (2M, 0.04 mL, 15 moJo/c) and 4 A 
molecular sieve~ (0.5 g) in dry toluene ( 12 mL). The mixture 
was stirn:d at I 05 oc for 18 h. The mixture was cooled to ca. 
50 oc. hot filtered through Celite®, and the residue washed 
with excess CH 2Cl2. The combined organic fractions were 
concentrated in vacuo and the residue purified using column 
chromatography on silica (petroleum ethcr-EtOAc, 3: I) to 
give 1-methyl-2-phenylbenzimidazolc ( Ia, 0.094 g, 90l'!v) as 
a brown solid, R1 = 0.3 (petroleum ether-EtOAc. 2:1 ): mp 
96 oe, lit. 12 mp 94-95 uc. The spectroscopic data obtained 
were consistent with those reported in the hteraturc. 12 
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